|
G |
A2M |
alpha-2-macroglobulin |
increases expression |
ISO |
Isoproterenol results in increased expression of A2M mRNA |
CTD |
PMID:21335049 |
|
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
|
|
G |
ABCA1 |
ATP binding cassette subfamily A member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ABCA1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ABCB1A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
ISO EXP |
Isoproterenol results in decreased expression of ABCB4 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
|
|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
decreases expression increases expression |
ISO EXP |
Isoproterenol results in decreased expression of ABCC3 mRNA Isoproterenol results in increased expression of ABCC3 mRNA |
CTD |
PMID:21335049 PMID:24286936 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 (PEL blood group) |
increases expression |
ISO |
Isoproterenol results in increased expression of ABCC4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 (JR blood group) |
increases expression |
ISO |
Isoproterenol results in increased expression of ABCG2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
|
|
G |
ABHD2 |
abhydrolase domain containing 2, acylglycerol lipase |
increases expression |
ISO |
Isoproterenol results in increased expression of ABHD2 mRNA |
CTD |
PMID:20211217 |
|
NCBI chr15:89,040,998...89,202,355
Ensembl chr15:89,087,459...89,202,355
|
|
G |
ABHD4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
Isoproterenol results in increased expression of ABHD4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:22,598,300...22,612,963
Ensembl chr14:22,598,290...22,612,963
|
|
G |
ABI3 |
ABI family member 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of ABI3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:49,210,707...49,223,225
Ensembl chr17:49,210,411...49,223,225
|
|
G |
ABLIM3 |
actin binding LIM protein family member 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of ABLIM3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:149,141,493...149,260,542
Ensembl chr 5:149,141,483...149,260,542
|
|
G |
ACACA |
acetyl-CoA carboxylase alpha |
multiple interactions decreases phosphorylation increases phosphorylation |
ISO |
triacsin C inhibits the reaction [Isoproterenol results in increased phosphorylation of ACACA protein] Isoproterenol results in decreased phosphorylation of ACACA protein |
CTD |
PMID:18390901 PMID:27491814 |
|
NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
|
|
G |
ACADL |
acyl-CoA dehydrogenase long chain |
multiple interactions decreases expression |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADL mRNA; Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADL mRNA]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADL mRNA]] |
CTD |
PMID:25045214 PMID:30303030 |
|
NCBI chr 2:210,187,923...210,225,447
Ensembl chr 2:210,187,126...210,225,447
|
|
G |
ACADM |
acyl-CoA dehydrogenase medium chain |
decreases activity multiple interactions decreases expression |
ISO |
Isoproterenol results in decreased activity of ACADM protein [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADM mRNA; Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADM mRNA]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADM mRNA]] |
CTD |
PMID:19826179 PMID:25045214 PMID:30303030 |
|
NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575
|
|
G |
ACADS |
acyl-CoA dehydrogenase short chain |
multiple interactions decreases expression |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADS mRNA Isoproterenol results in decreased expression of ACADS mRNA |
CTD |
PMID:30303030 |
|
NCBI chr12:120,725,826...120,740,008
Ensembl chr12:120,725,774...120,740,008
|
|
G |
ACADVL |
acyl-CoA dehydrogenase very long chain |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of ACADVL mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADVL mRNA |
CTD |
PMID:30303030 |
|
NCBI chr17:7,217,125...7,225,266
Ensembl chr17:7,217,125...7,225,266
|
|
G |
ACE |
angiotensin I converting enzyme |
multiple interactions increases activity |
ISO |
oleuropein inhibits the reaction [Isoproterenol results in increased activity of ACE protein] |
CTD |
PMID:26056852 |
|
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
ACE2 |
angiotensin converting enzyme 2 |
increases expression decreases activity multiple interactions |
ISO |
Isoproterenol results in increased expression of ACE2 mRNA Isoproterenol results in decreased activity of ACE2 protein [Isoproterenol results in decreased activity of ACE2 protein] which results in decreased abundance of angiotensin I (1-7); xanthone inhibits the reaction [[Isoproterenol results in decreased activity of ACE2 protein] which results in decreased abundance of angiotensin I (1-7)]; xanthone inhibits the reaction [Isoproterenol results in decreased activity of ACE2 protein] Isoproterenol results in increased expression of ACE2 protein |
CTD |
PMID:20003209 PMID:20409916 PMID:36414029 |
|
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
|
|
G |
ACER2 |
alkaline ceramidase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of ACER2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:19,409,009...19,452,505
Ensembl chr 9:19,409,009...19,452,505
|
|
G |
ACSL1 |
acyl-CoA synthetase long chain family member 1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of ACSL1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
|
|
G |
ACTA1 |
actin alpha 1, skeletal muscle |
multiple interactions |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of ACTA1 mRNA; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of ACTA1 mRNA] |
CTD |
PMID:10710348 |
|
NCBI chr 1:229,431,245...229,434,094
Ensembl chr 1:229,430,365...229,434,104
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions increases expression decreases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in decreased expression of ACTA2 mRNA] Glyburide promotes the reaction [Isoproterenol results in increased expression of ACTA2 protein]; pyrvinium inhibits the reaction [Glyburide promotes the reaction [Isoproterenol results in increased expression of ACTA2 protein]]; pyrvinium inhibits the reaction [Isoproterenol results in increased expression of ACTA2 protein]; xanthone inhibits the reaction [Isoproterenol results in increased expression of ACTA2 protein] Isoproterenol results in increased expression of ACTA2 mRNA; Isoproterenol results in increased expression of ACTA2 protein |
CTD |
PMID:18089841 PMID:20003209 PMID:24945829 PMID:28526319 PMID:35305975 PMID:36414029 More...
|
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
|
|
G |
ACTB |
actin beta |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ACTB mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
|
|
G |
ACTG2 |
actin gamma 2, smooth muscle |
increases expression |
ISO |
Isoproterenol results in increased expression of ACTG2 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 2:73,893,008...73,919,865
Ensembl chr 2:73,892,314...73,919,865
|
|
G |
ADA |
adenosine deaminase |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of ADA mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
|
|
G |
ADAM17 |
ADAM metallopeptidase domain 17 |
multiple interactions increases expression |
ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of ADAM17 mRNA] |
CTD |
PMID:37528096 |
|
NCBI chr 2:9,488,486...9,555,830
Ensembl chr 2:9,488,486...9,556,732
|
|
G |
ADAM22 |
ADAM metallopeptidase domain 22 |
increases expression |
ISO |
Isoproterenol results in increased expression of ADAM22 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:87,934,251...88,202,889
Ensembl chr 7:87,934,143...88,202,889
|
|
G |
ADAM8 |
ADAM metallopeptidase domain 8 |
increases expression |
ISO |
Isoproterenol results in increased expression of ADAM8 mRNA |
CTD |
PMID:20211217 |
|
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
|
|
G |
ADAMTSL2 |
ADAMTS like 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of ADAMTSL2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:133,532,164...133,575,519
Ensembl chr 9:133,532,164...133,575,519
|
|
G |
ADAMTSL4 |
ADAMTS like 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of ADAMTSL4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:150,549,408...150,560,937
Ensembl chr 1:150,549,369...150,560,937
|
|
G |
ADCY5 |
adenylate cyclase 5 |
increases response to substance multiple interactions |
ISO |
ADCY5 protein results in increased susceptibility to Isoproterenol [ADCY5 protein results in increased susceptibility to Isoproterenol] which results in decreased expression of SOD2 protein; SOD2 protein inhibits the reaction [ADCY5 protein results in increased susceptibility to Isoproterenol] |
CTD |
PMID:12869393 PMID:23536361 |
|
NCBI chr 3:123,282,296...123,449,090
Ensembl chr 3:123,282,296...123,449,090
|
|
G |
ADCY6 |
adenylate cyclase 6 |
affects response to substance |
ISO |
ADCY6 protein affects the susceptibility to Isoproterenol |
CTD |
PMID:12393090 |
|
NCBI chr12:48,766,194...48,789,974
Ensembl chr12:48,766,194...48,789,089
|
|
G |
ADCY9 |
adenylate cyclase 9 |
multiple interactions |
EXP |
[Isoproterenol co-treated with Miconazole] results in increased activity of ADCY9 protein alternative form |
CTD |
PMID:30607468 |
|
NCBI chr16:3,953,387...4,116,442
Ensembl chr16:3,953,387...4,116,442
|
|
G |
ADD3 |
adducin 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ADD3 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr10:109,996,373...110,135,565
Ensembl chr10:109,996,368...110,135,565
|
|
G |
ADGRD1 |
adhesion G protein-coupled receptor D1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ADGRD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:130,953,907...131,141,469
Ensembl chr12:130,953,907...131,141,469
|
|
G |
ADGRF5 |
adhesion G protein-coupled receptor F5 |
increases expression |
ISO |
Isoproterenol results in increased expression of ADGRF5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:46,852,522...46,954,939
Ensembl chr 6:46,852,522...46,954,943
|
|
G |
ADGRL4 |
adhesion G protein-coupled receptor L4 |
increases expression |
ISO |
Isoproterenol results in increased expression of ADGRL4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:78,889,764...79,006,730
Ensembl chr 1:78,889,764...79,282,124
|
|
G |
ADH1C |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
increases expression |
ISO |
Isoproterenol results in increased expression of ADH1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746
|
|
G |
ADM |
adrenomedullin |
multiple interactions increases expression |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of ADM mRNA; [Phenylephrine co-treated with Isoproterenol] results in increased expression of ADM protein; ADM protein inhibits the reaction [Isoproterenol promotes the reaction [ADM protein results in increased abundance of Cyclic AMP]]; CALCA protein inhibits the reaction [Isoproterenol promotes the reaction [ADM protein results in increased abundance of Cyclic AMP]]; Isoproterenol promotes the reaction [ADM protein results in increased abundance of Cyclic AMP] Isoproterenol results in increased expression of ADM mRNA; Isoproterenol results in increased expression of ADM protein |
CTD |
PMID:12732346 PMID:17250927 PMID:17306419 |
|
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
|
|
G |
ADRA1B |
adrenoceptor alpha 1B |
multiple interactions decreases expression |
ISO |
ADRA1B protein affects the reaction [Isoproterenol results in increased abundance of Cyclic AMP] Isoproterenol results in decreased expression of ADRA1B mRNA |
CTD |
PMID:12649302 PMID:20003209 |
|
NCBI chr 5:159,865,086...159,989,205
Ensembl chr 5:159,865,080...159,973,012
|
|
G |
ADRB1 |
adrenoceptor beta 1 |
multiple interactions decreases expression increases phosphorylation increases activity affects response to substance increases uptake |
EXP ISO |
[Isoproterenol binds to and results in increased activity of ADRB1 protein] which results in increased abundance of Cyclic AMP; Atenolol inhibits the reaction [Isoproterenol results in increased activity of ADRB1 protein]; Carvedilol inhibits the reaction [Isoproterenol results in increased activity of ADRB1 protein]; CGP 12177 inhibits the reaction [Isoproterenol results in increased activity of ADRB1 protein]; CGP 20712A inhibits the reaction [Isoproterenol results in increased activity of ADRB1 protein]; Isoproterenol binds to and results in increased activity of ADRB1 protein; Isoproterenol inhibits the reaction [cyanopindolol binds to ADRB1 protein]; Isoproterenol inhibits the reaction [Iodocyanopindolol binds to ADRB1 protein]; Isoproterenol promotes the reaction [ADRB1 protein binds to ARRB1 protein]; Isoproterenol promotes the reaction [ADRB1 protein binds to ARRB2 protein]; Isoproterenol promotes the reaction [ADRB1 protein results in increased abundance of Cyclic AMP]; Isoproterenol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of ADRB1 protein] Isoproterenol results in decreased expression of ADRB1 mRNA Isoproterenol results in increased phosphorylation of ADRB1 protein [ADRB3 affects the expression of ADRB1 mRNA] which affects the susceptibility to Isoproterenol ADRB1 protein polymorphism affects the susceptibility to Isoproterenol Isoproterenol results in increased uptake of ADRB1 protein ADRB1 protein promotes the reaction [Isoproterenol results in decreased expression of NPPA protein]; ADRB1 protein promotes the reaction [Isoproterenol results in increased abundance of Cyclic AMP]; AGT affects the reaction [Isoproterenol results in decreased expression of ADRB1 mRNA]; Isoproterenol binds to and results in increased activity of ADRB1 protein; Isoproterenol inhibits the reaction [Iodocyanopindolol binds to ADRB1 protein]; Metoprolol inhibits the reaction [Isoproterenol results in decreased expression of ADRB1 mRNA] Isoproterenol results in decreased expression of ADRB1; Isoproterenol results in decreased expression of ADRB1 mRNA |
CTD |
PMID:1312942 PMID:8096834 PMID:8723169 PMID:11159692 PMID:12761341 PMID:12963636 PMID:14502278 PMID:14730417 PMID:15627480 PMID:16731636 PMID:17200720 PMID:17350036 PMID:18194989 PMID:18378355 PMID:18787115 PMID:20003209 More...
|
|
NCBI chr10:114,043,866...114,046,904
Ensembl chr10:114,043,866...114,046,904
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
multiple interactions increases activity affects expression increases uptake decreases expression increases phosphorylation increases expression |
EXP ISO |
4-(1H-imidazol-4-ylmethyl)piperidine promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein]; [Isoproterenol binds to ADRB2 protein] which results in increased phosphorylation of MAPK1 protein; [Isoproterenol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein; [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP; [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein; [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein; [Isoproterenol results in increased activity of ADRB2 protein] which results in increased chemical synthesis of Cyclic AMP; [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Isoproterenol; Atenolol inhibits the reaction [[Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; Atenolol inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein]; clobenpropit promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein]; Cobalt promotes the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein]; Histamine promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein]; ICI 118551 inhibits the reaction [[Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; ICI 118551 inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein]; ICI 118551 inhibits the reaction [Isoproterenol results in increased activity of ADRB2 protein]; imidazole promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein]; Isoproterenol binds to and results in increased activity of ADRB2 protein; Isoproterenol inhibits the reaction [cyanopindolol binds to ADRB2 protein]; Isoproterenol promotes the reaction [ADRB2 protein binds to ARRB2 protein]; Ketotifen inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Isoproterenol]; Propranolol inhibits the reaction [[Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein]; Zinc promotes the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein] Isoproterenol affects the expression of ADRB2 mRNA Isoproterenol results in increased uptake of ADRB2 protein [Isoproterenol results in increased activity of ADRB2 protein] which results in increased secretion of Histamine; ADRB2 protein promotes the reaction [Isoproterenol results in increased abundance of Cyclic AMP] Isoproterenol results in decreased expression of ADRB2; Isoproterenol results in decreased expression of ADRB2 mRNA [GNA15 protein results in increased susceptibility to Isoproterenol] which results in increased activity of ADRB2 protein; ADRB2 protein affects the reaction [Isoproterenol results in increased expression of IL18 mRNA]; CAV1 protein promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein]; ICI 118551 inhibits the reaction [Isoproterenol results in increased activity of ADRB2 protein] Isoproterenol results in increased phosphorylation of ADRB2 protein Isoproterenol results in increased expression of ADRB2 mRNA |
CTD |
PMID:9875846 PMID:10226872 PMID:10516654 PMID:11164953 PMID:11752207 PMID:12920204 PMID:12963636 PMID:14730417 PMID:15178407 PMID:16036225 PMID:16980553 PMID:17196553 PMID:17350036 PMID:17925438 PMID:18378355 PMID:18820136 PMID:19483313 PMID:21177286 PMID:21629661 PMID:24705868 PMID:27825928 PMID:34601065 More...
|
|
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
ADRB3 |
adrenoceptor beta 3 |
multiple interactions increases activity increases expression |
EXP ISO |
[Isoproterenol binds to and results in increased activity of ADRB3 protein] which results in increased abundance of Cyclic AMP; Isoproterenol binds to and results in increased activity of ADRB3 protein; Isoproterenol inhibits the reaction [cyanopindolol binds to ADRB3 protein]; L 748,337 inhibits the reaction [Isoproterenol results in increased activity of ADRB3 protein] Isoproterenol results in increased expression of ADRB3 mRNA; Isoproterenol results in increased expression of ADRB3 protein [ADRB3 affects the expression of ADRB1 mRNA] which affects the susceptibility to Isoproterenol 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Isoproterenol results in increased activity of ADRB3 protein]; 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Isoproterenol results in increased expression of ADRB3 protein]; BRL 37344 promotes the reaction [Isoproterenol results in increased expression of ADRB3 mRNA]; BRL 37344 promotes the reaction [Isoproterenol results in increased expression of ADRB3 protein]; Isoproterenol binds to and results in increased activity of ADRB3 protein |
CTD |
PMID:1682311 PMID:7815362 PMID:11159692 PMID:14730417 PMID:15009959 PMID:17622774 PMID:18553954 PMID:18820136 PMID:20654104 More...
|
|
NCBI chr 8:37,962,990...37,966,599
Ensembl chr 8:37,962,990...37,966,599
|
|
G |
AEN |
apoptosis enhancing nuclease |
decreases expression |
ISO |
Isoproterenol results in decreased expression of AEN mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:88,604,683...88,632,281
Ensembl chr15:88,621,337...88,632,281
|
|
G |
AGBL5 |
AGBL carboxypeptidase 5 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of AGBL5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:27,050,364...27,070,618
Ensembl chr 2:27,042,364...27,070,622
|
|
G |
AGT |
angiotensinogen |
multiple interactions increases expression |
ISO EXP |
adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [Isoproterenol promotes the reaction [Dexamethasone results in increased expression of AGT protein]]; ICI 118551 inhibits the reaction [Isoproterenol promotes the reaction [Dexamethasone results in increased expression of AGT protein]]; Isoproterenol promotes the reaction [Dexamethasone results in increased expression of AGT protein]; Propranolol inhibits the reaction [Isoproterenol promotes the reaction [Dexamethasone results in increased expression of AGT protein]] Isoproterenol results in increased expression of AGT protein AGT affects the reaction [Isoproterenol results in decreased expression of ADRB1 mRNA]; AGT affects the reaction [Isoproterenol results in decreased expression of GRK2 mRNA]; AGT inhibits the reaction [Isoproterenol results in increased expression of COL3A1 protein]; Isoproterenol inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; Isoproterenol inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]; Losartan inhibits the reaction [Isoproterenol results in increased expression of AGT protein]; Losartan promotes the reaction [Isoproterenol results in increased expression of AGT protein]; natakalim inhibits the reaction [Isoproterenol results in increased expression of AGT protein]; Quercetin inhibits the reaction [Isoproterenol results in increased expression of AGT protein]; Quinapril inhibits the reaction [Isoproterenol results in increased expression of AGT protein]; Quinapril promotes the reaction [Isoproterenol results in increased expression of AGT protein]; Rutin inhibits the reaction [Isoproterenol results in increased expression of AGT protein]; trandolapril inhibits the reaction [Isoproterenol results in increased expression of AGT protein]; xanthone inhibits the reaction [Isoproterenol results in increased expression of AGT protein] Isoproterenol results in increased expression of AGT mRNA; Isoproterenol results in increased expression of AGT protein Propranolol inhibits the reaction [Isoproterenol results in increased expression of AGT protein] |
CTD |
PMID:1534315 PMID:1653766 PMID:7843740 PMID:11709406 PMID:16731636 PMID:19023134 PMID:19483313 PMID:20003209 PMID:20409916 PMID:24117263 PMID:27890915 PMID:36414029 More...
|
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AGTR1 |
angiotensin II receptor type 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of AGTR1A mRNA |
CTD |
PMID:17350036 |
|
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
|
|
G |
AHCY |
adenosylhomocysteinase |
increases expression |
ISO |
Isoproterenol results in increased expression of AHCY mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:34,231,981...34,311,836
Ensembl chr20:34,280,268...34,311,802
|
|
G |
AHNAK2 |
AHNAK nucleoprotein 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of AHNAK2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:104,937,253...104,978,374
Ensembl chr14:104,937,244...104,978,374
|
|
G |
AHR |
aryl hydrocarbon receptor |
increases expression decreases expression |
EXP ISO |
Isoproterenol results in increased expression of AHR mRNA Isoproterenol results in decreased expression of AHR mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AHSG |
alpha 2-HS glycoprotein |
increases expression |
ISO |
Isoproterenol results in increased expression of AHSG mRNA |
CTD |
PMID:20003209 PMID:21335049 |
|
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
|
|
G |
AIF1 |
allograft inflammatory factor 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of AIF1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:31,615,234...31,617,015
Ensembl chr 6:31,615,217...31,617,021
|
|
G |
AK4 |
adenylate kinase 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of AK4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:65,147,552...65,232,145
Ensembl chr 1:65,147,549...65,232,145
|
|
G |
AKAP1 |
A-kinase anchoring protein 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of AKAP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:57,085,246...57,121,344
Ensembl chr17:57,085,092...57,121,346
|
|
G |
AKAP13 |
A-kinase anchoring protein 13 |
increases expression |
ISO |
Isoproterenol results in increased expression of AKAP13 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:85,380,603...85,749,358
Ensembl chr15:85,380,571...85,749,358
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
increases phosphorylation decreases phosphorylation multiple interactions decreases expression |
ISO |
Isoproterenol results in increased phosphorylation of AKT1 protein Isoproterenol results in decreased phosphorylation of AKT1 protein 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one promotes the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein]; 5-Methoxypsoralen inhibits the reaction [Isoproterenol results in decreased phosphorylation of AKT1 protein]; [Isoproterenol co-treated with POSTN protein] results in decreased expression of AKT1 mRNA; [PDE3B protein co-treated with AKT1 protein] inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein]; Enalapril promotes the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein]; plantamajoside inhibits the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein]; swietenine inhibits the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein]; Valsartan inhibits the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein] Isoproterenol results in decreased expression of AKT1 mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of AKT1 protein]; Isoproterenol results in increased phosphorylation of and results in increased activity of AKT1 protein; plantamajoside inhibits the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein]; swietenine inhibits the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein]; Valsartan inhibits the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of AKT1 protein] |
CTD |
PMID:15178407 PMID:15618457 PMID:15951400 PMID:16716347 PMID:17623046 PMID:18806606 PMID:19167487 PMID:20003209 PMID:30303030 PMID:31009642 PMID:32686902 PMID:35815753 More...
|
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
ALDH2 |
aldehyde dehydrogenase 2 family member |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ALDH2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
|
|
G |
ALDH3A2 |
aldehyde dehydrogenase 3 family member A2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760
|
|
G |
ALPK2 |
alpha kinase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of ALPK2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr18:58,481,247...58,629,091
Ensembl chr18:58,481,247...58,629,091
|
|
G |
ALPK3 |
alpha kinase 3 |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of ALPK3 mRNA; Isoproterenol results in decreased expression of ALPK3 protein MIR384 mRNA inhibits the reaction [Isoproterenol results in decreased expression of ALPK3 mRNA] |
CTD |
PMID:35510648 |
|
NCBI chr15:84,817,356...84,873,479
Ensembl chr15:84,817,356...84,873,479
|
|
G |
ALPP |
alkaline phosphatase, placental |
multiple interactions increases expression |
EXP |
Amphetamine promotes the reaction [Isoproterenol results in increased expression of ALPP mRNA]; Chlorpromazine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]; Clozapine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]; Desipramine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]; ICI 118551 inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]; norfluoxetine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA] |
CTD |
PMID:16036225 |
|
NCBI chr 2:232,378,751...232,382,889
Ensembl chr 2:232,378,724...232,382,889
|
|
G |
AMY2B |
amylase alpha 2B |
multiple interactions |
ISO |
Atenolol inhibits the reaction [Isoproterenol results in increased secretion of and results in increased activity of AMY1A protein]; Isoproterenol results in increased secretion of and results in increased activity of AMY1A protein; Propranolol inhibits the reaction [Isoproterenol results in increased secretion of and results in increased activity of AMY1A protein] |
CTD |
PMID:21173550 |
|
NCBI chr 1:103,554,644...103,579,534
Ensembl chr 1:103,553,815...103,579,534
|
|
G |
ANG |
angiogenin |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of ANG mRNA Doxycycline inhibits the reaction [Isoproterenol results in increased expression of ANG mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
|
|
G |
ANGPT2 |
angiopoietin 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of ANGPT2 mRNA |
CTD |
PMID:22908232 |
|
NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409
|
|
G |
ANGPTL2 |
angiopoietin like 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ANGPTL2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:127,087,348...127,122,635
Ensembl chr 9:127,087,348...127,122,635
|
|
G |
ANGPTL6 |
angiopoietin like 6 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ANGPTL6 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr19:10,092,338...10,106,190
Ensembl chr19:10,092,338...10,102,678
|
|
G |
ANP32A |
acidic nuclear phosphoprotein 32 family member A |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ANP32A mRNA |
CTD |
PMID:20003209 PMID:21335049 |
|
NCBI chr15:68,778,535...68,820,895
Ensembl chr15:68,778,535...68,820,897
|
|
G |
ANXA1 |
annexin A1 |
multiple interactions increases expression |
ISO |
ANXA1 affects the reaction [Isoproterenol results in decreased secretion of IL6 protein] Isoproterenol results in increased expression of ANXA1 mRNA |
CTD |
PMID:16835395 PMID:20003209 |
|
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,393
|
|
G |
AOC1 |
amine oxidase copper containing 1 |
multiple interactions increases activity |
ISO |
Cycloheximide inhibits the reaction [Isoproterenol results in increased activity of AOC1 protein]; Dactinomycin inhibits the reaction [Isoproterenol results in increased activity of AOC1 protein]; H 35-25 inhibits the reaction [Isoproterenol results in increased activity of AOC1 protein]; pimagedine inhibits the reaction [Isoproterenol results in increased activity of AOC1 protein] |
CTD |
PMID:2860926 PMID:6218830 |
|
NCBI chr 7:150,852,120...150,861,504
Ensembl chr 7:150,824,627...150,861,504
|
|
G |
AOC3 |
amine oxidase copper containing 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of AOC3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:42,851,199...42,858,124
Ensembl chr17:42,851,184...42,858,130
|
|
G |
AOX1 |
aldehyde oxidase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of AOX1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:200,586,014...200,682,241
Ensembl chr 2:200,586,014...200,677,064
|
|
G |
AP1B1 |
adaptor related protein complex 1 subunit beta 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of AP1B1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr22:29,327,680...29,388,570
Ensembl chr22:29,327,680...29,388,583
|
|
G |
APAF1 |
apoptotic peptidase activating factor 1 |
increases expression |
EXP |
Isoproterenol results in increased expression of APAF1 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,290...98,735,433
|
|
G |
APEX1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of APEX1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
|
|
G |
APLN |
apelin |
multiple interactions decreases expression |
ISO |
Plant Extracts inhibits the reaction [Isoproterenol results in decreased expression of APLN mRNA]; Plant Extracts inhibits the reaction [Isoproterenol results in decreased expression of APLN protein] Isoproterenol results in decreased expression of APLN mRNA; Isoproterenol results in decreased expression of APLN protein |
CTD |
PMID:19960946 |
|
NCBI chr X:129,645,259...129,654,956
Ensembl chr X:129,645,259...129,654,956
|
|
G |
APOA2 |
apolipoprotein A2 |
increases expression |
ISO |
Isoproterenol results in increased expression of APOA2 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 1:161,222,292...161,223,628
Ensembl chr 1:161,222,292...161,223,631
|
|
G |
APOD |
apolipoprotein D |
increases expression |
ISO |
Isoproterenol results in increased expression of APOD mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:195,568,705...195,583,940
Ensembl chr 3:195,568,705...195,584,033
|
|
G |
APPBP2 |
amyloid beta precursor protein binding protein 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of APPBP2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:60,443,158...60,526,242
Ensembl chr17:60,443,158...60,526,242
|
|
G |
APPL2 |
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of APPL2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:105,173,300...105,236,174
Ensembl chr12:105,173,297...105,236,203
|
|
G |
ARF4 |
ADP ribosylation factor 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of ARF4 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 3:57,571,363...57,597,344
Ensembl chr 3:57,571,363...57,598,220
|
|
G |
ARHGAP12 |
Rho GTPase activating protein 12 |
increases expression |
ISO |
Isoproterenol results in increased expression of ARHGAP12 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:31,805,398...31,928,876
Ensembl chr10:31,805,398...31,928,876
|
|
G |
ARHGAP18 |
Rho GTPase activating protein 18 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ARHGAP18 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:129,576,132...129,710,177
Ensembl chr 6:129,576,132...129,710,177
|
|
G |
ARHGAP20 |
Rho GTPase activating protein 20 |
increases expression |
ISO |
Isoproterenol results in increased expression of ARHGAP20 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:110,577,043...110,713,189
Ensembl chr11:110,577,042...110,713,189
|
|
G |
ARHGAP24 |
Rho GTPase activating protein 24 |
increases expression |
ISO |
Isoproterenol results in increased expression of ARHGAP24 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:85,475,150...86,002,666
Ensembl chr 4:85,475,150...86,002,668
|
|
G |
ARHGDIB |
Rho GDP dissociation inhibitor beta |
increases expression |
ISO |
Isoproterenol results in increased expression of ARHGDIB mRNA |
CTD |
PMID:30303030 |
|
NCBI chr12:14,942,015...14,961,601
Ensembl chr12:14,942,031...14,961,728
|
|
G |
ARID4B |
AT-rich interaction domain 4B |
increases expression |
ISO |
Isoproterenol results in increased expression of ARID4B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:235,166,902...235,328,179
Ensembl chr 1:235,131,634...235,328,219
|
|
G |
ARID5B |
AT-rich interaction domain 5B |
increases expression |
ISO |
Isoproterenol results in increased expression of ARID5B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944
|
|
G |
ARL17B |
ADP ribosylation factor like GTPase 17B |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ARF2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:46,274,184...46,361,787
Ensembl chr17:46,274,784...46,361,766 Ensembl chr17:46,274,784...46,361,766
|
|
G |
ARL4A |
ADP ribosylation factor like GTPase 4A |
increases expression |
ISO |
Isoproterenol results in increased expression of ARL4A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:12,686,903...12,690,958
Ensembl chr 7:12,686,856...12,690,958
|
|
G |
ARNT2 |
aryl hydrocarbon receptor nuclear translocator 2 |
decreases expression increases expression |
EXP ISO |
Isoproterenol results in decreased expression of ARNT2 mRNA Isoproterenol results in increased expression of ARNT2 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr15:80,404,382...80,597,933
Ensembl chr15:80,404,350...80,597,933
|
|
G |
ARRB1 |
arrestin beta 1 |
multiple interactions |
EXP |
Isoproterenol promotes the reaction [ADRB1 protein binds to ARRB1 protein] |
CTD |
PMID:18787115 |
|
NCBI chr11:75,260,122...75,351,661
Ensembl chr11:75,260,122...75,351,705
|
|
G |
ARRB2 |
arrestin beta 2 |
affects localization multiple interactions |
EXP ISO |
Isoproterenol affects the localization of ARRB2 protein ARRB2 protein promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK1 protein]; ARRB2 protein promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein]; Isoproterenol promotes the reaction [ADRB1 protein binds to ARRB2 protein]; Isoproterenol promotes the reaction [ADRB2 protein binds to ARRB2 protein]; S-nitrosocysteine inhibits the reaction [Isoproterenol affects the localization of ARRB2 protein] |
CTD |
PMID:17482545 PMID:17925438 PMID:18787115 PMID:21078978 |
|
NCBI chr17:4,710,632...4,721,497
Ensembl chr17:4,710,596...4,721,499
|
|
G |
ARRDC2 |
arrestin domain containing 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of ARRDC2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:18,001,124...18,014,102
Ensembl chr19:18,001,132...18,014,102
|
|
G |
ARRDC3 |
arrestin domain containing 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of ARRDC3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:91,368,631...91,383,317
Ensembl chr 5:91,368,631...91,383,317
|
|
G |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ASAP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:130,052,104...130,443,674
Ensembl chr 8:130,052,104...130,443,674
|
|
G |
ASB11 |
ankyrin repeat and SOCS box containing 11 |
increases expression |
ISO |
Isoproterenol results in increased expression of ASB11 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:15,281,697...15,315,640
Ensembl chr X:15,281,697...15,315,640
|
|
G |
ASCC3 |
activating signal cointegrator 1 complex subunit 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of ASCC3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:100,508,194...100,881,329
Ensembl chr 6:100,508,194...100,881,372
|
|
G |
ASNS |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression |
ISO |
Isoproterenol results in increased expression of ASNS mRNA |
CTD |
PMID:21335049 PMID:21823215 |
|
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
|
|
G |
ASPH |
aspartate beta-hydroxylase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ASPH mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:61,500,556...61,714,592
Ensembl chr 8:61,500,556...61,714,640
|
|
G |
ASPN |
asporin |
increases expression |
ISO |
Isoproterenol results in increased expression of ASPN mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:92,456,205...92,482,506
Ensembl chr 9:92,456,205...92,482,506
|
|
G |
ATAD2 |
ATPase family AAA domain containing 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of ATAD2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:123,319,850...123,416,350
Ensembl chr 8:123,319,850...123,416,350
|
|
G |
ATF2 |
activating transcription factor 2 |
multiple interactions increases phosphorylation |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:18089841 |
|
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
|
|
G |
ATF3 |
activating transcription factor 3 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of ATF3 mRNA Isoproterenol results in increased expression of ATF3 protein N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased expression of ATF3 protein] |
CTD |
PMID:21823215 PMID:25136830 |
|
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
|
|
G |
ATP10D |
ATPase phospholipid transporting 10D (putative) |
increases expression |
ISO |
Isoproterenol results in increased expression of ATP10D mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:47,485,275...47,593,486
Ensembl chr 4:47,485,275...47,593,486
|
|
G |
ATP2A2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
multiple interactions decreases expression |
ISO |
astragaloside A inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased activity of ATP2A2 protein]; astragaloside A inhibits the reaction [Isoproterenol results in decreased expression of ATP2A2 mRNA]; candesartan inhibits the reaction [Isoproterenol results in decreased expression of ATP2A2 protein]; Isoproterenol results in decreased expression of and results in decreased activity of ATP2A2 protein Isoproterenol results in decreased expression of ATP2A2 mRNA; Isoproterenol results in decreased expression of ATP2A2 protein |
CTD |
PMID:16723803 PMID:17509559 |
|
NCBI chr12:110,280,616...110,351,093
Ensembl chr12:110,280,756...110,351,093
|
|
G |
ATP5F1A |
ATP synthase F1 subunit alpha |
multiple interactions decreases expression |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5F1A mRNA Isoproterenol results in decreased expression of ATP5F1A mRNA |
CTD |
PMID:20003209 PMID:30303030 |
|
NCBI chr18:46,080,248...46,104,227
Ensembl chr18:46,080,248...46,104,334
|
|
G |
ATP5F1D |
ATP synthase F1 subunit delta |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5F1D mRNA |
CTD |
PMID:30303030 |
|
NCBI chr19:1,241,751...1,244,825
Ensembl chr19:1,241,746...1,244,825
|
|
G |
ATP5MC1 |
ATP synthase membrane subunit c locus 1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5MC1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr17:48,892,787...48,895,871
Ensembl chr17:48,892,765...48,895,871
|
|
G |
ATP5ME |
ATP synthase membrane subunit e |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in increased expression of ATP5ME mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 4:672,436...674,276
Ensembl chr 4:672,436...674,330
|
|
G |
ATP5PD |
ATP synthase peripheral stalk subunit d |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in increased expression of ATP5PD mRNA |
CTD |
PMID:30303030 |
|
NCBI chr17:75,038,863...75,046,969
Ensembl chr17:75,038,863...75,046,985
|
|
G |
ATP5PO |
ATP synthase peripheral stalk subunit OSCP |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5PO mRNA |
CTD |
PMID:30303030 |
|
NCBI chr21:33,903,453...33,915,804
Ensembl chr21:33,903,453...33,915,814
|
|
G |
ATP6AP2 |
ATPase H+ transporting accessory protein 2 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP6AP2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr X:40,580,970...40,606,848
Ensembl chr X:40,579,372...40,606,848
|
|
G |
ATP6V1E1 |
ATPase H+ transporting V1 subunit E1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ATP6V1E1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:17,592,136...17,628,822
Ensembl chr22:17,592,136...17,628,749
|
|
G |
ATP8B1 |
ATPase phospholipid transporting 8B1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ATP8B1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr18:57,646,426...57,803,315
Ensembl chr18:57,646,426...57,803,315
|
|
G |
ATXN10 |
ataxin 10 |
increases expression |
ISO |
Isoproterenol results in increased expression of ATXN10 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:45,671,834...45,845,307
Ensembl chr22:45,671,798...45,845,307
|
|
G |
AUTS2 |
activator of transcription and developmental regulator AUTS2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of AUTS2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:69,598,475...70,793,506
Ensembl chr 7:69,598,296...70,793,506
|
|
G |
AZI2 |
5-azacytidine induced 2 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of AZI2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 3:28,321,047...28,348,824
Ensembl chr 3:28,315,003...28,349,050
|
|
G |
BAG1 |
BAG cochaperone 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of BAG1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 9:33,252,471...33,264,708
Ensembl chr 9:33,247,820...33,264,720
|
|
G |
BAG4 |
BAG cochaperone 4 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of BAG4 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 8:38,176,855...38,213,301
Ensembl chr 8:38,176,533...38,213,301
|
|
G |
BAK1 |
BCL2 antagonist/killer 1 |
decreases expression |
EXP |
Isoproterenol results in decreased expression of BAK1 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions decreases expression |
ISO EXP |
Isoproterenol results in increased expression of BAX protein 2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BAX protein]; [Acrolein results in increased susceptibility to Isoproterenol] which results in increased expression of BAX protein; [Streptozocin co-treated with Isoproterenol] affects the expression of BAX protein; Acrolein promotes the reaction [Isoproterenol results in increased expression of BAX mRNA]; Acrolein promotes the reaction [Isoproterenol results in increased expression of BAX protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of BAX mRNA]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of BAX protein]; erdosteine inhibits the reaction [Isoproterenol results in increased expression of BAX protein]; Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BAX protein]]; Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BAX protein]; Plant Extracts inhibits the reaction [[Acrolein results in increased susceptibility to Isoproterenol] which results in increased expression of BAX protein]; Plant Extracts inhibits the reaction [Acrolein promotes the reaction [Isoproterenol results in increased expression of BAX mRNA]]; Plant Extracts inhibits the reaction [Acrolein promotes the reaction [Isoproterenol results in increased expression of BAX protein]]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of BAX protein]; punicalagin inhibits the reaction [Isoproterenol results in increased expression of BAX protein]; Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of BAX mRNA]; Tretinoin inhibits the reaction [Isoproterenol results in increased expression of BAX mRNA] Isoproterenol results in decreased expression of BAX mRNA Isoproterenol results in increased expression of BAX mRNA; Isoproterenol results in increased expression of BAX protein |
CTD |
PMID:15052282 PMID:16116328 PMID:17961425 PMID:24286936 PMID:24954035 PMID:27491814 PMID:29414845 PMID:30152906 PMID:32007421 PMID:33210414 PMID:35430261 PMID:36593721 PMID:37806379 More...
|
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCAT1 |
branched chain amino acid transaminase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of BCAT1 mRNA |
CTD |
PMID:20211217 PMID:23558518 PMID:24286936 |
|
NCBI chr12:24,810,024...24,949,340
Ensembl chr12:24,810,024...24,949,101
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression multiple interactions increases expression |
ISO |
Isoproterenol results in decreased expression of BCL2 protein 2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]; [Acrolein results in increased susceptibility to Isoproterenol] which results in decreased expression of BCL2 protein; [erdosteine co-treated with Isoproterenol] affects the expression of BCL2 protein; [Isoproterenol co-treated with POSTN protein] results in increased expression of BCL2 mRNA; [Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein; Acrolein promotes the reaction [Isoproterenol results in decreased expression of BCL2 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of BCL2 mRNA]; Apigenin inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein]; echinocystic acid affects the reaction [Isoproterenol affects the expression of BCL2 mRNA]; Enalapril inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein]; Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]]; Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]; Hesperidin inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [[Acrolein results in increased susceptibility to Isoproterenol] which results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [Acrolein promotes the reaction [Isoproterenol results in decreased expression of BCL2 mRNA]]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein]; punicalagin inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein] Isoproterenol results in decreased expression of BCL2 mRNA; Isoproterenol results in decreased expression of BCL2 protein |
CTD |
PMID:11218852 PMID:12791704 PMID:15052282 PMID:19573579 PMID:24954035 PMID:27491814 PMID:29414845 PMID:30152906 PMID:30303030 PMID:30623541 PMID:32007421 PMID:33210414 PMID:35430261 PMID:35608392 PMID:36593721 PMID:37806379 More...
|
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
increases expression decreases expression multiple interactions |
ISO EXP |
Isoproterenol results in increased expression of BCL2L1 mRNA Isoproterenol results in decreased expression of BCL2L1 mRNA; Isoproterenol results in decreased expression of BCL2L1 protein Isoproterenol results in increased expression of BCL2L1 mRNA alternative form; Isoproterenol results in increased expression of BCL2L1 protein; Isoproterenol results in increased expression of BCL2L1 protein alternative form Apigenin inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 protein]; CGP 20712A inhibits the reaction [Isoproterenol results in increased expression of BCL2L1 protein]; geraniol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA]; Metoprolol inhibits the reaction [Isoproterenol results in increased expression of BCL2L1 protein]; Perindopril inhibits the reaction [Isoproterenol results in increased expression of BCL2L1 mRNA alternative form]; Thymol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA] |
CTD |
PMID:12738230 PMID:16116328 PMID:20003209 PMID:24286936 PMID:26996544 PMID:30152906 PMID:35608392 More...
|
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BCL2L11 |
BCL2 like 11 |
increases expression |
ISO EXP |
Isoproterenol results in increased expression of BCL2L11 protein Isoproterenol results in increased expression of BCL2L11 mRNA |
CTD |
PMID:14996839 PMID:24286936 |
|
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
|
|
G |
BDH1 |
3-hydroxybutyrate dehydrogenase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of BDH1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323
|
|
G |
BICD1 |
BICD cargo adaptor 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of BICD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:32,106,847...32,383,633
Ensembl chr12:32,106,835...32,383,633
|
|
G |
BIRC2 |
baculoviral IAP repeat containing 2 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of BIRC2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
|
|
G |
BMAL1 |
basic helix-loop-helix ARNT like 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of BMAL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266
|
|
G |
BMF |
Bcl2 modifying factor |
increases expression |
ISO |
Isoproterenol results in increased expression of BMF mRNA |
CTD |
PMID:24286936 |
|
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
|
|
G |
BMP10 |
bone morphogenetic protein 10 |
decreases response to substance multiple interactions |
EXP ISO |
BMP10 protein results in decreased susceptibility to Isoproterenol BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; STAT3 protein affects the reaction [BMP10 protein results in decreased susceptibility to Isoproterenol] BMP10 protein inhibits the reaction [Isoproterenol results in increased cleavage of PARP1 protein]; BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of COL1A1 protein]; BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of COL3A1 protein]; STAT3 protein affects the reaction [BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]] |
CTD |
PMID:31712309 |
|
NCBI chr 2:68,860,909...68,871,397
Ensembl chr 2:68,860,909...68,871,397
|
|
G |
BMP2 |
bone morphogenetic protein 2 |
increases expression |
ISO |
isoprenaline increases expression of mRNA in neonatal rat cardiomyocytes |
RGD |
PMID:26873969 |
RGD:11526363 |
NCBI chr20:6,767,686...6,780,246
Ensembl chr20:6,767,686...6,780,246
|
|
G |
BMP4 |
bone morphogenetic protein 4 |
increases expression |
ISO |
isoprenaline increases expression of mRNA in neonatal rat cardiomyocytes |
RGD |
PMID:26873969 |
RGD:11526363 |
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
|
|
G |
BMP7 |
bone morphogenetic protein 7 |
increases expression |
ISO |
isoprenaline increases expression of mRNA in neonatal rat cardiomyocytes |
RGD |
PMID:26873969 |
RGD:11526363 |
NCBI chr20:57,168,753...57,266,641
Ensembl chr20:57,168,753...57,266,641
|
|
G |
BNIP1 |
BCL2 interacting protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of BNIP1 protein |
CTD |
PMID:15052282 |
|
NCBI chr 5:173,144,531...173,164,387
Ensembl chr 5:173,144,442...173,164,387
|
|
G |
BNIP3 |
BCL2 interacting protein 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of BNIP3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
|
|
G |
BOK |
BCL2 family apoptosis regulator BOK |
decreases expression |
ISO |
Isoproterenol results in decreased expression of BOK mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 2:241,551,393...241,574,131
Ensembl chr 2:241,551,424...241,574,131
|
|
G |
BRD4 |
bromodomain containing 4 |
decreases expression multiple interactions increases expression |
ISO |
Isoproterenol results in decreased expression of BRD4 mRNA bellidifolin inhibits the reaction [Isoproterenol results in increased expression of BRD4 mRNA]; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of BRD4 protein] Isoproterenol results in increased expression of BRD4 mRNA; Isoproterenol results in increased expression of BRD4 protein |
CTD |
PMID:20003209 PMID:37528096 |
|
NCBI chr19:15,235,519...15,332,539
Ensembl chr19:15,235,519...15,332,545
|
|
G |
BRWD1 |
bromodomain and WD repeat domain containing 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of BRWD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr21:39,184,176...39,321,212
Ensembl chr21:39,184,176...39,321,559
|
|
G |
BSDC1 |
BSD domain containing 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of BSDC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:32,364,633...32,394,441
Ensembl chr 1:32,364,633...32,394,731
|
|
G |
C3 |
complement C3 |
increases expression multiple interactions decreases expression |
ISO EXP |
Isoproterenol results in increased expression of C3 mRNA Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of C3 protein]; pifithrin inhibits the reaction [Isoproterenol results in increased expression of C3 protein]; S100A9 protein affects the reaction [Isoproterenol results in increased expression of C3 protein] Isoproterenol results in decreased expression of C3 mRNA Isoproterenol results in increased expression of C3 mRNA; Isoproterenol results in increased expression of C3 protein |
CTD |
PMID:20003209 PMID:24286936 PMID:32924446 |
|
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
C4B |
complement C4B (Chido/Rodgers blood group) |
increases expression |
ISO |
Isoproterenol results in increased expression of C4B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:32,014,795...32,035,418
Ensembl chr 6:32,014,795...32,035,418
|
|
G |
C5 |
complement C5 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of C5 protein]; pifithrin inhibits the reaction [Isoproterenol results in increased expression of C5 protein]; S100A9 protein affects the reaction [Isoproterenol results in increased expression of C5 protein] |
CTD |
PMID:32924446 |
|
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
|
|
G |
C9 |
complement C9 |
increases expression |
ISO |
Isoproterenol results in increased expression of C9 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 5:39,284,140...39,364,495
Ensembl chr 5:39,284,140...39,371,324
|
|
G |
CA4 |
carbonic anhydrase 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of CAR4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:60,149,973...60,179,021
Ensembl chr17:60,149,942...60,170,899
|
|
G |
CACNA1C |
calcium voltage-gated channel subunit alpha1 C |
increases expression |
ISO |
Isoproterenol results in increased expression of CACNA1C mRNA |
CTD |
PMID:17526999 |
|
NCBI chr12:1,970,780...2,697,950
Ensembl chr12:1,970,772...2,697,950
|
|
G |
CADM4 |
cell adhesion molecule 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CADM4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:43,622,368...43,641,984
Ensembl chr19:43,622,368...43,639,850
|
|
G |
CALCA |
calcitonin related polypeptide alpha |
multiple interactions |
ISO |
CALCA protein inhibits the reaction [Isoproterenol promotes the reaction [ADM protein results in increased abundance of Cyclic AMP]] |
CTD |
PMID:17306419 |
|
NCBI chr11:14,966,668...14,972,351
Ensembl chr11:14,966,622...14,972,354
|
|
G |
CALCRL |
calcitonin receptor like receptor |
multiple interactions increases expression |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of CALCRL mRNA Isoproterenol results in increased expression of CALCRL mRNA; Isoproterenol results in increased expression of CALCRL protein |
CTD |
PMID:16987513 PMID:17250927 PMID:17306419 |
|
NCBI chr 2:187,341,964...187,448,252
Ensembl chr 2:187,341,964...187,448,460
|
|
G |
CALM3 |
calmodulin 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CALM3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:46,601,074...46,610,782
Ensembl chr19:46,601,074...46,610,782
|
|
G |
CALR |
calreticulin |
increases expression |
ISO |
Isoproterenol results in increased expression of CALR mRNA |
CTD |
PMID:21823215 |
|
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
|
|
G |
CALR3 |
calreticulin 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of CALR3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:16,479,061...16,496,167
Ensembl chr19:16,479,061...16,496,167
|
|
G |
CAMK2B |
calcium/calmodulin dependent protein kinase II beta |
increases expression |
ISO |
Isoproterenol results in increased expression of CAMK2B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
|
|
G |
CAMK2D |
calcium/calmodulin dependent protein kinase II delta |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of CAMK2D protein [Carvedilol co-treated with aliskiren] inhibits the reaction [Isoproterenol results in increased expression of CAMK2D protein]; aliskiren inhibits the reaction [Isoproterenol results in increased expression of CAMK2D protein]; Carvedilol inhibits the reaction [Isoproterenol results in increased expression of CAMK2D protein] |
CTD |
PMID:26982530 |
|
NCBI chr 4:113,451,032...113,761,738
Ensembl chr 4:113,418,054...113,761,927
|
|
G |
CAMKK2 |
calcium/calmodulin dependent protein kinase kinase 2 |
decreases phosphorylation |
ISO |
Isoproterenol results in decreased phosphorylation of CAMKK2 protein |
CTD |
PMID:27491814 |
|
NCBI chr12:121,237,692...121,297,819
Ensembl chr12:121,237,675...121,298,308
|
|
G |
CAPN1 |
calpain 1 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of CAPN1 mRNA Quercetin inhibits the reaction [Isoproterenol results in increased expression of CAPN1 mRNA] |
CTD |
PMID:27527349 |
|
NCBI chr11:65,181,373...65,212,006
Ensembl chr11:65,180,566...65,212,006
|
|
G |
CAPN10 |
calpain 10 |
increases expression |
ISO |
Isoproterenol results in increased expression of CAPN10 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:240,586,734...240,599,104
Ensembl chr 2:240,586,734...240,617,705
|
|
G |
CAPN2 |
calpain 2 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of CAPN2 mRNA Quercetin inhibits the reaction [Isoproterenol results in increased expression of CAPN2 mRNA] |
CTD |
PMID:27527349 |
|
NCBI chr 1:223,701,597...223,776,018
Ensembl chr 1:223,701,593...223,776,018
|
|
G |
CARMIL1 |
capping protein regulator and myosin 1 linker 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CARMIL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:25,279,374...25,620,530
Ensembl chr 6:25,279,078...25,620,530
|
|
G |
CASP1 |
caspase 1 |
decreases expression increases expression |
EXP |
Isoproterenol results in decreased expression of CASP1 mRNA Isoproterenol results in increased expression of CASP1 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP2 |
caspase 2 |
decreases expression increases expression |
ISO |
Isoproterenol results in decreased expression of CASP2 mRNA Isoproterenol results in increased expression of CASP2 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases expression increases cleavage increases activity |
EXP ISO |
Acetylcysteine inhibits the reaction [Isoproterenol results in increased activity of and results in increased cleavage of CASP3 protein]; BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; Isoproterenol results in increased activity of and results in increased cleavage of CASP3 protein Isoproterenol results in increased cleavage of CASP3 protein Isoproterenol results in increased activity of CASP3 protein [Carvedilol co-treated with aliskiren] inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; [erdosteine co-treated with Isoproterenol] affects the expression of CASP3 protein; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; aliskiren inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; anethole inhibits the reaction [Isoproterenol results in increased cleavage of CASP3 protein]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; benidipine inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein]; Carvedilol inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; caryophyllene inhibits the reaction [Isoproterenol results in increased expression of CASP3 mRNA]; Enalapril inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; Glyburide promotes the reaction [Isoproterenol results in increased activity of CASP3 protein]; Hesperidin inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; pifithrin inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; Progesterone inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein]; punicalagin inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; pyrvinium inhibits the reaction [Glyburide promotes the reaction [Isoproterenol results in increased activity of CASP3 protein]]; pyrvinium inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein]; S100A9 protein affects the reaction [Isoproterenol results in increased expression of CASP3 protein]; sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein]; Vanillic Acid inhibits the reaction [Isoproterenol results in increased expression of CASP3 mRNA] Isoproterenol results in increased expression of CASP3 mRNA; Isoproterenol results in increased expression of CASP3 protein BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; Isoproterenol inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]; RAPGEF3 mutant form inhibits the reaction [Isoproterenol inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]]; STAT3 protein affects the reaction [BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]] |
CTD |
PMID:11218852 PMID:17136323 PMID:17961425 PMID:20726854 PMID:21745194 PMID:24286936 PMID:25269373 PMID:25794854 PMID:26982530 PMID:27491814 PMID:28266775 PMID:30152906 PMID:30623541 PMID:31712309 PMID:32865837 PMID:32924446 PMID:33210414 PMID:34816538 PMID:35014750 PMID:35305975 PMID:35430261 PMID:36593721 PMID:37806379 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP6 |
caspase 6 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CASP6 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 4:109,664,388...109,709,767
Ensembl chr 4:109,688,622...109,703,583
|
|
G |
CASP7 |
caspase 7 |
multiple interactions decreases expression |
EXP ISO |
Acetylcysteine inhibits the reaction [Isoproterenol results in increased activity of and results in increased cleavage of CASP7 protein]; Isoproterenol results in increased activity of and results in increased cleavage of CASP7 protein [Isoproterenol co-treated with POSTN protein] results in decreased expression of CASP7 mRNA Isoproterenol results in decreased expression of CASP7 mRNA |
CTD |
PMID:17136323 PMID:24286936 PMID:30303030 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of CASP8 mRNA; Isoproterenol results in increased expression of CASP8 protein Apigenin inhibits the reaction [Isoproterenol results in increased expression of CASP8 protein]; caryophyllene inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA]; Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA]; Vanillic Acid inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA] |
CTD |
PMID:25794854 PMID:26996544 PMID:30152906 PMID:34816538 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases expression increases cleavage increases activity multiple interactions |
ISO |
Isoproterenol results in increased expression of CASP9 mRNA; Isoproterenol results in increased expression of CASP9 protein Isoproterenol results in increased cleavage of CASP9 protein Isoproterenol results in increased activity of CASP9 protein anethole inhibits the reaction [Isoproterenol results in increased cleavage of CASP9 protein]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of CASP9 protein]; caryophyllene inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA]; sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of CASP9 protein]; Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA]; Vanillic Acid inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA] |
CTD |
PMID:24286936 PMID:25794854 PMID:26996544 PMID:30152906 PMID:32865837 PMID:34816538 PMID:35430261 More...
|
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
decreases expression multiple interactions decreases activity increases activity increases expression |
ISO |
Isoproterenol results in decreased expression of CAT protein 5-Methoxypsoralen inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; [Rosuvastatin Calcium co-treated with Isoproterenol] inhibits the reaction [Interleukin-6 results in increased expression of CAT protein]; [Streptozocin co-treated with Isoproterenol] affects the activity of CAT protein; anethole inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Apigenin inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Atenolol inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Atenolol promotes the reaction [Quercetin inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]]; benidipine inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Carvedilol inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased activity of CAT protein]; caryophyllene inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Desmodium gangeticum extract inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; dicarbine inhibits the reaction [Isoproterenol results in increased activity of CAT protein]; Enalapril inhibits the reaction [Isoproterenol results in decreased expression of CAT protein]; erdosteine inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; ferruginol inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Gallic Acid inhibits the reaction [Isoproterenol results in decreased expression of CAT protein]; geraniol inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; geraniol inhibits the reaction [Isoproterenol results in decreased expression of CAT mRNA]; Glyburide promotes the reaction [Isoproterenol results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Isoproterenol results in decreased expression of CAT protein]; imetit inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased activity of CAT protein]; Isoproterenol results in decreased expression of and results in decreased activity of CAT protein; mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; punicalagin inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; pyrvinium inhibits the reaction [Glyburide promotes the reaction [Isoproterenol results in decreased activity of CAT protein]]; pyrvinium inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Quercetin inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Quercetin promotes the reaction [Atenolol inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]]; Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Thymol inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Tretinoin inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Vincristine inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Vincristine inhibits the reaction [Isoproterenol results in decreased expression of CAT protein] Isoproterenol results in decreased expression of CAT mRNA; Isoproterenol results in decreased expression of CAT protein Isoproterenol results in increased expression of CAT mRNA |
CTD |
PMID:1840475 PMID:12708743 PMID:15740881 PMID:16584858 PMID:16697266 PMID:19146839 PMID:20003209 PMID:21322096 PMID:22391854 PMID:24201307 PMID:24954035 PMID:25269373 PMID:25496245 PMID:25537132 PMID:26721194 PMID:27527349 PMID:30152906 PMID:30623541 PMID:32007421 PMID:32946155 PMID:33210414 PMID:34816538 PMID:35014750 PMID:35130744 PMID:35305975 PMID:35430261 PMID:35608392 PMID:35815753 PMID:36593721 PMID:37806379 More...
|
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CAV1 |
caveolin 1 |
multiple interactions |
ISO |
CAV1 protein promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] |
CTD |
PMID:18820136 |
|
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
|
|
G |
CAV3 |
caveolin 3 |
affects localization |
ISO |
Isoproterenol affects the localization of CAV3 protein |
CTD |
PMID:19299911 |
|
NCBI chr 3:8,733,802...8,746,758
Ensembl chr 3:8,733,802...8,841,808
|
|
G |
CBLB |
Cbl proto-oncogene B |
increases expression |
ISO |
Isoproterenol results in increased expression of CBLB mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:105,655,461...105,869,449
Ensembl chr 3:105,655,461...105,869,552
|
|
G |
CCDC80 |
coiled-coil domain containing 80 |
increases expression |
ISO |
Isoproterenol results in increased expression of CCDC80 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:112,596,797...112,641,143
Ensembl chr 3:112,596,797...112,649,530
|
|
G |
CCDC85A |
coiled-coil domain containing 85A |
increases expression |
ISO |
Isoproterenol results in increased expression of CCDC85A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:56,183,852...56,386,174
Ensembl chr 2:56,183,990...56,386,172
|
|
G |
CCL15 |
C-C motif chemokine ligand 15 |
increases expression |
ISO |
Isoproterenol results in increased expression of CCL6 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:35,997,582...36,001,553
Ensembl chr17:35,996,440...36,001,553
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
decreases secretion |
EXP |
Isoproterenol results in decreased secretion of CCL17 protein |
CTD |
PMID:12871855 |
|
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of CCL2 mRNA |
CTD |
PMID:21823215 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL23 |
C-C motif chemokine ligand 23 |
increases expression |
ISO |
Isoproterenol results in increased expression of CCL9 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:36,013,058...36,017,972
Ensembl chr17:36,013,056...36,017,972
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
multiple interactions increases expression decreases expression |
EXP ISO |
Isoproterenol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL3 protein] Isoproterenol results in increased expression of CCL3 protein Isoproterenol results in decreased expression of CCL3 mRNA Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein] |
CTD |
PMID:9863660 PMID:12538206 PMID:21335049 PMID:24286936 |
|
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
decreases expression increases expression |
EXP ISO |
Isoproterenol results in decreased expression of CCL7 mRNA Isoproterenol results in increased expression of CCL7 mRNA |
CTD |
PMID:20211217 PMID:24286936 |
|
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CCN2 |
cellular communication network factor 2 |
increases expression multiple interactions decreases expression |
ISO |
Isoproterenol results in increased expression of CCN2 mRNA Isoproterenol results in increased expression of CCN2 mRNA; Isoproterenol results in increased expression of CCN2 protein Quercetin inhibits the reaction [Isoproterenol results in increased expression of CCN2 mRNA]; Quercetin inhibits the reaction [Isoproterenol results in increased expression of CCN2 protein]; Rutin inhibits the reaction [Isoproterenol results in increased expression of CCN2 mRNA]; Rutin inhibits the reaction [Isoproterenol results in increased expression of CCN2 protein] Isoproterenol results in decreased expression of CCN2 mRNA |
CTD |
PMID:20003209 PMID:24117263 PMID:24286936 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CCND1 |
cyclin D1 |
decreases expression increases expression |
ISO |
Isoproterenol results in decreased expression of CCND1 mRNA Isoproterenol results in increased expression of CCND1 mRNA |
CTD |
PMID:20003209 PMID:21335049 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCND3 |
cyclin D3 |
increases expression |
ISO |
Isoproterenol results in increased expression of CCND3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:41,934,933...42,050,035
Ensembl chr 6:41,934,934...42,050,357
|
|
G |
CCNG2 |
cyclin G2 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of CCNG2 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CCR1 mRNA |
CTD |
PMID:20211217 |
|
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
|
|
G |
CD14 |
CD14 molecule |
increases expression |
ISO |
Isoproterenol results in increased expression of CD14 mRNA |
CTD |
PMID:20003209 PMID:20211217 |
|
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CD163 |
CD163 molecule |
increases expression |
ISO |
Isoproterenol results in increased expression of CD163 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:7,470,811...7,503,777
Ensembl chr12:7,470,811...7,503,893
|
|
G |
CD302 |
CD302 molecule |
increases expression |
ISO |
Isoproterenol results in increased expression of CD302 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:159,768,628...159,798,208
Ensembl chr 2:159,768,628...159,798,255
|
|
G |
CD36 |
CD36 molecule (CD36 blood group) |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CD36 protein |
CTD |
PMID:19826179 |
|
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
|
|
G |
CD38 |
CD38 molecule |
multiple interactions |
ISO |
Isoproterenol promotes the reaction [CD38 gene mutant form results in increased activity of REN protein] |
CTD |
PMID:23343681 |
|
NCBI chr 4:15,778,328...15,853,232
Ensembl chr 4:15,778,275...15,853,232
|
|
G |
CD74 |
CD74 molecule |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CD74 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969
|
|
G |
CDC37 |
cell division cycle 37, HSP90 cochaperone |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of CDC37 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr19:10,391,133...10,403,542
Ensembl chr19:10,391,133...10,420,121
|
|
G |
CDC37L1 |
cell division cycle 37 like 1, HSP90 cochaperone |
increases expression |
ISO |
Isoproterenol results in increased expression of CDC37L1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:4,679,569...4,708,399
Ensembl chr 9:4,679,559...4,708,399
|
|
G |
CDC42EP3 |
CDC42 effector protein 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CDC42EP3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:37,641,944...37,672,949
Ensembl chr 2:37,641,882...37,738,468
|
|
G |
CDC42EP4 |
CDC42 effector protein 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of CDC42EP4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:73,283,624...73,312,001
Ensembl chr17:73,283,624...73,312,005
|
|
G |
CDH11 |
cadherin 11 |
increases expression |
ISO |
Isoproterenol results in increased expression of CDH11 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:64,943,753...65,123,744
Ensembl chr16:64,943,753...65,126,112
|
|
G |
CDH13 |
cadherin 13 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CDH13 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:82,626,969...83,800,640
Ensembl chr16:82,626,965...83,800,640
|
|
G |
CDH2 |
cadherin 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CDH2 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of CDK1 mRNA; Isoproterenol results in increased expression of CDK1 protein Atenolol inhibits the reaction [Isoproterenol results in increased expression of CDK1 mRNA] |
CTD |
PMID:9593584 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of CDKN1A mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CDO1 |
cysteine dioxygenase type 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CDO1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:115,804,733...115,816,659
Ensembl chr 5:115,804,733...115,816,659
|
|
G |
CDS2 |
CDP-diacylglycerol synthase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of CDS2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:5,127,008...5,197,887
Ensembl chr20:5,126,879...5,197,887
|
|
G |
CDV3 |
CDV3 homolog |
increases expression |
ISO |
Isoproterenol results in increased expression of CDV3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:133,573,686...133,590,274
Ensembl chr 3:133,573,686...133,590,261
|
|
G |
CDYL |
chromodomain Y like |
increases expression |
ISO |
Isoproterenol results in increased expression of CDYL mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:4,706,138...4,955,544
Ensembl chr 6:4,706,159...4,955,551
|
|
G |
CEBPD |
CCAAT enhancer binding protein delta |
increases expression |
ISO |
Isoproterenol results in increased expression of CEBPD mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164
|
|
G |
CEBPG |
CCAAT enhancer binding protein gamma |
increases expression |
ISO |
Isoproterenol results in increased expression of CEBPG mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:33,373,709...33,382,686
Ensembl chr19:33,373,685...33,382,686
|
|
G |
CENPA |
centromere protein A |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CENPA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:26,786,056...26,794,589
Ensembl chr 2:26,764,289...26,801,067
|
|
G |
CEP192 |
centrosomal protein 192 |
increases expression |
ISO |
Isoproterenol results in increased expression of CEP192 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr18:12,991,362...13,125,036
Ensembl chr18:12,991,362...13,125,052
|
|
G |
CFH |
complement factor H |
increases expression |
ISO |
Isoproterenol results in increased expression of CFH mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:196,652,043...196,747,504
Ensembl chr 1:196,651,754...196,752,476
|
|
G |
CFTR |
CF transmembrane conductance regulator |
multiple interactions increases activity |
EXP ISO |
[Isoproterenol co-treated with Adenosine] results in increased activity of CFTR protein; Baclofen promotes the reaction [Isoproterenol results in increased activity of CFTR protein]; Enkephalin, Leucine-2-Alanine promotes the reaction [Isoproterenol results in increased activity of CFTR protein]; Serotonin promotes the reaction [Isoproterenol results in increased activity of CFTR protein] |
CTD |
PMID:15020588 PMID:15039139 PMID:15151902 |
|
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
|
|
G |
CH25H |
cholesterol 25-hydroxylase |
increases expression |
ISO |
Isoproterenol results in increased expression of CH25H mRNA |
CTD |
PMID:20211217 |
|
NCBI chr10:89,205,629...89,207,317
Ensembl chr10:89,205,629...89,207,317
|
|
G |
CHAC1 |
ChaC glutathione specific gamma-glutamylcyclotransferase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CHAC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512
|
|
G |
CHKA |
choline kinase alpha |
increases expression |
ISO |
Isoproterenol results in increased expression of CHKA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:68,052,859...68,121,388
Ensembl chr11:68,052,859...68,121,444
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of CHUK mRNA |
CTD |
PMID:30303030 |
|
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
|
|
G |
CIDEC |
cell death inducing DFFA like effector c |
multiple interactions |
ISO |
Isoproterenol results in increased expression of and results in decreased degradation of CIDEC protein; KT 5720 inhibits the reaction [Isoproterenol results in increased expression of CIDEC protein] |
CTD |
PMID:21097823 |
|
NCBI chr 3:9,866,710...9,880,253
Ensembl chr 3:9,866,711...9,880,255
|
|
G |
CILP |
cartilage intermediate layer protein |
increases expression |
ISO |
Isoproterenol results in increased expression of CILP mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:65,194,760...65,211,473
Ensembl chr15:65,194,760...65,211,473
|
|
G |
CIRBP |
cold inducible RNA binding protein |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CIRBP mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:1,269,332...1,274,880
Ensembl chr19:1,259,384...1,274,880
|
|
G |
CITED2 |
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of CITED2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648
|
|
G |
CITED4 |
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CITED4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:40,861,054...40,862,363
Ensembl chr 1:40,861,054...40,862,363
|
|
G |
CKB |
creatine kinase B |
multiple interactions increases activity |
ISO |
benidipine inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]]; Carvedilol inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]]; Gallic Acid inhibits the reaction [Isoproterenol results in increased secretion of [CKM protein binds to CKB protein]]; imetit inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]]; Isoproterenol results in increased expression of [CKM protein binds to CKB protein]; Isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]; Isoproterenol results in increased secretion of [CKM protein binds to CKB protein]; Lutein inhibits the reaction [Isoproterenol results in increased activity of CKB protein] |
CTD |
PMID:19146839 PMID:22391854 PMID:25269373 PMID:25496245 PMID:34435724 |
|
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
|
|
G |
CKM |
creatine kinase, M-type |
multiple interactions increases secretion |
ISO |
[Carvedilol co-treated with aliskiren] inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of CKM protein]; aliskiren inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of CKM protein]; benidipine inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]]; Carvedilol inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]]; Carvedilol inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of CKM protein]; Gallic Acid inhibits the reaction [Isoproterenol results in increased secretion of [CKM protein binds to CKB protein]]; imetit inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]]; Isoproterenol results in increased expression of [CKM protein binds to CKB protein]; Isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]; Isoproterenol results in increased expression of and results in increased secretion of CKM protein; Isoproterenol results in increased secretion of [CKM protein binds to CKB protein]; Quercetin inhibits the reaction [Isoproterenol results in increased secretion of CKM protein] |
CTD |
PMID:19146839 PMID:22391854 PMID:25269373 PMID:25496245 PMID:26982530 PMID:27527349 More...
|
|
NCBI chr19:45,306,413...45,322,875
Ensembl chr19:45,306,413...45,322,875
|
|
G |
CLCA1 |
chloride channel accessory 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CLCA1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:86,468,927...86,500,259
Ensembl chr 1:86,468,368...86,500,259
|
|
G |
CLCN3 |
chloride voltage-gated channel 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CLCN3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:169,620,578...169,723,673
Ensembl chr 4:169,612,633...169,723,673
|
|
G |
CLEC1A |
C-type lectin domain family 1 member A |
increases expression |
ISO |
Isoproterenol results in increased expression of CLEC1A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:10,069,554...10,098,985
Ensembl chr12:10,069,554...10,111,627
|
|
G |
CLEC2D |
C-type lectin domain family 2 member D |
increases expression |
ISO |
Isoproterenol results in increased expression of CLEC2D mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:9,669,713...9,699,553
Ensembl chr12:9,664,969...9,699,553
|
|
G |
CLEC4D |
C-type lectin domain family 4 member D |
increases expression |
ISO |
Isoproterenol results in increased expression of CLEC4D mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:8,513,503...8,531,696
Ensembl chr12:8,509,475...8,522,366
|
|
G |
CLEC6A |
C-type lectin domain containing 6A |
increases expression |
ISO |
Isoproterenol results in increased expression of CLEC4N mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:8,455,962...8,478,330
Ensembl chr12:8,455,962...8,478,330
|
|
G |
CLIC5 |
chloride intracellular channel 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of CLIC5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:45,880,827...46,129,819
Ensembl chr 6:45,880,827...46,080,348
|
|
G |
CLIP1 |
CAP-Gly domain containing linker protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CLIP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:122,271,469...122,422,956
Ensembl chr12:122,271,432...122,422,669
|
|
G |
CLIP4 |
CAP-Gly domain containing linker protein family member 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CLIP4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:29,097,726...29,183,808
Ensembl chr 2:29,097,705...29,199,777
|
|
G |
CLPB |
ClpB family mitochondrial disaggregase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CLPB mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:72,285,495...72,434,531
Ensembl chr11:72,285,495...72,434,680
|
|
G |
CLU |
clusterin |
increases expression |
ISO |
Isoproterenol results in increased expression of CLU mRNA; Isoproterenol results in increased expression of CLU protein |
CTD |
PMID:15052282 PMID:20003209 |
|
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
|
|
G |
CNKSR1 |
connector enhancer of kinase suppressor of Ras 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CNKSR1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:26,177,491...26,189,884
Ensembl chr 1:26,177,484...26,189,884
|
|
G |
CNKSR3 |
CNKSR family member 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of CNKSR3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:154,387,515...154,510,685
Ensembl chr 6:154,387,515...154,510,685
|
|
G |
COBLL1 |
cordon-bleu WH2 repeat protein like 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of COBLL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:164,657,931...164,842,076
Ensembl chr 2:164,653,624...164,843,679
|
|
G |
COL15A1 |
collagen type XV alpha 1 chain |
decreases expression |
ISO |
Isoproterenol results in decreased expression of COL15A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:98,943,907...99,070,787
Ensembl chr 9:98,943,179...99,070,787
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions increases expression |
ISO |
manidipine inhibits the reaction [Isoproterenol results in increased expression of COL1A1 mRNA]; MIR214 mRNA promotes the reaction [Isoproterenol results in increased expression of COL1A1 mRNA] isoprenaline increases expression of Col1a1 protein in blood serum BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of COL1A1 protein]; celastrol methyl ester inhibits the reaction [Isoproterenol results in increased expression of COL1A1 mRNA]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of COL1A1 mRNA]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of COL1A1 protein]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of COL1A1 mRNA]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of COL1A1 protein] Isoproterenol results in increased expression of COL1A1 mRNA; Isoproterenol results in increased expression of COL1A1 protein |
CTD RGD |
PMID:9559417 PMID:24945829 PMID:26692091 PMID:28526319 PMID:31009642 PMID:31712309 PMID:35014750 PMID:37269933 PMID:27318893 More...
|
RGD:156430318 |
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL2A1 |
collagen type II alpha 1 chain |
multiple interactions decreases expression |
ISO |
[N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with U 0126] inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; [N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with U 0126] inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 protein]; DUSP1 protein inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; DUSP1 protein inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 protein]; JUNB protein promotes the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; MAP2K1 protein promotes the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; MAP2K1 protein promotes the reaction [Isoproterenol results in decreased expression of COL2A1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 protein]; Propranolol inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; Propranolol inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 protein]; U 0126 inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; U 0126 inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 protein] Isoproterenol results in decreased expression of COL2A1 mRNA; Isoproterenol results in decreased expression of COL2A1 protein |
CTD |
PMID:21177286 |
|
NCBI chr12:47,972,967...48,006,212
Ensembl chr12:47,972,967...48,004,554
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
multiple interactions increases expression |
ISO |
AGT inhibits the reaction [Isoproterenol results in increased expression of COL3A1 protein]; manidipine inhibits the reaction [Isoproterenol results in increased expression of COL3A1 mRNA]; MIR214 mRNA promotes the reaction [Isoproterenol results in increased expression of COL3A1 mRNA] isoprenaline increases expression of Col3a1 protein in blood serum BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of COL3A1 protein]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of COL3A1 mRNA]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of COL3A1 protein]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of COL3A1 mRNA]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of COL3A1 protein] Isoproterenol results in increased expression of COL3A1 mRNA; Isoproterenol results in increased expression of COL3A1 protein |
CTD RGD |
PMID:9559417 PMID:20409916 PMID:26692091 PMID:31009642 PMID:31712309 PMID:35014750 PMID:27318893 More...
|
RGD:156430318 |
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
COL5A1 |
collagen type V alpha 1 chain |
decreases expression |
ISO |
Isoproterenol results in decreased expression of COL5A1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 9:134,641,803...134,844,843
Ensembl chr 9:134,641,803...134,844,843
|
|
G |
COL5A2 |
collagen type V alpha 2 chain |
increases expression |
ISO |
Isoproterenol results in increased expression of COL5A2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:189,031,898...189,441,111
Ensembl chr 2:189,031,898...189,225,312
|
|
G |
COMT |
catechol-O-methyltransferase |
increases methylation |
EXP |
COMT protein results in increased methylation of Isoproterenol |
CTD |
PMID:11160877 |
|
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
|
|
G |
COPS3 |
COP9 signalosome subunit 3 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of COPS3 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr17:17,246,616...17,281,246
Ensembl chr17:17,246,616...17,281,273
|
|
G |
CORIN |
corin, serine peptidase |
increases expression |
ISO |
Isoproterenol results in increased expression of CORIN mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:47,594,001...47,838,067
Ensembl chr 4:47,593,999...47,838,106
|
|
G |
CP |
ceruloplasmin |
multiple interactions increases expression decreases activity |
ISO |
allyl sulfide inhibits the reaction [Isoproterenol results in decreased activity of CP protein] Isoproterenol results in increased expression of CP protein Isoproterenol results in increased expression of CP mRNA |
CTD |
PMID:1521861 PMID:15261977 PMID:20003209 |
|
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
|
|
G |
CPNE8 |
copine 8 |
increases expression |
ISO |
Isoproterenol results in increased expression of CPNE8 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:38,652,203...38,906,835
Ensembl chr12:38,646,822...38,907,430
|
|
G |
CPS1 |
carbamoyl-phosphate synthase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CPS1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107
|
|
G |
CPT1A |
carnitine palmitoyltransferase 1A |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of CPT1A mRNA |
CTD |
PMID:30303030 |
|
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
|
|
G |
CPT1B |
carnitine palmitoyltransferase 1B |
multiple interactions decreases expression |
ISO |
Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT1B mRNA]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT1B mRNA]] |
CTD |
PMID:25045214 |
|
NCBI chr22:50,568,861...50,578,612
Ensembl chr22:50,568,861...50,578,465
|
|
G |
CPT2 |
carnitine palmitoyltransferase 2 |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of CPT2 mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of CPT2 mRNA; Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT2 mRNA]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT2 mRNA]] |
CTD |
PMID:25045214 PMID:30303030 |
|
NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197
|
|
G |
CRB1 |
crumbs cell polarity complex component 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CRB1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:197,201,504...197,478,455
Ensembl chr 1:197,268,204...197,478,455
|
|
G |
CRBN |
cereblon |
increases expression |
ISO |
Isoproterenol results in increased expression of CRBN mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:3,149,633...3,179,717
Ensembl chr 3:3,144,628...3,179,727
|
|
G |
CREB1 |
cAMP responsive element binding protein 1 |
multiple interactions increases phosphorylation |
ISO |
oxophenylarsine inhibits the reaction [Isoproterenol results in increased phosphorylation of CREB1 protein] CREM protein inhibits the reaction [Isoproterenol results in increased activity of CREB1 protein]; swietenine inhibits the reaction [Isoproterenol results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:12791704 PMID:17141199 PMID:21745194 PMID:32686902 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
G |
CREM |
cAMP responsive element modulator |
multiple interactions increases expression affects localization |
ISO |
CREM protein inhibits the reaction [Isoproterenol results in increased activity of CREB1 protein]; CREM protein inhibits the reaction [Isoproterenol results in increased expression of FOS mRNA]; CREM protein inhibits the reaction [Isoproterenol results in increased expression of NPPA protein] Isoproterenol results in increased expression of CREM mRNA; Isoproterenol results in increased expression of CREM protein Isoproterenol affects the localization of CREM protein |
CTD |
PMID:12791704 PMID:20211217 |
|
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
|
|
G |
CRLF1 |
cytokine receptor like factor 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CRLF1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:18,593,237...18,606,799
Ensembl chr19:18,572,220...18,607,741
|
|
G |
CRP |
C-reactive protein |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of CRP protein benidipine inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of CRP protein]; geraniol inhibits the reaction [Isoproterenol results in increased expression of CRP protein]; Isoproterenol results in increased expression of and results in increased secretion of CRP protein |
CTD |
PMID:25269373 PMID:35608392 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CRYAB |
crystallin alpha B |
multiple interactions |
ISO |
Isoproterenol inhibits the reaction [arsenite results in increased expression of CRYAB protein] |
CTD |
PMID:8769853 |
|
NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722
|
|
G |
CRYBA4 |
crystallin beta A4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CRYBA4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:26,590,220...26,630,669
Ensembl chr22:26,621,963...26,630,669
|
|
G |
CS |
citrate synthase |
decreases activity |
ISO |
Isoproterenol results in decreased activity of CS protein |
CTD |
PMID:27491814 |
|
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
|
|
G |
CSDC2 |
cold shock domain containing C2 |
increases expression |
ISO |
Isoproterenol results in increased expression of CSDC2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:41,561,010...41,576,666
Ensembl chr22:41,561,010...41,577,741
|
|
G |
CSF2RB |
colony stimulating factor 2 receptor subunit beta |
increases expression |
ISO |
Isoproterenol results in increased expression of CSF2RB mRNA; Isoproterenol results in increased expression of CSF2RB2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:36,913,628...36,940,439
Ensembl chr22:36,913,628...36,940,439
|
|
G |
CSK |
C-terminal Src kinase |
multiple interactions |
ISO |
CSK protein promotes the reaction [Isoproterenol results in increased abundance of Cyclic AMP]; Isoproterenol inhibits the reaction [CSK protein promotes the reaction [Epinephrine results in increased abundance of Cyclic AMP]] |
CTD |
PMID:1699227 |
|
NCBI chr15:74,782,080...74,803,197
Ensembl chr15:74,782,080...74,803,197
|
|
G |
CTF1 |
cardiotrophin 1 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of CTF1 mRNA; Isoproterenol results in increased expression of CTF1 protein Spironolactone inhibits the reaction [Isoproterenol results in increased expression of CTF1 mRNA]; Spironolactone inhibits the reaction [Isoproterenol results in increased expression of CTF1 protein]; valsartan inhibits the reaction [Isoproterenol results in increased expression of CTF1 mRNA]; valsartan inhibits the reaction [Isoproterenol results in increased expression of CTF1 protein] |
CTD |
PMID:23288202 |
|
NCBI chr16:30,895,846...30,903,560
Ensembl chr16:30,896,614...30,903,547
|
|
G |
CTH |
cystathionine gamma-lyase |
multiple interactions |
ISO |
[Isoproterenol co-treated with Caffeine] results in decreased expression of CTH mRNA |
CTD |
PMID:29447158 |
|
NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851
|
|
G |
CTHRC1 |
collagen triple helix repeat containing 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CTHRC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:103,371,538...103,382,989
Ensembl chr 8:103,371,538...103,382,989
|
|
G |
CTNNAL1 |
catenin alpha like 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CTNNAL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:108,942,577...109,013,499
Ensembl chr 9:108,942,569...109,013,522
|
|
G |
CTNNB1 |
catenin beta 1 |
multiple interactions increases expression |
ISO |
[Glyburide co-treated with Isoproterenol] results in increased expression of CTNNB1 mRNA; Glyburide promotes the reaction [Isoproterenol results in increased expression of CTNNB1 protein]; pyrvinium inhibits the reaction [[Glyburide co-treated with Isoproterenol] results in increased expression of CTNNB1 mRNA]; pyrvinium inhibits the reaction [Glyburide promotes the reaction [Isoproterenol results in increased expression of CTNNB1 protein]]; pyrvinium inhibits the reaction [Isoproterenol results in increased expression of CTNNB1 mRNA]; pyrvinium inhibits the reaction [Isoproterenol results in increased expression of CTNNB1 protein] Isoproterenol results in increased expression of CTNNB1 mRNA; Isoproterenol results in increased expression of CTNNB1 protein |
CTD |
PMID:35305975 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CTNNBIP1 |
catenin beta interacting protein 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CTNNBIP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:9,848,276...9,910,269
Ensembl chr 1:9,848,276...9,910,336
|
|
G |
CTPS2 |
CTP synthase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of CTPS2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:16,587,999...16,712,910
Ensembl chr X:16,587,999...16,712,936
|
|
G |
CTSB |
cathepsin B |
multiple interactions increases activity decreases expression decreases activity |
ISO |
caffeic acid inhibits the reaction [Isoproterenol results in increased activity of CTSB protein]; Curcumin inhibits the reaction [Isoproterenol results in increased activity of CTSB protein]; epigallocatechin gallate inhibits the reaction [Isoproterenol results in increased activity of CTSB protein]; naringin inhibits the reaction [Isoproterenol results in decreased activity of CTSB protein]; naringin inhibits the reaction [Isoproterenol results in increased activity of CTSB protein]; Phytic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] Isoproterenol results in decreased expression of CTSB mRNA |
CTD |
PMID:2015110 PMID:8534267 PMID:17188415 PMID:18294627 PMID:20391626 PMID:21335049 PMID:25560919 More...
|
|
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
|
|
G |
CTSD |
cathepsin D |
multiple interactions affects activity increases activity decreases activity increases expression |
ISO |
[ferulic acid co-treated with Ascorbic Acid] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein]; [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein]; [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein]; alliin affects the reaction [Isoproterenol affects the activity of CTSD protein]; caffeic acid inhibits the reaction [Isoproterenol affects the activity of CTSD protein]; Curcumin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein]; Curcumin inhibits the reaction [Isoproterenol results in increased activity of CTSD protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSD protein]; epigallocatechin gallate inhibits the reaction [Isoproterenol affects the activity of CTSD protein]; mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein]; Methylprednisolone inhibits the reaction [Isoproterenol results in increased expression of CTSD mRNA]; naringin inhibits the reaction [Isoproterenol results in increased activity of CTSD protein]; Phytic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSD protein]; Plant Extracts inhibits the reaction [Isoproterenol results in increased activity of CTSD protein]; S-allylcysteine inhibits the reaction [Isoproterenol results in increased expression of CTSD mRNA] Isoproterenol results in increased expression of CTSD mRNA; Isoproterenol results in increased expression of CTSD protein |
CTD |
PMID:894732 PMID:2015110 PMID:8534267 PMID:11829124 PMID:14499179 PMID:17045618 PMID:17182065 PMID:17188415 PMID:17623887 PMID:18294627 PMID:18424012 PMID:19172585 PMID:19641666 PMID:20391626 PMID:21762681 PMID:25560919 More...
|
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
|
|
G |
CTSL |
cathepsin L |
increases expression |
ISO |
Isoproterenol results in increased expression of CTSL mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
|
|
G |
CUL1 |
cullin 1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of CUL1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 7:148,697,756...148,801,110
Ensembl chr 7:148,697,914...148,801,110
|
|
G |
CUL4B |
cullin 4B |
increases expression |
ISO |
Isoproterenol results in increased expression of CUL4B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:120,523,858...120,575,532
Ensembl chr X:120,505,920...120,604,074
|
|
G |
CUX2 |
cut like homeobox 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CUX2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:111,034,165...111,350,554
Ensembl chr12:111,034,165...111,350,554
|
|
G |
CUZD1 |
CUB and zona pellucida like domains 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CUZD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:122,832,158...122,845,857
Ensembl chr10:122,832,158...122,846,175
|
|
G |
CXCL13 |
C-X-C motif chemokine ligand 13 |
increases expression |
ISO |
Isoproterenol results in increased expression of CXCL13 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:77,511,753...77,611,834
Ensembl chr 4:77,511,753...77,611,834
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions increases expression |
EXP |
Isoproterenol promotes the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]; Isoproterenol promotes the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein] Isoproterenol results in increased expression of CXCL8 mRNA |
CTD |
PMID:9258252 PMID:21088047 PMID:32816093 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CXCL9 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
increases activity |
ISO |
Isoproterenol results in increased activity of CXCR2 protein |
CTD |
PMID:15477226 |
|
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
|
|
G |
CXXC5 |
CXXC finger protein 5 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CXXC5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:139,647,299...139,683,882
Ensembl chr 5:139,647,299...139,683,882
|
|
G |
CYBA |
cytochrome b-245 alpha chain |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of CYBA mRNA CPU0213 inhibits the reaction [Isoproterenol results in increased expression of CYBA mRNA]; pimagedine inhibits the reaction [Isoproterenol results in increased expression of CYBA mRNA] |
CTD |
PMID:18594475 |
|
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
|
|
G |
CYCS |
cytochrome c, somatic |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of CYCS protein Apigenin inhibits the reaction [Isoproterenol results in increased expression of CYCS protein] |
CTD |
PMID:30152906 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
decreases expression increases expression multiple interactions |
EXP ISO |
Isoproterenol results in decreased expression of CYP1A1 mRNA Isoproterenol results in increased expression of CYP1A1 mRNA Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A1 protein]; Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A1 protein]] |
CTD |
PMID:15627480 PMID:15710352 PMID:18725507 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
multiple interactions |
EXP ISO |
Isoproterenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]; Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] |
CTD |
PMID:15710352 PMID:18493746 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CYP1B1 mRNA |
CTD |
PMID:18725507 PMID:20003209 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP26B1 |
cytochrome P450 family 26 subfamily B member 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:72,129,238...72,147,862
Ensembl chr 2:72,129,238...72,147,862
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
increases activity |
ISO |
Isoproterenol results in increased activity of CYP2A5 protein |
CTD |
PMID:11162586 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
increases expression |
ISO |
Isoproterenol results in increased expression of CYP2B10 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP2C18 |
cytochrome P450 family 2 subfamily C member 18 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of CYP2C11 mRNA |
CTD |
PMID:18725507 |
|
NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
affects expression |
ISO |
Isoproterenol affects the expression of CYP2E1 mRNA |
CTD |
PMID:18725507 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
CYSLTR1 |
cysteinyl leukotriene receptor 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of CYSLTR1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:78,271,468...78,327,611
Ensembl chr X:78,271,468...78,327,691
|
|
G |
DAG1 |
dystroglycan 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DAG1 |
CTD |
PMID:18808529 |
|
NCBI chr 3:49,468,948...49,535,615
Ensembl chr 3:49,468,713...49,535,618
|
|
G |
DAP |
death associated protein |
multiple interactions increases expression |
ISO |
[Isoproterenol co-treated with POSTN protein] results in increased expression of DAP mRNA Isoproterenol results in increased expression of DAP mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 5:10,679,230...10,761,234
Ensembl chr 5:10,679,230...10,761,234
|
|
G |
DBP |
D-box binding PAR bZIP transcription factor |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DBP mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:48,630,030...48,637,379
Ensembl chr19:48,630,030...48,637,379
|
|
G |
DCAKD |
dephospho-CoA kinase domain containing |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DCAKD mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:45,023,338...45,061,131
Ensembl chr17:45,023,338...45,061,131
|
|
G |
DCN |
decorin |
increases expression |
ISO |
Isoproterenol results in increased expression of DCN mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:91,140,484...91,182,817
Ensembl chr12:91,140,484...91,183,217
|
|
G |
DCT |
dopachrome tautomerase |
increases expression |
ISO |
Isoproterenol results in increased expression of DCT mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:94,436,811...94,549,406
Ensembl chr13:94,436,811...94,479,682
|
|
G |
DCTN5 |
dynactin subunit 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of DCTN5 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr16:23,641,466...23,677,472
Ensembl chr16:23,641,466...23,677,472
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of DDIT3 mRNA [Acrolein results in increased susceptibility to Isoproterenol] which results in increased expression of DDIT3 protein; Acrolein promotes the reaction [Isoproterenol results in increased expression of DDIT3 mRNA]; Plant Extracts inhibits the reaction [[Acrolein results in increased susceptibility to Isoproterenol] which results in increased expression of DDIT3 protein]; Plant Extracts inhibits the reaction [Acrolein promotes the reaction [Isoproterenol results in increased expression of DDIT3 mRNA]] |
CTD |
PMID:21823215 PMID:29414845 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DDIT4 |
DNA damage inducible transcript 4 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of DDIT4 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
|
|
G |
DDOST |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit |
increases expression |
ISO |
Isoproterenol results in increased expression of DDOST mRNA |
CTD |
PMID:21823215 |
|
NCBI chr 1:20,651,777...20,661,369
Ensembl chr 1:20,651,767...20,661,544
|
|
G |
DEFB1 |
defensin beta 1 |
decreases expression increases expression |
ISO |
Isoproterenol results in decreased expression of DEFB1 mRNA Isoproterenol results in increased expression of DEFB1 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936
|
|
G |
DENND4A |
DENN domain containing 4A |
increases expression |
ISO |
Isoproterenol results in increased expression of DENND4A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:65,659,123...65,792,293
Ensembl chr15:65,658,046...65,792,293
|
|
G |
DERL2 |
derlin 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of DERL2 mRNA |
CTD |
PMID:21823215 |
|
NCBI chr17:5,471,254...5,486,817
Ensembl chr17:5,471,254...5,486,811
|
|
G |
DERL3 |
derlin 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DERL3 mRNA |
CTD |
PMID:21823215 |
|
NCBI chr22:23,834,503...23,839,006
Ensembl chr22:23,834,503...23,839,128
|
|
G |
DES |
desmin |
multiple interactions decreases expression |
ISO |
Lutein inhibits the reaction [Isoproterenol results in decreased expression of DES protein] |
CTD |
PMID:34435724 |
|
NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,735
|
|
G |
DFFB |
DNA fragmentation factor subunit beta |
increases expression |
ISO |
Isoproterenol results in increased expression of DFFB mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429
|
|
G |
DHCR24 |
24-dehydrocholesterol reductase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DHCR24 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
|
|
G |
DHRS3 |
dehydrogenase/reductase 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DHRS3 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 1:12,567,910...12,618,210
Ensembl chr 1:12,567,910...12,618,210
|
|
G |
DHRS7 |
dehydrogenase/reductase 7 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DHRS7 mRNA |
CTD |
PMID:20003209 PMID:21335049 |
|
NCBI chr14:60,144,119...60,169,889
Ensembl chr14:60,144,119...60,169,856
|
|
G |
DHRS7C |
dehydrogenase/reductase 7C |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DHRS7C mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:9,771,438...9,791,592
Ensembl chr17:9,771,434...9,791,592
|
|
G |
DIAPH2 |
diaphanous related formin 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of DIAPH2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:96,684,842...97,604,997
Ensembl chr X:96,684,712...97,604,997
|
|
G |
DIO2 |
iodothyronine deiodinase 2 |
increases expression increases activity |
ISO |
Isoproterenol results in increased expression of DIO2 mRNA Isoproterenol results in increased activity of DIO2 protein |
CTD |
PMID:15345674 PMID:20003209 |
|
NCBI chr14:80,197,526...80,231,057
Ensembl chr14:80,197,526...80,387,757
|
|
G |
DIXDC1 |
DIX domain containing 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of DIXDC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:111,927,315...112,022,653
Ensembl chr11:111,927,144...112,022,653
|
|
G |
DLAT |
dihydrolipoamide S-acetyltransferase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DLAT mRNA |
CTD |
PMID:21335049 |
|
NCBI chr11:112,025,408...112,064,404
Ensembl chr11:112,025,033...112,064,404
|
|
G |
DMAC2L |
distal membrane arm assembly component 2 like |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of DMAC2L mRNA |
CTD |
PMID:30303030 |
|
NCBI chr14:50,311,516...50,327,957
Ensembl chr14:50,312,324...50,335,558
|
|
G |
DMD |
dystrophin |
multiple interactions decreases expression |
ISO |
DMD gene mutant form promotes the reaction [ITGB1 gene affects the susceptibility to Isoproterenol] Isoproterenol results in decreased expression of DMD |
CTD |
PMID:18340010 PMID:18808529 |
|
NCBI chr X:31,119,222...33,339,388
Ensembl chr X:31,097,677...33,339,609
|
|
G |
DNAJB11 |
DnaJ heat shock protein family (Hsp40) member B11 |
increases expression |
ISO |
Isoproterenol results in increased expression of DNAJB11 mRNA |
CTD |
PMID:21823215 |
|
NCBI chr 3:186,570,720...186,585,793
Ensembl chr 3:186,567,403...186,585,800
|
|
G |
DNAJB9 |
DnaJ heat shock protein family (Hsp40) member B9 |
increases expression |
ISO |
Isoproterenol results in increased expression of DNAJB9 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
|
|
G |
DNM1L |
dynamin 1 like |
increases phosphorylation |
ISO |
Isoproterenol results in increased phosphorylation of DNM1L protein |
CTD |
PMID:27491814 |
|
NCBI chr12:32,679,301...32,745,650
Ensembl chr12:32,679,200...32,745,650
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
decreases expression increases expression |
ISO |
Isoproterenol results in decreased expression of DNMT3A mRNA Isoproterenol results in increased expression of DNMT3A protein |
CTD |
PMID:20003209 PMID:24945829 |
|
NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
|
|
G |
DNMT3B |
DNA methyltransferase 3 beta |
increases expression |
ISO |
Isoproterenol results in increased expression of DNMT3B mRNA |
CTD |
PMID:21335049 |
|
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
|
|
G |
DNTTIP2 |
deoxynucleotidyltransferase terminal interacting protein 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of DNTTIP2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:93,866,284...93,879,206
Ensembl chr 1:93,866,284...93,879,918
|
|
G |
DOC2GP |
double C2 domain gamma, pseudogene |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DOC2G mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:67,613,524...67,615,664
Ensembl chr11:67,612,837...67,616,257
|
|
G |
DOCK10 |
dedicator of cytokinesis 10 |
increases expression |
ISO |
Isoproterenol results in increased expression of DOCK10 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:224,765,090...225,042,468
Ensembl chr 2:224,765,090...225,042,468
|
|
G |
DOCK9 |
dedicator of cytokinesis 9 |
increases expression |
ISO |
Isoproterenol results in increased expression of DOCK9 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:98,793,429...99,088,619
Ensembl chr13:98,793,429...99,086,625
|
|
G |
DPEP1 |
dipeptidase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of DPEP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:89,613,308...89,641,540
Ensembl chr16:89,613,308...89,638,456
|
|
G |
DPP7 |
dipeptidyl peptidase 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of DPP7 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:137,110,546...137,118,306
Ensembl chr 9:137,110,542...137,118,309
|
|
G |
DSG2 |
desmoglein 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DSG2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr18:31,498,177...31,549,008
Ensembl chr18:31,498,177...31,549,008
|
|
G |
DTX4 |
deltex E3 ubiquitin ligase 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of DTX4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:59,171,430...59,208,588
Ensembl chr11:59,171,430...59,208,588
|
|
G |
DUSP1 |
dual specificity phosphatase 1 |
multiple interactions |
ISO |
DUSP1 protein inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; DUSP1 protein inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 protein]; DUSP1 protein inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK1 protein]; DUSP1 protein inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:21177286 |
|
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
|
|
G |
DUSP4 |
dual specificity phosphatase 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of DUSP4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684
|
|
G |
DUSP5 |
dual specificity phosphatase 5 |
decreases expression |
ISO |
isoprenaline decreases expression of Dusp5 mRNA and protein in cardiac muscle cells |
RGD |
PMID:27318893 |
RGD:156430318 |
NCBI chr10:110,497,907...110,511,533
Ensembl chr10:110,497,907...110,511,533
|
|
G |
DUSP8 |
dual specificity phosphatase 8 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of DUSP8 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:1,554,051...1,572,848
Ensembl chr11:1,554,051...1,572,271
|
|
G |
DXO |
decapping exoribonuclease |
increases expression |
ISO |
Isoproterenol results in increased expression of DXO mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 6:31,969,815...31,972,138
Ensembl chr 6:31,969,810...31,972,290
|
|
G |
ECM1 |
extracellular matrix protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ECM1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:150,508,109...150,513,789
Ensembl chr 1:150,508,062...150,513,789
|
|
G |
EDEM1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of EDEM1 mRNA |
CTD |
PMID:21335049 PMID:21823215 |
|
NCBI chr 3:5,187,707...5,219,958
Ensembl chr 3:5,187,646...5,219,958
|
|
G |
EDN1 |
endothelin 1 |
multiple interactions increases activity increases expression |
ISO |
Cyclosporine inhibits the reaction [Isoproterenol results in increased activity of EDN1 promoter]; Glyburide inhibits the reaction [natakalim inhibits the reaction [Isoproterenol results in increased expression of EDN1 mRNA]]; Glyburide inhibits the reaction [natakalim inhibits the reaction [Isoproterenol results in increased expression of EDN1 protein]]; N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Isoproterenol results in increased expression of EDN1 mRNA]; N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Isoproterenol results in increased expression of EDN1 protein]; natakalim inhibits the reaction [Isoproterenol results in increased expression of EDN1 mRNA]; natakalim inhibits the reaction [Isoproterenol results in increased expression of EDN1 protein]; Nifedipine inhibits the reaction [Isoproterenol results in increased activity of EDN1 promoter] Isoproterenol results in increased expression of EDN1 mRNA; Isoproterenol results in increased expression of EDN1 protein |
CTD |
PMID:9861301 PMID:11435416 PMID:27174236 PMID:27890915 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EDNRA |
endothelin receptor type A |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of EDNRA mRNA Isoproterenol results in increased expression of EDNRA mRNA; Isoproterenol results in increased expression of EDNRA protein CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA]; CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA protein]; natakalim inhibits the reaction [Isoproterenol results in increased expression of EDNRA protein]; pimagedine inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA] |
CTD |
PMID:18594475 PMID:20003209 PMID:20307649 PMID:27174236 |
|
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
|
|
G |
EDNRB |
endothelin receptor type B |
multiple interactions increases expression |
ISO |
CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRB mRNA]; natakalim inhibits the reaction [Isoproterenol results in increased expression of EDNRB protein] Isoproterenol results in increased expression of EDNRB mRNA; Isoproterenol results in increased expression of EDNRB protein |
CTD |
PMID:18594475 PMID:27174236 |
|
NCBI chr13:77,895,481...77,975,527
Ensembl chr13:77,895,481...77,975,529
|
|
G |
EEF1AKMT1 |
EEF1A lysine methyltransferase 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of EEF1AKMT1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:20,728,731...20,773,961
Ensembl chr13:20,728,731...20,773,961
|
|
G |
EFHD2 |
EF-hand domain family member D2 |
increases expression |
ISO |
Isoproterenol results in increased expression of EFHD2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:15,409,888...15,430,339
Ensembl chr 1:15,409,888...15,430,339
|
|
G |
EGFR |
epidermal growth factor receptor |
increases expression multiple interactions |
ISO EXP |
Isoproterenol results in increased expression of EGFR mRNA Isoproterenol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein] |
CTD |
PMID:18787115 PMID:20003209 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGR1 |
early growth response 1 |
multiple interactions increases expression decreases expression |
ISO |
EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 mRNA]; EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 protein]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of ACTA1 mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of JUN mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of NAB2 mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of NPPA mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of SP1 mRNA] Isoproterenol results in increased expression of EGR1 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein] Isoproterenol results in decreased expression of EGR1 mRNA |
CTD |
PMID:10710348 PMID:15621046 PMID:20003209 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
|
|
G |
EIF4A2 |
eukaryotic translation initiation factor 4A2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of EIF4A2 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 3:186,783,577...186,789,897
Ensembl chr 3:186,783,205...186,789,897
|
|
G |
EIF4E |
eukaryotic translation initiation factor 4E |
decreases expression |
ISO |
Isoproterenol results in decreased expression of EIF4E mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:98,879,276...98,929,133
Ensembl chr 4:98,879,276...98,929,133
|
|
G |
ELL2 |
elongation factor for RNA polymerase II 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of ELL2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:95,885,098...95,961,851
Ensembl chr 5:95,885,098...95,961,851
|
|
G |
ELN |
elastin |
multiple interactions increases expression |
ISO |
[Isoproterenol co-treated with Hydralazine] results in increased expression of ELN protein Isoproterenol results in increased expression of ELN protein |
CTD |
PMID:3446201 |
|
NCBI chr 7:74,028,173...74,069,907
Ensembl chr 7:74,027,789...74,069,907
|
|
G |
ELOVL1 |
ELOVL fatty acid elongase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ELOVL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:43,363,401...43,368,011
Ensembl chr 1:43,363,398...43,368,074
|
|
G |
ELP1 |
elongator acetyltransferase complex subunit 1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of ELP1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 9:108,867,517...108,934,124
Ensembl chr 9:108,866,898...108,934,328
|
|
G |
ENC1 |
ectodermal-neural cortex 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ENC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:74,627,409...74,640,728
Ensembl chr 5:74,627,406...74,641,424
|
|
G |
ENO1 |
enolase 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ENO1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
|
|
G |
ENPP1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ENPP1 protein |
CTD |
PMID:21414308 |
|
NCBI chr 6:131,808,020...131,895,155
Ensembl chr 6:131,808,016...131,895,155
|
|
G |
ENTPD1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ENTPD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:95,694,186...95,877,266
Ensembl chr10:95,711,779...95,877,266
|
|
G |
EPS8 |
EGFR pathway substrate 8, signaling adaptor |
increases expression |
ISO |
Isoproterenol results in increased expression of EPS8 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:15,620,134...15,789,388
Ensembl chr12:15,620,134...15,882,329
|
|
G |
EREG |
epiregulin |
increases expression |
EXP |
Isoproterenol results in increased expression of EREG mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
|
|
G |
ERP29 |
endoplasmic reticulum protein 29 |
increases expression |
ISO |
Isoproterenol results in increased expression of ERP29 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr12:112,013,426...112,023,449
Ensembl chr12:112,013,348...112,023,449
|
|
G |
ERRFI1 |
ERBB receptor feedback inhibitor 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ERRFI1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:8,011,727...8,026,309
Ensembl chr 1:8,004,404...8,026,309
|
|
G |
ETF1 |
eukaryotic translation termination factor 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ETF1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:138,506,095...138,543,236
Ensembl chr 5:138,506,095...138,543,236
|
|
G |
EZH1 |
enhancer of zeste 1 polycomb repressive complex 2 subunit |
increases expression |
ISO |
Isoproterenol results in increased expression of EZH1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:42,700,275...42,745,040
Ensembl chr17:42,700,275...42,745,049
|
|
G |
F13A1 |
coagulation factor XIII A chain |
increases expression |
ISO |
Isoproterenol results in increased expression of F13A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013
|
|
G |
FABP3 |
fatty acid binding protein 3 |
increases expression decreases expression |
ISO |
Isoproterenol results in increased expression of FABP3 protein Isoproterenol results in decreased expression of FABP3 protein |
CTD |
PMID:19549929 PMID:19826179 PMID:19854236 PMID:22878004 |
|
NCBI chr 1:31,359,588...31,373,076
Ensembl chr 1:31,365,253...31,376,850
|
|
G |
FABP5 |
fatty acid binding protein 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of FABP5 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 8:81,280,536...81,284,775
Ensembl chr 8:81,280,536...81,284,777
|
|
G |
FAM110D |
family with sequence similarity 110 member D |
increases expression |
ISO |
Isoproterenol results in increased expression of FAM110D mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:26,159,079...26,163,962
Ensembl chr 1:26,159,079...26,163,962
|
|
G |
FAM117B |
family with sequence similarity 117 member B |
increases expression |
ISO |
Isoproterenol results in increased expression of FAM117B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:202,634,969...202,769,757
Ensembl chr 2:202,634,969...202,769,757
|
|
G |
FARP1 |
FERM, ARH/RhoGEF and pleckstrin domain protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of FARP1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr13:98,142,589...98,455,176
Ensembl chr13:98,142,562...98,455,176
|
|
G |
FAS |
Fas cell surface death receptor |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of FAS mRNA Apigenin inhibits the reaction [Isoproterenol results in increased expression of FAS protein]; caryophyllene inhibits the reaction [Isoproterenol results in increased expression of FAS mRNA]; Thymol inhibits the reaction [Isoproterenol results in increased expression of FAS mRNA]; Vanillic Acid inhibits the reaction [Isoproterenol results in increased expression of FAS mRNA] Isoproterenol results in increased expression of FAS mRNA; Isoproterenol results in increased expression of FAS protein |
CTD |
PMID:11218852 PMID:20003209 PMID:24286936 PMID:25794854 PMID:26996544 PMID:30152906 PMID:34816538 More...
|
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
increases expression |
ISO |
Isoproterenol results in increased expression of FASLG protein |
CTD |
PMID:19001025 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FBLIM1 |
filamin binding LIM protein 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of FBLIM1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:15,756,638...15,786,589
Ensembl chr 1:15,756,607...15,786,594
|
|
G |
FBLN2 |
fibulin 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of FBLN2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:13,549,125...13,638,404
Ensembl chr 3:13,549,125...13,638,422
|
|
G |
FBXL20 |
F-box and leucine rich repeat protein 20 |
increases expression |
ISO |
Isoproterenol results in increased expression of FBXL20 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:39,252,663...39,402,556
Ensembl chr17:39,252,663...39,402,523
|
|
G |
FBXO31 |
F-box protein 31 |
increases expression |
ISO |
Isoproterenol results in increased expression of FBXO31 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:87,326,987...87,392,121
Ensembl chr16:87,326,987...87,392,142
|
|
G |
FBXO32 |
F-box protein 32 |
increases expression |
ISO |
Isoproterenol results in increased expression of FBXO32 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:123,497,889...123,541,206
Ensembl chr 8:123,497,889...123,541,206
|
|
G |
FBXO9 |
F-box protein 9 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of FBXO9 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 6:53,064,998...53,100,873
Ensembl chr 6:53,051,991...53,100,873
|
|
G |
FBXW7 |
F-box and WD repeat domain containing 7 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of FBXW7 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:152,320,544...152,536,092
Ensembl chr 4:152,320,544...152,536,092
|
|
G |
FCGR2B |
Fc gamma receptor IIb |
increases expression |
ISO |
Isoproterenol results in increased expression of FCGR2B mRNA |
CTD |
PMID:20003209 PMID:20211217 |
|
NCBI chr 1:161,647,243...161,678,654
Ensembl chr 1:161,663,143...161,678,654
|
|
G |
FCGR3A |
Fc gamma receptor IIIa |
increases expression |
ISO |
Isoproterenol results in increased expression of FCGR4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
|
|
G |
FEN1 |
flap structure-specific endonuclease 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of FEN1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr11:61,792,911...61,797,238
Ensembl chr11:61,792,911...61,797,238
|
|
G |
FETUB |
fetuin B |
increases expression |
ISO |
Isoproterenol results in increased expression of FETUB mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:186,635,969...186,653,141
Ensembl chr 3:186,635,969...186,653,141
|
|
G |
FGF16 |
fibroblast growth factor 16 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of FGF16 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:77,447,389...77,457,278
Ensembl chr X:77,447,389...77,457,278
|
|
G |
FGFR3 |
fibroblast growth factor receptor 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of FGFR3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872
|
|
G |
FHL1 |
four and a half LIM domains 1 |
decreases expression increases expression |
EXP ISO |
Isoproterenol results in decreased expression of FHL1 mRNA Isoproterenol results in increased expression of FHL1 mRNA |
CTD |
PMID:20211217 PMID:23558518 PMID:24286936 |
|
NCBI chr X:136,146,702...136,211,359
Ensembl chr X:136,146,702...136,211,359
|
|
G |
FIS1 |
fission, mitochondrial 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of FIS1 protein |
CTD |
PMID:27491814 |
|
NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316
|
|
G |
FKBP1B |
FKBP prolyl isomerase 1B |
multiple interactions decreases expression |
ISO |
1-(methanesulfonamido-1-naphthyloxy)-2-(N-(4-methane sulfonamidophenethyl)-N-acetamido)ethane inhibits the reaction [Isoproterenol results in decreased expression of FKBP1B mRNA]; 1-(methanesulfonamido-1-naphthyloxy)-2-(N-(4-methane sulfonamidophenethyl)-N-acetamido)ethane inhibits the reaction [Isoproterenol results in decreased expression of FKBP1B protein]; dofetilide inhibits the reaction [Isoproterenol results in decreased expression of FKBP1B mRNA]; dofetilide inhibits the reaction [Isoproterenol results in decreased expression of FKBP1B protein] Isoproterenol results in decreased expression of FKBP1B mRNA; Isoproterenol results in decreased expression of FKBP1B protein |
CTD |
PMID:20723002 |
|
NCBI chr 2:24,033,206...24,063,681
Ensembl chr 2:24,049,701...24,063,681
|
|
G |
FKBP4 |
FKBP prolyl isomerase 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of FKBP4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:2,794,970...2,805,423
Ensembl chr12:2,794,970...2,805,423
|
|
G |
FKBP5 |
FKBP prolyl isomerase 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of FKBP5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
|
|
G |
FLT1 |
fms related receptor tyrosine kinase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of FLT1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
|
|
G |
FMO1 |
flavin containing dimethylaniline monoxygenase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of FMO1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:171,248,494...171,285,978
Ensembl chr 1:171,248,471...171,285,978
|
|
G |
FMO2 |
flavin containing dimethylaniline monoxygenase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of FMO2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:171,185,208...171,212,686
Ensembl chr 1:171,185,249...171,212,686
|
|
G |
FN1 |
fibronectin 1 |
decreases expression increases expression multiple interactions |
EXP ISO |
Isoproterenol results in decreased expression of FN1 protein Isoproterenol results in increased expression of FN1 protein Glyburide promotes the reaction [Isoproterenol results in increased expression of FN1 protein]; pyrvinium inhibits the reaction [Glyburide promotes the reaction [Isoproterenol results in increased expression of FN1 protein]]; pyrvinium inhibits the reaction [Isoproterenol results in increased expression of FN1 protein]; Quercetin inhibits the reaction [Isoproterenol results in increased expression of FN1 protein]; Rutin inhibits the reaction [Isoproterenol results in increased expression of FN1 protein] Isoproterenol results in increased expression of FN1 mRNA |
CTD |
PMID:11821714 PMID:20003209 PMID:24117263 PMID:35305975 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO |
[N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with U 0126] inhibits the reaction [Isoproterenol results in increased expression of FOS mRNA]; [Phenylephrine co-treated with Isoproterenol] results in increased expression of FOS mRNA; Doxycycline inhibits the reaction [Isoproterenol results in increased expression of FOS mRNA]; U 0126 inhibits the reaction [Isoproterenol results in increased expression of FOS mRNA] Isoproterenol results in increased expression of FOS mRNA; Isoproterenol results in increased expression of FOS protein Isoproterenol results in increased expression of FOS; Isoproterenol results in increased expression of FOS mRNA CREM protein inhibits the reaction [Isoproterenol results in increased expression of FOS mRNA]; Isoproterenol promotes the reaction [JUN protein binds to FOS protein]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of FOS] |
CTD |
PMID:7544033 PMID:7905536 PMID:10710348 PMID:12791704 PMID:14764439 PMID:18089841 PMID:21177286 More...
|
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
FOSB |
FosB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Isoproterenol results in increased expression of FOSB |
CTD |
PMID:7905536 |
|
NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179
|
|
G |
FOSL1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of FOSL1 mRNA [N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with U 0126] inhibits the reaction [Isoproterenol results in increased expression of FOSL1 mRNA]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased expression of FOSL1 mRNA]; U 0126 inhibits the reaction [Isoproterenol results in increased expression of FOSL1 mRNA] Isoproterenol results in increased expression of FOSL1 mRNA; Isoproterenol results in increased expression of FOSL1 protein |
CTD |
PMID:20211217 PMID:21177286 |
|
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
|
|
G |
FOSL2 |
FOS like 2, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of FOSL2 mRNA; Isoproterenol results in increased expression of FOSL2 protein [N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with U 0126] inhibits the reaction [Isoproterenol results in increased expression of FOSL2 mRNA]; U 0126 inhibits the reaction [Isoproterenol results in increased expression of FOSL2 mRNA] |
CTD |
PMID:21177286 |
|
NCBI chr 2:28,392,858...28,417,317
Ensembl chr 2:28,392,448...28,417,317
|
|
G |
FOXO1 |
forkhead box O1 |
increases phosphorylation |
ISO |
Isoproterenol results in increased phosphorylation of FOXO1 protein |
CTD |
PMID:15618457 |
|
NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
|
|
G |
FOXO3 |
forkhead box O3 |
increases expression |
ISO |
Isoproterenol results in increased expression of FOXO3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
|
|
G |
FRY |
FRY microtubule binding protein |
increases expression |
ISO |
Isoproterenol results in increased expression of FRY mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:32,031,774...32,299,125
Ensembl chr13:31,846,713...32,299,125
|
|
G |
FSHB |
follicle stimulating hormone subunit beta |
multiple interactions increases expression |
ISO |
CPU0213 inhibits the reaction [Isoproterenol results in increased expression of FSHB protein] |
CTD |
PMID:20307649 |
|
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
|
|
G |
FTL |
ferritin light chain |
increases expression |
ISO |
Isoproterenol results in increased expression of FTL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
|
|
G |
FUS |
FUS RNA binding protein |
decreases expression |
ISO |
Isoproterenol results in decreased expression of FUS mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:31,180,110...31,194,871
Ensembl chr16:31,180,138...31,191,605
|
|
G |
G3BP2 |
G3BP stress granule assembly factor 2 |
multiple interactions increases expression |
ISO |
G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of MYH7 mRNA]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of MYH7 protein]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of NPPA mRNA]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of NPPA protein]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of NPPB mRNA]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of NPPB protein]; Isoproterenol promotes the reaction [G3BP2 protein binds to NFKBIA protein] Isoproterenol results in increased expression of G3BP2 mRNA; Isoproterenol results in increased expression of G3BP2 protein |
CTD |
PMID:28816235 |
|
NCBI chr 4:75,642,786...75,724,437
Ensembl chr 4:75,641,849...75,724,589
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
multiple interactions increases activity |
ISO |
Atenolol inhibits the reaction [Isoproterenol results in increased activity of G6PD protein]; Cycloheximide inhibits the reaction [Isoproterenol results in increased activity of G6PD protein]; Dactinomycin inhibits the reaction [Isoproterenol results in increased activity of G6PD protein]; Gallopamil inhibits the reaction [Isoproterenol results in increased activity of G6PD protein] |
CTD |
PMID:1978808 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GABARAPL1 |
GABA type A receptor associated protein like 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of GABARAPL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:10,212,877...10,223,128
Ensembl chr12:10,212,458...10,223,128
|
|
G |
GADD45G |
growth arrest and DNA damage inducible gamma |
increases expression |
ISO |
Isoproterenol results in increased expression of GADD45G mRNA |
CTD |
PMID:21823215 |
|
NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555
|
|
G |
GAL |
galanin and GMAP prepropeptide |
multiple interactions increases activity increases expression decreases activity |
ISO |
[ferulic acid co-treated with Ascorbic Acid] inhibits the reaction [Isoproterenol results in increased activity of GAL protein]; [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in decreased activity of GAL protein]; [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of GAL protein]; Betaine inhibits the reaction [Isoproterenol results in decreased activity of GAL protein]; Betaine inhibits the reaction [Isoproterenol results in increased activity of GAL protein]; naringin inhibits the reaction [Isoproterenol results in increased activity of GAL protein]; S-allylcysteine inhibits the reaction [Isoproterenol results in increased expression of GAL mRNA] |
CTD |
PMID:2015110 PMID:11829124 PMID:14499179 PMID:17045618 PMID:17182065 PMID:17188415 PMID:19294532 More...
|
|
NCBI chr11:68,684,544...68,691,175
Ensembl chr11:68,683,779...68,691,175
|
|
G |
GALNT15 |
polypeptide N-acetylgalactosaminyltransferase 15 |
increases expression |
ISO |
Isoproterenol results in increased expression of GALNT15 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:16,174,680...16,248,224
Ensembl chr 3:16,174,680...16,231,992
|
|
G |
GAS5 |
growth arrest specific 5 |
increases expression decreases expression |
ISO |
Isoproterenol results in increased expression of GAS5 mRNA Isoproterenol results in decreased expression of GAS5 mRNA |
CTD |
PMID:20003209 PMID:28526319 |
|
NCBI chr 1:173,863,901...173,869,045
Ensembl chr 1:173,858,559...173,868,882
|
|
G |
GAS6 |
growth arrest specific 6 |
multiple interactions decreases expression |
ISO |
natakalim inhibits the reaction [Isoproterenol results in decreased expression of GAS6 protein] |
CTD |
PMID:27890915 |
|
NCBI chr13:113,820,549...113,864,076
Ensembl chr13:113,820,549...113,864,076
|
|
G |
GATA4 |
GATA binding protein 4 |
multiple interactions |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of GATA4 mRNA Isoproterenol promotes the reaction [NFATC1 protein binds to GATA4 protein] |
CTD |
PMID:10710348 PMID:11435416 |
|
NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,959...11,760,002
|
|
G |
GBP6 |
guanylate binding protein family member 6 |
increases expression |
ISO |
Isoproterenol results in increased expression of GBP6 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:89,364,059...89,388,160
Ensembl chr 1:89,364,059...89,388,160
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
decreases expression |
ISO |
Isoproterenol results in decreased expression of GCLC mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
increases expression multiple interactions decreases expression |
ISO |
Isoproterenol results in increased expression of GCLM mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of GCLM mRNA Isoproterenol results in decreased expression of GCLM mRNA |
CTD |
PMID:20003209 PMID:21335049 PMID:30303030 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GCNT2 |
glucosaminyl (N-acetyl) transferase 2 (I blood group) |
increases expression |
ISO |
Isoproterenol results in increased expression of GCNT2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:10,521,351...10,629,368
Ensembl chr 6:10,492,223...10,629,368
|
|
G |
GDA |
guanine deaminase |
increases expression |
ISO |
Isoproterenol results in increased expression of GDA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:72,114,608...72,259,869
Ensembl chr 9:72,114,595...72,257,193
|
|
G |
GEM |
GTP binding protein overexpressed in skeletal muscle |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of GEM mRNA Doxycycline inhibits the reaction [Isoproterenol results in increased expression of GEM mRNA] |
CTD |
PMID:18089841 |
|
NCBI chr 8:94,249,253...94,262,319
Ensembl chr 8:94,249,253...94,262,350
|
|
G |
GFPT2 |
glutamine-fructose-6-phosphate transaminase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of GFPT2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:180,300,698...180,353,336
Ensembl chr 5:180,300,698...180,353,336
|
|
G |
GGT5 |
gamma-glutamyltransferase 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of GGT5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:24,219,654...24,245,142
Ensembl chr22:24,219,654...24,245,108
|
|
G |
GHRL |
ghrelin and obestatin prepropeptide |
increases expression |
ISO |
Isoproterenol results in increased expression of GHRL protein |
CTD |
PMID:20572026 |
|
NCBI chr 3:10,285,666...10,292,947
Ensembl chr 3:10,285,666...10,292,947
|
|
G |
GHSR |
growth hormone secretagogue receptor |
increases expression |
ISO |
Isoproterenol results in increased expression of GHSR mRNA; Isoproterenol results in increased expression of GHSR protein |
CTD |
PMID:20572026 |
|
NCBI chr 3:172,443,291...172,448,456
Ensembl chr 3:172,443,291...172,448,456
|
|
G |
GIGYF2 |
GRB10 interacting GYF protein 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of GIGYF2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:232,697,331...232,860,605
Ensembl chr 2:232,697,299...232,860,605
|
|
G |
GJA1 |
gap junction protein alpha 1 |
multiple interactions decreases expression increases expression |
ISO |
[Isoproterenol co-treated with Metoprolol] results in increased expression of GJA1 protein Isoproterenol results in decreased expression of GJA1 mRNA Isoproterenol results in increased expression of GJA1 mRNA; Isoproterenol results in increased expression of GJA1 protein Doxycycline inhibits the reaction [Isoproterenol results in decreased expression of GJA1 mRNA] |
CTD |
PMID:16352648 PMID:18089841 PMID:20003209 PMID:20215810 |
|
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
|
|
G |
GK |
glycerol kinase |
increases activity |
ISO |
Isoproterenol results in increased activity of GK protein |
CTD |
PMID:12736183 |
|
NCBI chr X:30,653,423...30,731,462
Ensembl chr X:30,653,359...30,731,462
|
|
G |
GLB1 |
galactosidase beta 1 |
multiple interactions increases activity affects activity |
ISO |
caffeic acid inhibits the reaction [Isoproterenol affects the activity of GLB1 protein]; Phytic Acid inhibits the reaction [Isoproterenol results in increased activity of GLB1 protein] |
CTD |
PMID:20391626 PMID:25560919 |
|
NCBI chr 3:32,961,108...33,097,146
Ensembl chr 3:32,996,609...33,097,202
|
|
G |
GLG1 |
golgi glycoprotein 1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of GLG1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr16:74,447,440...74,607,114
Ensembl chr16:74,447,427...74,607,144
|
|
G |
GLUL |
glutamate-ammonia ligase |
increases expression |
ISO |
Isoproterenol results in increased expression of GLUL mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206
|
|
G |
GNA15 |
G protein subunit alpha 15 |
increases response to substance multiple interactions |
ISO |
GNA15 protein results in increased susceptibility to Isoproterenol [GNA15 protein results in increased susceptibility to Isoproterenol] which results in increased activity of ADRB2 protein |
CTD |
PMID:9875846 |
|
NCBI chr19:3,136,033...3,163,749
Ensembl chr19:3,136,033...3,163,749
|
|
G |
GNAL |
G protein subunit alpha L |
multiple interactions increases response to substance |
EXP |
Egtazic Acid inhibits the reaction [GNAL protein results in increased susceptibility to Isoproterenol] |
CTD |
PMID:15598656 |
|
NCBI chr18:11,689,264...11,885,685
Ensembl chr18:11,689,264...11,885,685
|
|
G |
GNAS |
GNAS complex locus |
multiple interactions increases response to substance |
ISO EXP |
GNAS protein affects the susceptibility to [Potassium Chloride co-treated with Isoproterenol]; Isoproterenol affects the expression of and affects the localization of GNAS protein GNAS protein results in increased susceptibility to Isoproterenol Egtazic Acid inhibits the reaction [GNAS protein results in increased susceptibility to Isoproterenol] |
CTD |
PMID:10696522 PMID:12376418 PMID:15598656 |
|
NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192
|
|
G |
GNG2 |
G protein subunit gamma 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of GNG2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:51,826,174...51,969,795
Ensembl chr14:51,826,195...51,979,342
|
|
G |
GNG3 |
G protein subunit gamma 3 |
multiple interactions |
ISO |
[Isoproterenol co-treated with Atorvastatin] affects the localization of GNG3 protein |
CTD |
PMID:19136528 |
|
NCBI chr11:62,706,446...62,709,201
Ensembl chr11:62,707,676...62,709,201
|
|
G |
GNS |
glucosamine (N-acetyl)-6-sulfatase |
increases expression |
ISO |
Isoproterenol results in increased expression of GNS mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:64,713,449...64,759,406
Ensembl chr12:64,713,445...64,759,431
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
ISO |
Carvedilol inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of GOT1 protein]; imetit inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of GOT1 protein]; Isoproterenol results in increased expression of and results in increased secretion of GOT1 protein |
CTD |
PMID:25496245 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GOT2 |
glutamic-oxaloacetic transaminase 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of GOT2 protein |
CTD |
PMID:19826179 |
|
NCBI chr16:58,707,131...58,734,316
Ensembl chr16:58,707,131...58,734,342
|
|
G |
GPAM |
glycerol-3-phosphate acyltransferase, mitochondrial |
decreases expression |
ISO |
Isoproterenol results in decreased expression of GPAM mRNA |
CTD |
PMID:21335049 |
|
NCBI chr10:112,149,865...112,227,677
Ensembl chr10:112,149,865...112,215,377
|
|
G |
GPCPD1 |
glycerophosphocholine phosphodiesterase 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of GPCPD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:5,544,439...5,611,006
Ensembl chr20:5,544,439...5,611,006
|
|
G |
GPIHBP1 |
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of GPIHBP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:143,213,218...143,217,170
Ensembl chr 8:143,213,218...143,217,170
|
|
G |
GPNMB |
glycoprotein nmb |
increases expression |
ISO |
Isoproterenol results in increased expression of GPNMB mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:23,246,775...23,275,108
Ensembl chr 7:23,235,967...23,275,108
|
|
G |
GPR160 |
G protein-coupled receptor 160 |
increases expression |
ISO |
Isoproterenol results in increased expression of GPR160 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:170,037,995...170,085,392
Ensembl chr 3:170,037,995...170,085,392
|
|
G |
GPR182 |
G protein-coupled receptor 182 |
increases expression |
ISO |
Isoproterenol results in increased expression of GPR182 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:56,994,492...56,998,877
Ensembl chr12:56,994,492...56,998,447
|
|
G |
GPT |
glutamic--pyruvic transaminase |
increases activity multiple interactions |
ISO |
Isoproterenol results in increased activity of GPT protein Carvedilol inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of GPT protein]; imetit inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of GPT protein]; Isoproterenol results in increased expression of and results in increased secretion of GPT protein; oleuropein inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of GPT protein] |
CTD |
PMID:25496245 PMID:26056852 PMID:35130744 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions decreases activity |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of GPX1 mRNA; benidipine inhibits the reaction [Isoproterenol results in decreased activity of GPX1 protein] |
CTD |
PMID:25269373 PMID:30303030 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GPX3 |
glutathione peroxidase 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of GPX3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
|
|
G |
GRINA |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of GRINA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:143,990,056...143,993,415
Ensembl chr 8:143,990,056...143,993,415
|
|
G |
GRK2 |
G protein-coupled receptor kinase 2 |
increases expression multiple interactions |
ISO EXP |
Isoproterenol results in increased expression of GRK2 mRNA Isoproterenol results in increased expression of GRK2 mRNA; Isoproterenol results in increased expression of GRK2 protein AGT affects the reaction [Isoproterenol results in decreased expression of GRK2 mRNA] |
CTD |
PMID:9788834 PMID:16731636 |
|
NCBI chr11:67,266,473...67,286,556
Ensembl chr11:67,266,473...67,286,556
|
|
G |
GRK5 |
G protein-coupled receptor kinase 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of GRK5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:119,207,571...119,459,745
Ensembl chr10:119,207,571...119,459,745
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions increases phosphorylation decreases phosphorylation |
ISO |
2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein]; 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein]; 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one promotes the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein]; Enalapril inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein]; plantamajoside inhibits the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein]; Valsartan inhibits the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:15951400 PMID:16716347 PMID:18806606 PMID:31009642 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions decreases activity increases activity decreases expression |
ISO |
abana inhibits the reaction [Isoproterenol results in decreased expression of GSR]; allyl sulfide inhibits the reaction [Isoproterenol results in decreased activity of GSR protein]; benidipine inhibits the reaction [Isoproterenol results in decreased activity of GSR protein]; Catechin inhibits the reaction [Isoproterenol results in decreased activity of GSR protein]; Desmodium gangeticum extract inhibits the reaction [Isoproterenol results in decreased activity of GSR protein]; dicarbine inhibits the reaction [Isoproterenol results in increased activity of GSR protein]; Gallic Acid inhibits the reaction [Isoproterenol results in decreased expression of GSR protein]; mangiferin inhibits the reaction [Isoproterenol results in decreased activity of GSR protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased activity of GSR protein]; S-allylcysteine inhibits the reaction [Isoproterenol results in decreased activity of GSR protein]; Tretinoin inhibits the reaction [Isoproterenol results in decreased activity of GSR protein] Isoproterenol results in decreased expression of GSR; Isoproterenol results in decreased expression of GSR protein |
CTD |
PMID:1840475 PMID:12557918 PMID:15261977 PMID:15740881 PMID:16697266 PMID:16757080 PMID:19146839 PMID:23261676 PMID:25269373 PMID:32007421 PMID:35130744 PMID:36593721 More...
|
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GSTA1 |
glutathione S-transferase alpha 1 |
multiple interactions decreases activity |
ISO |
benidipine inhibits the reaction [Isoproterenol results in decreased activity of GSTA1 protein] |
CTD |
PMID:25269373 |
|
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
|
|
G |
GSTO1 |
glutathione S-transferase omega 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of GSTO1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459
|
|
G |
GTF2A1 |
general transcription factor IIA subunit 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of GTF2A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:81,175,452...81,221,390
Ensembl chr14:81,175,452...81,221,377
|
|
G |
GUSB |
glucuronidase beta |
multiple interactions increases activity decreases activity increases expression |
ISO |
[ferulic acid co-treated with Ascorbic Acid] inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]; [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]; Betaine inhibits the reaction [Isoproterenol results in decreased activity of GUSB protein]; Betaine inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]; caffeic acid inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]; Curcumin inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]; epigallocatechin gallate inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]; mangiferin inhibits the reaction [Isoproterenol results in decreased activity of GUSB protein]; naringin inhibits the reaction [Isoproterenol results in decreased activity of GUSB protein]; naringin inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]; Phytic Acid inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]; S-allylcysteine inhibits the reaction [Isoproterenol results in increased expression of GUSB mRNA] |
CTD |
PMID:2015110 PMID:8534267 PMID:11829124 PMID:14499179 PMID:17045618 PMID:17182065 PMID:17188415 PMID:18294627 PMID:19172585 PMID:19294532 PMID:20391626 PMID:21762681 PMID:25560919 More...
|
|
NCBI chr 7:65,960,684...65,982,213
Ensembl chr 7:65,960,684...65,982,215
|
|
G |
H1-2 |
H1.2 linker histone, cluster member |
increases expression |
ISO |
Isoproterenol results in increased expression of H1F2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,055,740...26,056,470
|
|
G |
H1-4 |
H1.4 linker histone, cluster member |
increases expression |
ISO |
Isoproterenol results in increased expression of H1F4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:26,156,329...26,157,115
Ensembl chr 6:26,156,329...26,157,115
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
increases expression increases expression |
ISO |
Isoproterenol results in increased expression of H19 mRNA isoprenaline increases expression of H19 RNA in cardiac muscle cells |
CTD RGD |
PMID:20003209 PMID:27318893 |
RGD:156430318 |
NCBI chr11:1,995,176...2,001,466
Ensembl chr11:1,995,166...2,004,552
|
|
G |
H2AX |
H2A.X variant histone |
increases expression |
ISO |
Isoproterenol results in increased expression of H2AX mRNA |
CTD |
PMID:21335049 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
H3C3 |
H3 clustered histone 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of H3C3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:26,045,384...26,045,869
Ensembl chr 6:26,045,384...26,045,869
|
|
G |
HADHA |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of HADHA mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 2:26,190,635...26,244,632
Ensembl chr 2:26,190,635...26,244,672
|
|
G |
HAGHL |
hydroxyacylglutathione hydrolase like |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HAGHL mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:727,106...729,715
Ensembl chr16:726,936...735,525
|
|
G |
HAMP |
hepcidin antimicrobial peptide |
increases expression |
ISO |
Isoproterenol results in increased expression of HAMP mRNA |
CTD |
PMID:20211217 PMID:21335049 |
|
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
|
|
G |
HAP1 |
huntingtin associated protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of HAP1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr17:41,717,739...41,734,646
Ensembl chr17:41,717,742...41,734,644
|
|
G |
HARBI1 |
harbinger transposase derived 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of HARBI1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:46,602,861...46,617,895
Ensembl chr11:46,602,861...46,617,909
|
|
G |
HDAC2 |
histone deacetylase 2 |
increases phosphorylation multiple interactions |
ISO |
Isoproterenol results in increased phosphorylation of HDAC2 protein plantamajoside inhibits the reaction [Isoproterenol results in increased phosphorylation of HDAC2 protein]; Valsartan inhibits the reaction [Isoproterenol results in increased phosphorylation of HDAC2 protein] |
CTD |
PMID:31009642 |
|
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
|
|
G |
HEATR5B |
HEAT repeat containing 5B |
increases expression |
ISO |
Isoproterenol results in increased expression of HEATR5B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:36,980,895...37,084,372
Ensembl chr 2:36,968,383...37,084,372
|
|
G |
HECA |
hdc homolog, cell cycle regulator |
increases expression |
ISO |
Isoproterenol results in increased expression of HECA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:139,135,080...139,180,802
Ensembl chr 6:139,135,080...139,180,802
|
|
G |
HEPH |
hephaestin |
increases expression |
ISO |
Isoproterenol results in increased expression of HEPH mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:66,162,671...66,268,863
Ensembl chr X:66,162,671...66,268,867
|
|
G |
HERPUD1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of HERPUD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
|
|
G |
HERPUD2 |
HERPUD family member 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of HERPUD2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:35,632,659...35,695,135
Ensembl chr 7:35,632,659...35,697,459
|
|
G |
HES1 |
hes family bHLH transcription factor 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HES1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
|
|
G |
HEXA |
hexosaminidase subunit alpha |
increases expression |
ISO |
Isoproterenol results in increased expression of HEXA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:72,340,924...72,376,014
Ensembl chr15:72,340,924...72,376,420
|
|
G |
HFE |
homeostatic iron regulator |
increases expression |
ISO |
Isoproterenol results in increased expression of HFE mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,281...26,098,343
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HIF1A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HIF1AN |
hypoxia inducible factor 1 subunit alpha inhibitor |
decreases expression |
EXP |
Isoproterenol results in decreased expression of HIF1AN mRNA |
CTD |
PMID:24286936 |
|
NCBI chr10:100,535,943...100,559,998
Ensembl chr10:100,529,072...100,559,998
|
|
G |
HIF3A |
hypoxia inducible factor 3 subunit alpha |
increases expression |
EXP ISO |
Isoproterenol results in increased expression of HIF3A mRNA |
CTD |
PMID:24286936 |
|
NCBI chr19:46,297,042...46,343,433
Ensembl chr19:46,297,042...46,343,433
|
|
G |
HIPK1 |
homeodomain interacting protein kinase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of HIPK1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:113,929,324...113,977,869
Ensembl chr 1:113,929,324...113,977,869
|
|
G |
HIPK2 |
homeodomain interacting protein kinase 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HIPK2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:139,561,570...139,777,998
Ensembl chr 7:139,561,570...139,777,998
|
|
G |
HIPK3 |
homeodomain interacting protein kinase 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of HIPK3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:33,256,672...33,357,023
Ensembl chr11:33,256,672...33,357,023
|
|
G |
HK2 |
hexokinase 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HK2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359
|
|
G |
HLA-DMA |
major histocompatibility complex, class II, DM alpha |
decreases expression |
ISO |
Isoproterenol results in decreased expression of H2-DMA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:32,948,618...32,953,097
Ensembl chr 6:32,948,613...32,969,094
|
|
G |
HLA-DQA1 |
major histocompatibility complex, class II, DQ alpha 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of H2-AA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
|
|
G |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of H2-AB1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
|
|
G |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of H2-EB1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
|
|
G |
HLF |
HLF transcription factor, PAR bZIP family member |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HLF mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:55,264,960...55,325,187
Ensembl chr17:55,264,960...55,325,187
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions increases activity |
ISO |
7-hydroxycoumarin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein]; alliin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein]; naringin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] |
CTD |
PMID:16640830 PMID:16906524 PMID:19595682 PMID:26995004 |
|
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
|
|
G |
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of HMGCS1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions decreases expression increases expression |
EXP ISO |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased expression of HMOX1 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of HMOX1 protein] Isoproterenol results in decreased expression of HMOX1 mRNA; Isoproterenol results in decreased expression of HMOX1 protein Isoproterenol results in increased expression of HMOX1 mRNA; Isoproterenol results in increased expression of HMOX1 protein [erdosteine co-treated with Isoproterenol] results in increased expression of HMOX1 protein; anethole promotes the reaction [Isoproterenol results in increased expression of HMOX1 mRNA]; anethole promotes the reaction [Isoproterenol results in increased expression of HMOX1 protein]; Doxorubicin inhibits the reaction [Isoproterenol results in increased expression of HMOX1 mRNA]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased expression of HMOX1 mRNA]; punicalagin inhibits the reaction [Isoproterenol results in decreased expression of HMOX1 protein] |
CTD |
PMID:15179140 PMID:19483313 PMID:20003209 PMID:21823215 PMID:22908232 PMID:24929186 PMID:33210414 PMID:35430261 PMID:36593721 PMID:37806379 More...
|
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNRNPH3 |
heterogeneous nuclear ribonucleoprotein H3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HNRNPH3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:68,331,693...68,343,196
Ensembl chr10:68,331,174...68,343,193
|
|
G |
HNRNPR |
heterogeneous nuclear ribonucleoprotein R |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HNRNPR mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:23,304,688...23,344,284
Ensembl chr 1:23,303,771...23,344,336
|
|
G |
HOMER1 |
homer scaffold protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of HOMER1 mRNA alternative form |
CTD |
PMID:16786172 |
|
NCBI chr 5:79,372,636...79,514,134
Ensembl chr 5:79,372,636...79,514,134
|
|
G |
HOPX |
HOP homeobox |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HOPX mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:56,647,998...56,681,706
Ensembl chr 4:56,647,989...56,681,877
|
|
G |
HPCA |
hippocalcin |
affects localization |
ISO |
Isoproterenol affects the localization of HPCA protein |
CTD |
PMID:21078978 |
|
NCBI chr 1:32,885,996...32,894,646
Ensembl chr 1:32,885,994...32,898,441
|
|
G |
HPSE |
heparanase |
increases expression |
ISO |
Isoproterenol results in increased expression of HPSE protein |
CTD |
PMID:16327176 |
|
NCBI chr 4:83,292,461...83,335,153
Ensembl chr 4:83,292,461...83,335,153
|
|
G |
HRAS |
HRas proto-oncogene, GTPase |
increases activity |
ISO |
Isoproterenol results in increased activity of HRAS protein |
CTD |
PMID:8484791 |
|
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
|
|
G |
HS2ST1 |
heparan sulfate 2-O-sulfotransferase 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HS2ST1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:86,914,635...87,109,982
Ensembl chr 1:86,914,635...87,109,982
|
|
G |
HSD3B1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
|
|
G |
HSP90AA1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
|
|
G |
HSP90B1 |
heat shock protein 90 beta family member 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HSP90B1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
|
|
G |
HSPA1L |
heat shock protein family A (Hsp70) member 1 like |
increases expression decreases expression |
ISO EXP |
Isoproterenol results in increased expression of HSPA1L mRNA Isoproterenol results in decreased expression of HSPA1L mRNA |
CTD |
PMID:20003209 PMID:24286936 |
|
NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283
|
|
G |
HSPA2 |
heat shock protein family A (Hsp70) member 2 |
increases expression |
ISO EXP |
Isoproterenol results in increased expression of HSPA2 mRNA |
CTD |
PMID:20211217 PMID:24286936 |
|
NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions decreases expression |
ISO EXP |
Isoproterenol results in increased expression of HSPA5 mRNA [Acrolein results in increased susceptibility to Isoproterenol] which results in increased expression of HSPA5 protein; Acrolein promotes the reaction [Isoproterenol results in increased expression of HSPA5 mRNA]; Plant Extracts inhibits the reaction [[Acrolein results in increased susceptibility to Isoproterenol] which results in increased expression of HSPA5 protein]; Plant Extracts inhibits the reaction [Acrolein promotes the reaction [Isoproterenol results in increased expression of HSPA5 mRNA]] Isoproterenol results in decreased expression of HSPA5 mRNA |
CTD |
PMID:21335049 PMID:24286936 PMID:29414845 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
decreases expression |
ISO EXP |
Isoproterenol results in decreased expression of HSPA8 mRNA |
CTD |
PMID:20003209 PMID:24286936 |
|
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
HSPB1 |
heat shock protein family B (small) member 1 |
multiple interactions increases expression |
ISO |
Curcumin promotes the reaction [Isoproterenol results in increased expression of HSPB1 protein] Isoproterenol results in increased expression of HSP27 protein; Isoproterenol results in increased expression of HSPB1 protein |
CTD |
PMID:10559386 PMID:20125031 |
|
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
|
|
G |
HSPB7 |
heat shock protein family B (small) member 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of HSPB7 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 1:16,014,029...16,019,594
Ensembl chr 1:16,014,028...16,019,594
|
|
G |
HSPG2 |
heparan sulfate proteoglycan 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HSPG2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:21,822,244...21,937,310
Ensembl chr 1:21,822,244...21,937,310
|
|
G |
HSPH1 |
heat shock protein family H (Hsp110) member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of HSPH1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388
|
|
G |
HTRA2 |
HtrA serine peptidase 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HTRA2 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 2:74,529,405...74,533,556
Ensembl chr 2:74,529,596...74,533,350
|
|
G |
HTRA3 |
HtrA serine peptidase 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of HTRA3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:8,269,754...8,307,098
Ensembl chr 4:8,269,754...8,307,098
|
|
G |
HYOU1 |
hypoxia up-regulated 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of HYOU1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:119,044,188...119,057,205
Ensembl chr11:119,044,188...119,057,227
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ICAM1 mRNA |
CTD |
PMID:20003209 PMID:21335049 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
ID1 |
inhibitor of DNA binding 1 |
decreases expression increases expression |
ISO |
Isoproterenol results in decreased expression of ID1 mRNA isoprenaline increases expression of mRNA in neonatal rat cardiomyocytes |
CTD RGD |
PMID:21335049 PMID:26873969 |
RGD:11526363 |
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
|
|
G |
IER3 |
immediate early response 3 |
multiple interactions affects response to substance |
ISO |
IER3 protein affects the reaction [Isoproterenol results in increased abundance of Cyclic AMP]; Pertussis Toxin affects the reaction [IER3 protein affects the reaction [Isoproterenol results in increased abundance of Cyclic AMP]]; Pertussis Toxin affects the reaction [IER3 protein affects the susceptibility to Isoproterenol] |
CTD |
PMID:20713914 |
|
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
|
|
G |
IFNA1 |
interferon alpha 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of IFNA1 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316
|
|
G |
IFNG |
interferon gamma |
decreases secretion |
EXP |
Isoproterenol results in decreased secretion of IFNG protein |
CTD |
PMID:15342205 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IFNGR2 |
interferon gamma receptor 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of IFNGR2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr21:33,402,882...33,437,516
Ensembl chr21:33,403,413...33,479,348
|
|
G |
IFRD1 |
interferon related developmental regulator 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of IFRD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
|
|
G |
IFT74 |
intraflagellar transport 74 |
increases expression |
ISO |
Isoproterenol results in increased expression of IFT74 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:26,947,110...27,066,134
Ensembl chr 9:26,947,039...27,066,134
|
|
G |
IGF1 |
insulin like growth factor 1 |
decreases expression increases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of IGF1 mRNA Isoproterenol results in increased expression of IGF1 mRNA; Isoproterenol results in increased expression of IGF1 protein candesartan cilexetil inhibits the reaction [Isoproterenol results in increased expression of IGF1 mRNA]; candesartan cilexetil inhibits the reaction [Isoproterenol results in increased expression of IGF1 protein] |
CTD |
PMID:10547078 PMID:20003209 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGF1R |
insulin like growth factor 1 receptor |
increases expression |
ISO |
Isoproterenol results in increased expression of IGF1R mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
|
|
G |
IGF2BP2 |
insulin like growth factor 2 mRNA binding protein 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of IGF2BP2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:185,643,130...185,825,042
Ensembl chr 3:185,643,130...185,825,042
|
|
G |
IGFBP3 |
insulin like growth factor binding protein 3 |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of IGFBP3 SI 27 inhibits the reaction [Isoproterenol results in decreased expression of IGFBP3] |
CTD |
PMID:12883319 |
|
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
|
|
G |
IL10 |
interleukin 10 |
multiple interactions decreases expression |
ISO |
Isoproterenol promotes the reaction [Lipopolysaccharides results in increased expression of IL10 protein] Quercetin inhibits the reaction [Isoproterenol results in decreased expression of IL10 protein] |
CTD |
PMID:9038718 PMID:27527349 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12A |
interleukin 12A |
decreases expression |
ISO |
Isoproterenol results in decreased expression of IL12A protein |
CTD |
PMID:24286936 |
|
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
|
|
G |
IL12B |
interleukin 12B |
increases expression |
EXP |
Isoproterenol results in increased expression of IL12B protein |
CTD |
PMID:24286936 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL17A |
interleukin 17A |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of IL17A protein Glyburide promotes the reaction [Isoproterenol results in increased expression of IL17A protein]; pyrvinium inhibits the reaction [Glyburide promotes the reaction [Isoproterenol results in increased expression of IL17A protein]]; pyrvinium inhibits the reaction [Isoproterenol results in increased expression of IL17A protein] |
CTD |
PMID:19909738 PMID:35305975 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL17RD |
interleukin 17 receptor D |
increases expression |
ISO |
Isoproterenol results in increased expression of IL17RD mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:57,089,982...57,170,317
Ensembl chr 3:57,089,982...57,170,306
|
|
G |
IL18 |
interleukin 18 |
multiple interactions increases expression decreases expression |
ISO |
ADRB2 protein affects the reaction [Isoproterenol results in increased expression of IL18 mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Isoproterenol results in increased secretion of IL18 protein]; ICI 118551 inhibits the reaction [Isoproterenol results in increased expression of IL18 mRNA]; ICI 118551 inhibits the reaction [Isoproterenol results in increased expression of IL18 protein]; Isoproterenol results in increased expression of and results in increased secretion of IL18 protein; Isoproterenol results in increased expression of and results in increased stability of IL18 mRNA; Pertussis Toxin inhibits the reaction [Isoproterenol results in increased secretion of IL18 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of IL18 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased expression of IL18 mRNA]; wortmannin inhibits the reaction [Isoproterenol results in increased secretion of IL18 protein] Isoproterenol results in decreased expression of IL18 mRNA |
CTD |
PMID:15178407 PMID:21335049 PMID:24286936 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
IL1A |
interleukin 1 alpha |
decreases expression increases expression |
EXP ISO |
Isoproterenol results in decreased expression of IL1A mRNA Isoproterenol results in increased expression of IL1A mRNA |
CTD |
PMID:24286936 PMID:32816093 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions decreases expression increases expression |
ISO EXP |
SB 206553 inhibits the reaction [Isoproterenol results in increased expression of IL1B]; ZD 7155 inhibits the reaction [Isoproterenol results in increased expression of IL1B protein] Isoproterenol results in decreased expression of IL1B mRNA Isoproterenol results in decreased expression of IL1B mRNA; Isoproterenol results in decreased expression of IL1B protein Isoproterenol results in increased expression of IL1B mRNA; Isoproterenol results in increased expression of IL1B protein Isoproterenol results in increased expression of IL1B; Isoproterenol results in increased expression of IL1B mRNA Isoproterenol results in increased expression of IL1B; Isoproterenol results in increased expression of IL1B mRNA; Isoproterenol results in increased expression of IL1B protein 5-Methoxypsoralen inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of IL1B mRNA]; Glyburide promotes the reaction [Isoproterenol results in increased expression of IL1B protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]; punicalagin inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]; pyrvinium inhibits the reaction [Glyburide promotes the reaction [Isoproterenol results in increased expression of IL1B protein]]; pyrvinium inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]; Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL1B mRNA]; Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL1B mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]] |
CTD |
PMID:9387890 PMID:12215284 PMID:15302781 PMID:18487443 PMID:19023134 PMID:19904010 PMID:21335049 PMID:21762681 PMID:24286936 PMID:25045214 PMID:32816093 PMID:35014750 PMID:35305975 PMID:35430261 PMID:35815753 PMID:36593721 PMID:37806379 More...
|
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
affects response to substance |
EXP |
IL1RN protein affects the susceptibility to Isoproterenol |
CTD |
PMID:10487780 |
|
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL2 |
interleukin 2 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of IL2 mRNA; Isoproterenol results in increased expression of IL2 protein Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL2 mRNA]; Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL2 protein]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL2 mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL2 protein]] |
CTD |
PMID:25045214 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL24 |
interleukin 24 |
increases expression |
EXP |
Isoproterenol results in increased expression of IL24 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139
|
|
G |
IL4 |
interleukin 4 |
decreases expression increases expression |
EXP ISO |
Isoproterenol results in decreased expression of IL4 mRNA Isoproterenol results in increased expression of IL4 mRNA Isoproterenol results in increased expression of IL4 protein |
CTD |
PMID:24286936 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL4R |
interleukin 4 receptor |
increases expression |
ISO |
Isoproterenol results in increased expression of IL4RA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
|
|
G |
IL5RA |
interleukin 5 receptor subunit alpha |
affects response to substance |
EXP |
IL5RA protein affects the susceptibility to Isoproterenol |
CTD |
PMID:10487780 |
|
NCBI chr 3:3,066,324...3,110,374
Ensembl chr 3:3,066,324...3,126,613
|
|
G |
IL6 |
interleukin 6 |
multiple interactions increases secretion increases expression decreases expression decreases secretion |
ISO EXP |
ANXA1 affects the reaction [Isoproterenol results in decreased secretion of IL6 protein]; biochanin A inhibits the reaction [Isoproterenol results in increased expression of IL6 mRNA]; Genistein promotes the reaction [Isoproterenol results in increased secretion of IL6 protein]; Isoproterenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; oxophenylarsine inhibits the reaction [Isoproterenol results in increased secretion of IL6 protein]; SB 206553 inhibits the reaction [Isoproterenol results in increased expression of IL6]; ZD 7155 inhibits the reaction [Isoproterenol results in increased expression of IL6 protein] Isoproterenol results in increased expression of IL6 mRNA; Isoproterenol results in increased expression of IL6 protein Isoproterenol results in decreased expression of IL6 mRNA 5-Methoxypsoralen inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of IL6 mRNA]; Enalapril inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; erdosteine inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; ferruginol inhibits the reaction [Isoproterenol results in increased secretion of IL6 protein]; geraniol inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; Hesperidin inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; ICI 118551 inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; ICI 118551 inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; Isoproterenol inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Isoproterenol results in increased expression of and results in increased secretion of IL6 protein; Metformin inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of IL6 protein]; Metformin inhibits the reaction [Isoproterenol results in increased expression of IL6 mRNA]; punicalagin inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; Quercetin inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; xanthone inhibits the reaction [Isoproterenol results in increased expression of IL6 protein] Isoproterenol results in increased expression of IL6; Isoproterenol results in increased expression of IL6 mRNA; Isoproterenol results in increased expression of IL6 protein Isoproterenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] |
CTD |
PMID:9038718 PMID:9688336 PMID:10525314 PMID:11406463 PMID:15302781 PMID:16835395 PMID:17141199 PMID:18487443 PMID:19023134 PMID:19909738 PMID:21088047 PMID:21762681 PMID:21823215 PMID:24286936 PMID:24842192 PMID:26277537 PMID:27527349 PMID:30152906 PMID:30623541 PMID:32007421 PMID:32946155 PMID:33210414 PMID:35130744 PMID:35430261 PMID:35608392 PMID:35815753 PMID:36414029 PMID:37016276 PMID:37806379 More...
|
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IL7 |
interleukin 7 |
increases expression |
EXP ISO |
Isoproterenol results in increased expression of IL7 protein |
CTD |
PMID:24286936 |
|
NCBI chr 8:78,675,044...78,805,463
Ensembl chr 8:78,675,743...78,805,523
|
|
G |
IMMT |
inner membrane mitochondrial protein |
decreases expression |
ISO |
Isoproterenol results in decreased expression of IMMT mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:86,143,936...86,195,462
Ensembl chr 2:86,143,932...86,195,472
|
|
G |
INHBB |
inhibin subunit beta B |
increases expression |
ISO |
Isoproterenol results in increased expression of INHBB mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:120,346,136...120,351,803
Ensembl chr 2:120,346,136...120,351,803
|
|
G |
INS |
insulin |
multiple interactions increases expression affects expression |
ISO |
INS protein inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein]; OPC 3911 inhibits the reaction [INS protein inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein]] Isoproterenol results in increased expression of INS protein Isoproterenol affects the expression of INS protein |
CTD |
PMID:1129332 PMID:1170870 PMID:19167487 |
|
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
|
|
G |
INTS3 |
integrator complex subunit 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of INTS3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:153,728,050...153,774,808
Ensembl chr 1:153,728,050...153,774,808
|
|
G |
IPO13 |
importin 13 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of IPO13 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:43,946,950...43,968,022
Ensembl chr 1:43,946,950...43,968,022
|
|
G |
IRAK3 |
interleukin 1 receptor associated kinase 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of IRAK3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:66,189,214...66,254,622
Ensembl chr12:66,189,195...66,254,622
|
|
G |
IRS1 |
insulin receptor substrate 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of IRS1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:226,731,312...226,799,820
Ensembl chr 2:226,731,312...226,799,820
|
|
G |
IRX4 |
iroquois homeobox 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of IRX4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:1,877,413...1,887,179
Ensembl chr 5:1,877,413...1,887,236
|
|
G |
ITGAM |
integrin subunit alpha M |
multiple interactions |
EXP |
Isoproterenol promotes the reaction [Theophylline inhibits the reaction [Platelet Activating Factor results in increased expression of ITGAM protein]] |
CTD |
PMID:9762784 |
|
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
|
|
G |
ITGB1 |
integrin subunit beta 1 |
multiple interactions decreases expression |
ISO |
DMD gene mutant form promotes the reaction [ITGB1 gene affects the susceptibility to Isoproterenol] Isoproterenol results in decreased expression of ITGB1 |
CTD |
PMID:18340010 PMID:18808529 |
|
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
|
|
G |
ITGBL1 |
integrin subunit beta like 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of ITGBL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:101,452,675...101,720,856
Ensembl chr13:101,452,593...101,720,856
|
|
G |
ITIH3 |
inter-alpha-trypsin inhibitor heavy chain 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of ITIH3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:52,794,796...52,808,797
Ensembl chr 3:52,794,768...52,808,799
|
|
G |
ITIH4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of ITIH4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:52,812,962...52,830,672
Ensembl chr 3:52,812,962...52,830,688
|
|
G |
ITK |
IL2 inducible T cell kinase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ITK mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:157,180,840...157,255,185
Ensembl chr 5:157,142,933...157,255,185
|
|
G |
ITPKB |
inositol-trisphosphate 3-kinase B |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ITPKB mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:226,631,690...226,739,282
Ensembl chr 1:226,631,690...226,739,323
|
|
G |
JADE2 |
jade family PHD finger 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of JADE2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:134,523,952...134,583,227
Ensembl chr 5:134,524,312...134,583,230
|
|
G |
JARID2 |
jumonji and AT-rich interaction domain containing 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of JARID2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:15,246,069...15,522,042
Ensembl chr 6:15,246,069...15,522,042
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases expression increases expression |
ISO |
[N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with U 0126] inhibits the reaction [Isoproterenol results in increased expression of JUN mRNA]; [Phenylephrine co-treated with Isoproterenol] results in increased expression of JUN mRNA; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of JUN mRNA]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased expression of JUN mRNA] Isoproterenol results in decreased expression of JUN mRNA Isoproterenol results in increased expression of JUN mRNA; Isoproterenol results in increased expression of JUN protein [Isoproterenol co-treated with POSTN protein] results in decreased expression of JUN mRNA; Isoproterenol promotes the reaction [JUN protein binds to FOS protein] |
CTD |
PMID:10710348 PMID:14764439 PMID:21177286 PMID:30303030 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
JUNB |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of JUNB [N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with U 0126] inhibits the reaction [Isoproterenol results in increased expression of JUNB mRNA]; JUNB protein promotes the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; JUNB protein promotes the reaction [Isoproterenol results in decreased expression of SOX6 mRNA]; JUNB protein promotes the reaction [Isoproterenol results in decreased expression of SOX6 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased expression of JUNB mRNA]; U 0126 inhibits the reaction [Isoproterenol results in increased expression of JUNB mRNA] Isoproterenol results in increased expression of JUNB mRNA; Isoproterenol results in increased expression of JUNB protein |
CTD |
PMID:7905536 PMID:21177286 |
|
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
|
|
G |
KANK3 |
KN motif and ankyrin repeat domains 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of KANK3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:8,322,584...8,343,262
Ensembl chr19:8,322,584...8,343,262
|
|
G |
KCNA5 |
potassium voltage-gated channel subfamily A member 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of KCNA5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:5,043,879...5,046,788
Ensembl chr12:5,043,879...5,046,788
|
|
G |
KCNB1 |
potassium voltage-gated channel subfamily B member 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of KCNB1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:49,363,877...49,483,362
Ensembl chr20:49,293,394...49,484,297
|
|
G |
KCND2 |
potassium voltage-gated channel subfamily D member 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of KCND2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:120,272,908...120,750,337
Ensembl chr 7:120,273,175...120,750,337
|
|
G |
KCNE1 |
potassium voltage-gated channel subfamily E regulatory subunit 1 |
multiple interactions decreases expression |
EXP ISO |
Isoproterenol results in increased activity of [KCNQ1 protein binds to KCNE1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased activity of [KCNQ1 protein binds to KCNE1 protein]] Isoproterenol results in decreased expression of KCNE1 mRNA |
CTD |
PMID:16909339 PMID:20003209 |
|
NCBI chr21:34,446,688...34,512,210
Ensembl chr21:34,446,688...34,512,214
|
|
G |
KCNH6 |
potassium voltage-gated channel subfamily H member 6 |
increases expression |
ISO |
Isoproterenol results in increased expression of KCNH6 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:63,523,358...63,548,992
Ensembl chr17:63,523,334...63,548,977
|
|
G |
KCNQ1 |
potassium voltage-gated channel subfamily Q member 1 |
multiple interactions |
EXP ISO |
Isoproterenol results in increased activity of [KCNQ1 protein binds to KCNE1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased activity of [KCNQ1 protein binds to KCNE1 protein]] [Isoproterenol co-treated with POSTN protein] results in decreased expression of KCNQ1 mRNA |
CTD |
PMID:16909339 PMID:30303030 |
|
NCBI chr11:2,445,008...2,849,105
Ensembl chr11:2,444,654...2,849,105
|
|
G |
KCNT2 |
potassium sodium-activated channel subfamily T member 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of KCNT2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:196,225,779...196,608,440
Ensembl chr 1:196,225,779...196,609,225
|
|
G |
KDM6B |
lysine demethylase 6B |
decreases expression |
ISO |
Isoproterenol results in decreased expression of KDM6B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:7,834,217...7,854,796
Ensembl chr17:7,834,217...7,854,796
|
|
G |
KDR |
kinase insert domain receptor |
decreases expression |
ISO |
Isoproterenol results in decreased expression of KDR mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
decreases expression increases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of KEAP1 mRNA Isoproterenol results in increased expression of KEAP1 mRNA; Isoproterenol results in increased expression of KEAP1 protein [Isoproterenol co-treated with POSTN protein] results in decreased expression of KEAP1 mRNA; anethole inhibits the reaction [Isoproterenol results in increased expression of KEAP1 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of KEAP1 protein] |
CTD |
PMID:30303030 PMID:35430261 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
KIF1B |
kinesin family member 1B |
decreases expression |
ISO |
Isoproterenol results in decreased expression of KIF1B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:10,210,570...10,381,603
Ensembl chr 1:10,210,570...10,381,603
|
|
G |
KLF15 |
KLF transcription factor 15 |
increases expression |
ISO |
Isoproterenol results in increased expression of KLF15 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:126,288,125...126,357,408
Ensembl chr 3:126,342,635...126,357,408
|
|
G |
KLF3 |
KLF transcription factor 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of KLF3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:38,664,199...38,701,517
Ensembl chr 4:38,664,197...38,701,517
|
|
G |
KLHDC8A |
kelch domain containing 8A |
decreases expression |
ISO |
Isoproterenol results in decreased expression of KLHDC8A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:205,336,061...205,357,039
Ensembl chr 1:205,336,061...205,357,090
|
|
G |
KLHL2 |
kelch like family member 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of KLHL2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:165,207,561...165,323,156
Ensembl chr 4:165,207,561...165,323,156
|
|
G |
KLHL24 |
kelch like family member 24 |
increases expression |
ISO |
Isoproterenol results in increased expression of KLHL24 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519
|
|
G |
KLHL40 |
kelch like family member 40 |
increases expression |
ISO |
Isoproterenol results in increased expression of KLHL40 mRNA |
CTD |
PMID:20211217 |
|
NCBI chr 3:42,685,537...42,692,544
Ensembl chr 3:42,685,537...42,692,544
|
|
G |
KLHL41 |
kelch like family member 41 |
increases expression |
ISO |
Isoproterenol results in increased expression of KLHL41 mRNA |
CTD |
PMID:20211217 |
|
NCBI chr 2:169,509,702...169,526,258
Ensembl chr 2:169,509,702...169,526,258
|
|
G |
KLHL7 |
kelch like family member 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of KLHL7 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:23,105,785...23,177,914
Ensembl chr 7:23,105,758...23,177,914
|
|
G |
KMT5A |
lysine methyltransferase 5A |
decreases expression |
ISO |
Isoproterenol results in decreased expression of KMT5A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:123,384,132...123,409,353
Ensembl chr12:123,384,132...123,409,353
|
|
G |
KPNA3 |
karyopherin subunit alpha 3 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of KPNA3 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr13:49,699,320...49,792,682
Ensembl chr13:49,699,320...49,792,682
|
|
G |
KPNA6 |
karyopherin subunit alpha 6 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of KPNA6 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 1:32,108,056...32,176,563
Ensembl chr 1:32,108,056...32,176,563
|
|
G |
KRAS |
KRAS proto-oncogene, GTPase |
increases expression |
ISO |
Isoproterenol results in increased expression of KRAS mRNA |
CTD |
PMID:21335049 |
|
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
|
|
G |
KRT18 |
keratin 18 |
increases expression |
ISO |
Isoproterenol results in increased expression of KRT18 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
|
|
G |
KRT222 |
keratin 222 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of KRT222 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:40,654,665...40,665,177
Ensembl chr17:40,654,665...40,665,181
|
|
G |
KY |
kyphoscoliosis peptidase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of KY mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:134,599,923...134,651,022
Ensembl chr 3:134,599,923...134,651,636
|
|
G |
LAMA2 |
laminin subunit alpha 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of LAMA2 |
CTD |
PMID:18808529 |
|
NCBI chr 6:128,883,138...129,516,566
Ensembl chr 6:128,883,138...129,516,566
|
|
G |
LAMB1 |
laminin subunit beta 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of LAMB1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:107,923,799...108,003,161
Ensembl chr 7:107,923,799...108,003,213
|
|
G |
LBH |
LBH regulator of WNT signaling pathway |
decreases expression |
ISO |
Isoproterenol results in decreased expression of LBH mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:30,231,534...30,260,028
Ensembl chr 2:30,231,534...30,323,730
|
|
G |
LBP |
lipopolysaccharide binding protein |
increases expression |
ISO |
Isoproterenol results in increased expression of LBP mRNA |
CTD |
PMID:20003209 PMID:21335049 |
|
NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013
|
|
G |
LCAT |
lecithin-cholesterol acyltransferase |
multiple interactions decreases activity |
ISO |
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein]; alliin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein]; Desmodium gangeticum extract inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein]; epigallocatechin gallate inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein]; naringin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] |
CTD |
PMID:15740881 PMID:16640830 PMID:16906524 PMID:19595682 PMID:20024955 |
|
NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
|
|
G |
LCN2 |
lipocalin 2 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of LCN2 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
|
|
G |
LDHA |
lactate dehydrogenase A |
multiple interactions increases expression increases secretion |
ISO |
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased expression of LDHA protein]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of LDHA protein]; benidipine inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of LDHA protein]; caffeic acid inhibits the reaction [Isoproterenol results in increased expression of LDHA protein]; Gallic Acid inhibits the reaction [Isoproterenol results in increased secretion of LDHA protein]; Isoproterenol results in increased expression of and results in increased secretion of LDHA protein; naringin inhibits the reaction [Isoproterenol results in increased expression of LDHA protein]; oleuropein inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of LDHA protein] |
CTD |
PMID:17188415 PMID:19146839 PMID:21322096 PMID:21472895 PMID:21671307 PMID:25269373 PMID:26056852 More...
|
|
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
|
|
G |
LDHB |
lactate dehydrogenase B |
multiple interactions increases expression increases secretion |
ISO |
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased expression of LDHB protein]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of LDHB protein]; caffeic acid inhibits the reaction [Isoproterenol results in increased expression of LDHB protein]; Gallic Acid inhibits the reaction [Isoproterenol results in increased secretion of LDHB protein]; naringin inhibits the reaction [Isoproterenol results in increased expression of LDHB protein] |
CTD |
PMID:17188415 PMID:19146839 PMID:21322096 PMID:21472895 PMID:21671307 |
|
NCBI chr12:21,635,342...21,657,842
Ensembl chr12:21,635,342...21,757,857
|
|
G |
LEP |
leptin |
decreases secretion increases secretion increases expression multiple interactions |
EXP ISO |
Isoproterenol results in decreased secretion of LEP protein Isoproterenol results in increased secretion of LEP protein Isoproterenol results in increased expression of LEP protein CPU0213 inhibits the reaction [Isoproterenol results in increased expression of LEP protein] Propranolol inhibits the reaction [Isoproterenol results in decreased secretion of LEP protein] |
CTD |
PMID:11022189 PMID:20307649 PMID:25111128 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
LEPR |
leptin receptor |
multiple interactions increases expression |
ISO |
CPU0213 inhibits the reaction [Isoproterenol results in increased expression of LEPR mRNA]; CPU0213 inhibits the reaction [Isoproterenol results in increased expression of LEPR protein] Isoproterenol results in increased expression of LEPR mRNA; Isoproterenol results in increased expression of LEPR protein |
CTD |
PMID:20307649 |
|
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
|
|
G |
LGALS3 |
galectin 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of LGALS3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
|
|
G |
LGI1 |
leucine rich glioma inactivated 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of LGI1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:93,757,936...93,798,159
Ensembl chr10:93,757,840...93,806,272
|
|
G |
LGR6 |
leucine rich repeat containing G protein-coupled receptor 6 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of LGR6 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:202,193,799...202,319,761
Ensembl chr 1:202,193,799...202,319,781
|
|
G |
LILRB3 |
leukocyte immunoglobulin like receptor B3 |
increases expression |
ISO |
Isoproterenol results in increased expression of LILRB3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:54,216,278...54,223,007
Ensembl chr19:54,216,278...54,223,506
|
|
G |
LIMD1 |
LIM domain containing 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of LIMD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:45,594,751...45,686,341
Ensembl chr 3:45,555,394...45,686,341
|
|
G |
LIN7A |
lin-7 homolog A, crumbs cell polarity complex component |
increases expression |
ISO |
Isoproterenol results in increased expression of LIN7A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:80,792,520...80,937,934
Ensembl chr12:80,792,520...80,937,934
|
|
G |
LIPE |
lipase E, hormone sensitive type |
increases phosphorylation affects localization multiple interactions increases activity |
ISO |
Isoproterenol results in increased phosphorylation of LIPE protein Isoproterenol affects the localization of LIPE protein Papaverine inhibits the reaction [Isoproterenol affects the localization of LIPE protein]; Papaverine inhibits the reaction [Isoproterenol results in increased activity of LIPE protein] Sirolimus promotes the reaction [Isoproterenol results in increased phosphorylation of LIPE protein] |
CTD |
PMID:10894095 PMID:11160373 PMID:21042876 |
|
NCBI chr19:42,401,514...42,427,388
Ensembl chr19:42,401,514...42,427,388
|
|
G |
LITAF |
lipopolysaccharide induced TNF factor |
increases expression |
ISO |
Isoproterenol results in increased expression of LITAF mRNA |
CTD |
PMID:20003209 PMID:21335049 |
|
NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,547,722...11,636,381
|
|
G |
LMAN1 |
lectin, mannose binding 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of LMAN1 mRNA |
CTD |
PMID:21823215 |
|
NCBI chr18:59,327,823...59,359,265
Ensembl chr18:59,327,823...59,359,265
|
|
G |
LMCD1 |
LIM and cysteine rich domains 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of LMCD1 mRNA |
CTD |
PMID:20211217 PMID:23558518 |
|
NCBI chr 3:8,501,823...8,574,668
Ensembl chr 3:8,501,807...8,574,668
|
|
G |
LMOD3 |
leiomodin 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of LMOD3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:69,106,065...69,122,595
Ensembl chr 3:69,106,065...69,123,032
|
|
G |
LONRF3 |
LON peptidase N-terminal domain and ring finger 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of LONRF3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:118,974,614...119,018,355
Ensembl chr X:118,974,614...119,018,355
|
|
G |
LOX |
lysyl oxidase |
increases expression |
ISO |
Isoproterenol results in increased expression of LOX mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
|
|
G |
LPL |
lipoprotein lipase |
multiple interactions decreases expression increases expression decreases activity |
ISO |
cirazoline promotes the reaction [Isoproterenol results in increased expression of LPL mRNA]; naringin inhibits the reaction [Isoproterenol results in decreased activity of LPL protein] Isoproterenol results in decreased expression of LPL mRNA |
CTD |
PMID:9032464 PMID:16906524 PMID:21335049 |
|
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
|
|
G |
LRAT |
lecithin retinol acyltransferase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of LRAT mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:154,740,838...154,753,120
Ensembl chr 4:154,626,945...154,753,120
|
|
G |
LRG1 |
leucine rich alpha-2-glycoprotein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of LRG1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:4,536,402...4,540,036
Ensembl chr19:4,536,402...4,540,036
|
|
G |
LRPPRC |
leucine rich pentatricopeptide repeat containing |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of LRPPRC mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 2:43,886,224...43,996,265
Ensembl chr 2:43,886,224...43,996,226
|
|
G |
LRRC52 |
leucine rich repeat containing 52 |
increases expression |
ISO |
Isoproterenol results in increased expression of LRRC52 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:165,544,000...165,563,957
Ensembl chr 1:165,544,000...165,563,957
|
|
G |
LRRC58 |
leucine rich repeat containing 58 |
increases expression |
ISO |
Isoproterenol results in increased expression of LRRC58 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:120,324,509...120,349,354
Ensembl chr 3:120,324,509...120,349,354
|
|
G |
LRRC8C |
leucine rich repeat containing 8 VRAC subunit C |
increases expression |
ISO |
Isoproterenol results in increased expression of LRRC8C mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:89,615,824...89,719,533
Ensembl chr 1:89,633,072...89,769,903
|
|
G |
LSM14A |
LSM14A mRNA processing body assembly factor |
increases expression |
ISO |
Isoproterenol results in increased expression of LSM14A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:34,172,504...34,229,288
Ensembl chr19:34,172,504...34,229,288
|
|
G |
LSM3 |
LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
ISO |
Isoproterenol results in decreased expression of LSM3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:14,178,817...14,201,122
Ensembl chr 3:14,178,817...14,201,122
|
|
G |
LTBP2 |
latent transforming growth factor beta binding protein 2 |
increases expression increases expression |
ISO |
Isoproterenol results in increased expression of LTBP2 mRNA Isoproterenol increases expression of Ltbp2 mRNA in the heart |
CTD RGD |
PMID:20003209 PMID:29950403 |
RGD:156451654 |
NCBI chr14:74,498,183...74,612,237
Ensembl chr14:74,498,183...74,612,378
|
|
G |
LY6S |
lymphocyte antigen 6 family member S |
increases expression |
ISO |
Isoproterenol results in increased expression of LY6A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:143,040,839...143,076,471
Ensembl chr 8:143,041,844...143,045,678
|
|
G |
LYVE1 |
lymphatic vessel endothelial hyaluronan receptor 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of LYVE1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:10,556,966...10,568,665
Ensembl chr11:10,556,966...10,611,689
|
|
G |
MAF |
MAF bZIP transcription factor |
increases expression |
ISO |
Isoproterenol results in increased expression of MAF mRNA |
CTD |
PMID:30303030 |
|
NCBI chr16:79,202,622...79,600,737
Ensembl chr16:79,585,843...79,600,737
|
|
G |
MAFF |
MAF bZIP transcription factor F |
increases expression |
ISO |
Isoproterenol results in increased expression of MAFF mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
|
|
G |
MAN1A1 |
mannosidase alpha class 1A member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MAN1A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:119,177,205...119,350,605
Ensembl chr 6:119,177,205...119,349,761
|
|
G |
MAN2A1 |
mannosidase alpha class 2A member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MAN2A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:109,689,927...109,869,625
Ensembl chr 5:109,689,927...109,869,625
|
|
G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
multiple interactions |
ISO |
MAP2K1 protein affects the reaction [Isoproterenol results in increased expression of NPPA mRNA]; MAP2K1 protein affects the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK1 protein]; MAP2K1 protein affects the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK3 protein] MAP2K1 protein promotes the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; MAP2K1 protein promotes the reaction [Isoproterenol results in decreased expression of COL2A1 protein]; MAP2K1 protein promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK1 protein]; MAP2K1 protein promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:10888249 PMID:21177286 |
|
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
|
|
G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of MAP2K4 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
|
|
G |
MAP3K2 |
mitogen-activated protein kinase kinase kinase 2 |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of MAP3K2 mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of MAP3K2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 2:127,298,668...127,388,465
Ensembl chr 2:127,298,668...127,388,465
|
|
G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MAP3K5 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
|
|
G |
MAP3K6 |
mitogen-activated protein kinase kinase kinase 6 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MAP3K6 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 1:27,355,184...27,366,961
Ensembl chr 1:27,355,184...27,366,961
|
|
G |
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MAP3K8 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833
|
|
G |
MAP7 |
microtubule associated protein 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of MAP7 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:136,342,734...136,550,422
Ensembl chr 6:136,342,281...136,550,819
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases activity increases phosphorylation multiple interactions |
ISO EXP |
Isoproterenol results in increased activity of MAPK1 protein Isoproterenol results in increased phosphorylation of MAPK1 protein DUSP1 protein inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK1 protein]; MAP2K1 protein promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK1 protein] erdosteine inhibits the reaction [Isoproterenol results in increased expression of and results in increased phosphorylation of MAPK1 protein]; Isoproterenol inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; Isoproterenol results in increased expression of and results in increased phosphorylation of MAPK1 protein; Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK1 protein; MAP2K1 protein affects the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK1 protein]; MIR214 mRNA promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK1 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of MAPK1 protein]; SL 327 inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK1 protein] [Isoproterenol binds to ADRB2 protein] which results in increased phosphorylation of MAPK1 protein; [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein; ARRB2 protein promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK1 protein]; Isoproterenol inhibits the reaction [Estradiol results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:10888249 PMID:11093795 PMID:15292328 PMID:16980553 PMID:17623046 PMID:17925438 PMID:19002953 PMID:19483313 PMID:21177286 PMID:26692091 PMID:33210414 More...
|
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
multiple interactions increases phosphorylation |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:18089841 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases expression increases phosphorylation increases activity |
EXP ISO |
[Isoproterenol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein; [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein; ARRB2 protein promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein]; Isoproterenol inhibits the reaction [Estradiol results in decreased phosphorylation of MAPK3 protein] Isoproterenol results in increased expression of MAPK3 mRNA DUSP1 protein inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein]; MAP2K1 protein promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein] erdosteine inhibits the reaction [Isoproterenol results in increased expression of and results in increased phosphorylation of MAPK3 protein]; geraniol inhibits the reaction [Isoproterenol results in increased expression of MAPK3 mRNA]; geraniol inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein]; Isoproterenol inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]; Isoproterenol results in increased expression of and results in increased phosphorylation of MAPK3 protein; Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK3 protein; MAP2K1 protein affects the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK3 protein]; MIR214 mRNA promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of MAPK3 protein]; SL 327 inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:10888249 PMID:11093795 PMID:15292328 PMID:16980553 PMID:17623046 PMID:17925438 PMID:19002953 PMID:19483313 PMID:20215810 PMID:21177286 PMID:26692091 PMID:33210414 PMID:35608392 More...
|
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions increases expression increases activity increases phosphorylation |
ISO |
candesartan inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK8 protein] Isoproterenol results in increased expression of MAPK8 mRNA Isoproterenol results in increased activity of MAPK8 protein 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK8 protein]; geraniol inhibits the reaction [Isoproterenol results in increased expression of MAPK8 mRNA]; geraniol inhibits the reaction [Isoproterenol results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:10591028 PMID:15951400 PMID:20562518 PMID:35608392 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MARCHF7 |
membrane associated ring-CH-type finger 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of MARCHF7 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:159,712,506...159,771,027
Ensembl chr 2:159,712,457...159,771,027
|
|
G |
MAS1 |
MAS1 proto-oncogene, G protein-coupled receptor |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MAS1 protein |
CTD |
PMID:20409916 |
|
NCBI chr 6:159,888,787...159,917,447
Ensembl chr 6:159,890,988...159,917,447
|
|
G |
MB |
myoglobin |
increases expression multiple interactions increases secretion |
ISO |
Isoproterenol results in increased expression of MB protein sinapinic acid inhibits the reaction [Isoproterenol results in increased expression of MB protein] Isoproterenol results in increased secretion of MB protein |
CTD |
PMID:533011 PMID:19628585 PMID:32627257 |
|
NCBI chr22:35,606,764...35,623,354
Ensembl chr22:35,606,764...35,637,951
|
|
G |
MBD1 |
methyl-CpG binding domain protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MBD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr18:50,266,885...50,281,767
Ensembl chr18:50,266,882...50,281,774
|
|
G |
MBD5 |
methyl-CpG binding domain protein 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of MBD5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:148,020,927...148,516,971
Ensembl chr 2:148,021,011...148,516,971
|
|
G |
MCCC2 |
methylcrotonyl-CoA carboxylase subunit 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MCCC2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:71,587,340...71,658,706
Ensembl chr 5:71,579,531...71,658,706
|
|
G |
MCF2L |
MCF.2 cell line derived transforming sequence like |
increases expression |
ISO |
Isoproterenol results in increased expression of MCF2L mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:112,894,335...113,099,742
Ensembl chr13:112,894,378...113,099,742
|
|
G |
MDGA1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MDGA1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:37,630,679...37,697,883
Ensembl chr 6:37,630,679...37,699,306
|
|
G |
MEF2C |
myocyte enhancer factor 2C |
decreases expression increases expression |
ISO |
Isoproterenol results in decreased expression of MEF2C mRNA Isoproterenol results in increased expression of MEF2C mRNA |
CTD |
PMID:20003209 PMID:30303030 |
|
NCBI chr 5:88,717,117...88,904,105
Ensembl chr 5:88,717,117...88,904,257
|
|
G |
MEIG1 |
meiosis/spermiogenesis associated 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MEIG1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:14,954,228...14,988,050
Ensembl chr10:14,959,388...14,988,050
|
|
G |
METRN |
meteorin, glial cell differentiation regulator |
decreases expression |
ISO |
Isoproterenol results in decreased expression of METRN mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:715,118...719,655
Ensembl chr16:715,118...719,655
|
|
G |
MFAP5 |
microfibril associated protein 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of MFAP5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:8,645,943...8,662,826
Ensembl chr12:8,637,346...8,662,888
|
|
G |
MFN1 |
mitofusin 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MFN1 protein |
CTD |
PMID:27491814 |
|
NCBI chr 3:179,347,709...179,394,936
Ensembl chr 3:179,347,709...179,394,936
|
|
G |
MFN2 |
mitofusin 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MFN2 protein |
CTD |
PMID:26692091 PMID:27491814 |
|
NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211
|
|
G |
MGLL |
monoglyceride lipase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MGLL mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:127,689,066...127,823,185
Ensembl chr 3:127,689,062...128,052,190
|
|
G |
MGP |
matrix Gla protein |
increases expression |
ISO |
Isoproterenol results in increased expression of MGP mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:14,880,864...14,885,854
Ensembl chr12:14,880,864...14,885,857
|
|
G |
MGST1 |
microsomal glutathione S-transferase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MGST1 mRNA |
CTD |
PMID:20003209 PMID:21335049 |
|
NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259
|
|
G |
MIAT |
myocardial infarction associated transcript |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of MIAT Lutein inhibits the reaction [Isoproterenol results in increased expression of MIAT] |
CTD |
PMID:34435724 |
|
NCBI chr22:26,646,429...26,676,478
Ensembl chr22:26,646,411...26,676,475
|
|
G |
MIB1 |
MIB E3 ubiquitin protein ligase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MIB1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr18:21,704,916...21,870,953
Ensembl chr18:21,704,957...21,870,953
|
|
G |
MIR122 |
microRNA 122 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of MIR122 mRNA xanthone inhibits the reaction [Isoproterenol results in increased expression of MIR122 mRNA] |
CTD |
PMID:36414029 |
|
NCBI chr18:58,451,074...58,451,158
Ensembl chr18:58,451,074...58,451,158
|
|
G |
MIR133A1 |
microRNA 133a-1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MIR133A1 |
CTD |
PMID:19893015 |
|
NCBI chr18:21,825,698...21,825,785
Ensembl chr18:21,825,698...21,825,785
|
|
G |
MIR142 |
microRNA 142 |
increases expression |
ISO |
Isoproterenol results in increased expression of MIR142 mRNA |
CTD |
PMID:29355689 |
|
NCBI chr17:58,331,232...58,331,318
Ensembl chr17:58,331,232...58,331,318
|
|
G |
MIR145 |
microRNA 145 |
increases expression |
ISO |
isoprenaline increases expression of miRNA145 RNA in left ventricular myocardial tissues |
RGD |
PMID:35139769 |
RGD:155260312 |
NCBI chr 5:149,430,646...149,430,733
Ensembl chr 5:149,430,646...149,430,733
|
|
G |
MIR155 |
microRNA 155 |
increases expression |
ISO |
Isoproterenol results in increased expression of MIR155 mRNA |
CTD |
PMID:29355689 |
|
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
|
|
G |
MIR19A |
microRNA 19a |
increases expression |
ISO |
Isoproterenol results in increased expression of MIR19A mRNA |
CTD |
PMID:29355689 |
|
NCBI chr13:91,350,891...91,350,972
Ensembl chr13:91,350,891...91,350,972
|
|
G |
MIR200A |
microRNA 200a |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of MIR200A mRNA Lutein inhibits the reaction [Isoproterenol results in decreased expression of MIR200A mRNA] |
CTD |
PMID:34435724 |
|
NCBI chr 1:1,167,863...1,167,952
Ensembl chr 1:1,167,863...1,167,952
|
|
G |
MIR208A |
microRNA 208a |
increases expression decreases expression |
ISO |
Isoproterenol results in increased expression of MIR208A Isoproterenol results in decreased expression of MIR208A mRNA |
CTD |
PMID:26454886 PMID:29355689 |
|
NCBI chr14:23,388,596...23,388,666
Ensembl chr14:23,388,596...23,388,666
|
|
G |
MIR208B |
microRNA 208b |
increases expression |
ISO |
Isoproterenol results in increased expression of MIR208B mRNA |
CTD |
PMID:29355689 |
|
NCBI chr14:23,417,987...23,418,063
Ensembl chr14:23,417,987...23,418,063
|
|
G |
MIR21 |
microRNA 21 |
increases expression |
ISO |
Isoproterenol results in increased expression of MIR21 mRNA |
CTD |
PMID:28526319 PMID:29355689 |
|
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
|
|
G |
MIR214 |
microRNA 214 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of MIR214 mRNA MIR214 mRNA promotes the reaction [Isoproterenol results in increased expression of COL1A1 mRNA]; MIR214 mRNA promotes the reaction [Isoproterenol results in increased expression of COL3A1 mRNA]; MIR214 mRNA promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK1 protein]; MIR214 mRNA promotes the reaction [Isoproterenol results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:26692091 |
|
NCBI chr 1:172,138,798...172,138,907
Ensembl chr 1:172,138,798...172,138,907
|
|
G |
MIR30E |
microRNA 30e |
decreases expression |
ISO |
Isoproterenol decreases expression of Mir30e mRNA in the heart |
RGD |
PMID:28777253 |
RGD:401827856 |
NCBI chr 1:40,754,355...40,754,446
Ensembl chr 1:40,754,355...40,754,446
|
|
G |
MIR384 |
microRNA 384 |
multiple interactions decreases expression |
ISO |
MIR384 mRNA inhibits the reaction [Isoproterenol results in decreased expression of ALPK3 mRNA] Isoproterenol results in decreased expression of MIR384 mRNA |
CTD |
PMID:35510648 |
|
NCBI chr X:76,919,273...76,919,360
Ensembl chr X:76,919,273...76,919,360
|
|
G |
MIX23 |
mitochondrial matrix import factor 23 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MIX23 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:122,359,591...122,383,231
Ensembl chr 3:122,359,591...122,383,231
|
|
G |
MKNK2 |
MAPK interacting serine/threonine kinase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of MKNK2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:2,037,471...2,051,244
Ensembl chr19:2,037,465...2,051,244
|
|
G |
MLF1 |
myeloid leukemia factor 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MLF1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:158,571,194...158,606,456
Ensembl chr 3:158,571,163...158,607,252
|
|
G |
MLH1 |
mutL homolog 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MLH1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 3:36,993,466...37,050,846
Ensembl chr 3:36,993,226...37,050,896
|
|
G |
MMD |
monocyte to macrophage differentiation associated |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MMD mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:55,392,622...55,421,835
Ensembl chr17:55,392,622...55,421,924
|
|
G |
MMP1 |
matrix metallopeptidase 1 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of MMP1 SI 27 inhibits the reaction [Isoproterenol results in increased expression of MMP1] |
CTD |
PMID:12883319 |
|
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
|
|
G |
MMP11 |
matrix metallopeptidase 11 |
increases expression |
ISO |
Isoproterenol results in increased expression of MMP11 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:23,772,849...23,784,316
Ensembl chr22:23,768,226...23,784,316
|
|
G |
MMP14 |
matrix metallopeptidase 14 |
increases expression |
ISO |
Isoproterenol results in increased expression of MMP14 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr14:22,836,585...22,847,758
Ensembl chr14:22,836,560...22,849,041
|
|
G |
MMP15 |
matrix metallopeptidase 15 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MMP15 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:58,025,754...58,046,901
Ensembl chr16:58,025,754...58,046,901
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions increases expression increases activity |
ISO EXP |
Doxycycline inhibits the reaction [Isoproterenol results in increased activity of MMP2]; Isoproterenol results in increased expression of and results in increased activity of MMP2 protein geraniol inhibits the reaction [Isoproterenol results in increased expression of MMP2 mRNA] Isoproterenol results in increased expression of MMP2 mRNA; Isoproterenol results in increased expression of MMP2 protein |
CTD |
PMID:16327176 PMID:18089841 PMID:24929186 PMID:35608392 PMID:37016276 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP3 |
matrix metallopeptidase 3 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MMP3 mRNA] SI 27 inhibits the reaction [Isoproterenol results in increased expression of MMP3] |
CTD |
PMID:12883319 PMID:18089841 PMID:20003209 |
|
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions increases expression increases activity |
EXP ISO |
Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] CPU0213 inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]; geraniol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]; pimagedine inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] Isoproterenol results in increased activity of MMP9 Doxycycline inhibits the reaction [Isoproterenol results in increased activity of MMP9] |
CTD |
PMID:16574429 PMID:18089841 PMID:18594475 PMID:24929186 PMID:35608392 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MMRN1 |
multimerin 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MMRN1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:89,879,511...89,954,614
Ensembl chr 4:89,879,532...89,954,629
|
|
G |
MOSPD2 |
motile sperm domain containing 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of MOSPD2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:14,873,421...14,922,327
Ensembl chr X:14,873,421...14,922,327
|
|
G |
MPO |
myeloperoxidase |
multiple interactions increases expression increases activity |
ISO |
caffeic acid phenethyl ester inhibits the reaction [Isoproterenol results in increased activity of MPO protein]; Glyburide promotes the reaction [Isoproterenol results in increased activity of MPO protein]; pyrvinium inhibits the reaction [Isoproterenol results in increased activity of MPO protein]; sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of MPO protein] Isoproterenol results in increased expression of MPO protein |
CTD |
PMID:20693123 PMID:32865837 PMID:35014750 PMID:35305975 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MPP7 |
MAGUK p55 scaffold protein 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of MPP7 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:28,050,993...28,335,203
Ensembl chr10:28,050,993...28,334,486
|
|
G |
MRC1 |
mannose receptor C-type 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MRC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:17,809,348...17,911,164
Ensembl chr10:17,809,348...17,911,164
|
|
G |
MRPL41 |
mitochondrial ribosomal protein L41 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MRPL41 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:137,551,879...137,552,555
Ensembl chr 9:137,551,879...137,552,555
|
|
G |
MRPL45 |
mitochondrial ribosomal protein L45 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MRPL45 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:38,297,168...38,323,211
Ensembl chr17:38,297,023...38,323,217
|
|
G |
MSR1 |
macrophage scavenger receptor 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MSR1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:16,107,881...16,192,651
Ensembl chr 8:16,107,878...16,567,490
|
|
G |
MT1X |
metallothionein 1X |
increases expression |
ISO |
Isoproterenol results in increased expression of MT1 mRNA |
CTD |
PMID:20003209 PMID:21335049 |
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
MT2A |
metallothionein 2A |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MT2 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
MTCH2 |
mitochondrial carrier 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of MTCH2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:47,604,317...47,642,559
Ensembl chr11:47,617,315...47,642,607
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
increases phosphorylation multiple interactions |
ISO |
Isoproterenol results in increased phosphorylation of MTOR protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Isoproterenol results in increased phosphorylation of MTOR protein]; Sirolimus inhibits the reaction [Isoproterenol results in increased phosphorylation of MTOR protein]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased phosphorylation of MTOR protein]] |
CTD |
PMID:17623046 PMID:25045214 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
MTSS1 |
MTSS I-BAR domain containing 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MTSS1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:124,550,784...124,728,473
Ensembl chr 8:124,550,784...124,728,473
|
|
G |
MUSTN1 |
musculoskeletal, embryonic nuclear protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MUSTN1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:52,833,121...52,835,019
Ensembl chr 3:52,833,114...52,835,019
|
|
G |
MYBPC3 |
myosin binding protein C3 |
multiple interactions affects response to substance |
ISO EXP |
MYBPC3 gene mutant form results in increased susceptibility to [Isoproterenol co-treated with Phenylephrine] MYBPC3 protein affects the susceptibility to Isoproterenol MYBPC3 mutant form results in increased susceptibility to [Isoproterenol co-treated with Phenylephrine] |
CTD |
PMID:22076249 PMID:23896226 |
|
NCBI chr11:47,331,406...47,352,702
Ensembl chr11:47,331,406...47,352,702
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
ISO |
Isoproterenol results in increased expression of MYC mRNA |
CTD |
PMID:20003209 PMID:20211217 PMID:21823215 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
MYCN |
MYCN proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MYCN mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:15,940,550...15,947,004
Ensembl chr 2:15,940,550...15,947,007
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of MYD88 mRNA; Isoproterenol results in increased expression of MYD88 protein anethole inhibits the reaction [Isoproterenol results in increased expression of MYD88 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of MYD88 protein]; Metformin inhibits the reaction [Isoproterenol results in increased expression of MYD88 mRNA] |
CTD |
PMID:24842192 PMID:35430261 |
|
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
|
|
G |
MYH6 |
myosin heavy chain 6 |
multiple interactions increases expression |
ISO |
plantamajoside inhibits the reaction [Isoproterenol results in increased expression of MYH6 protein]; PPARA protein promotes the reaction [celastrol methyl ester inhibits the reaction [Isoproterenol results in decreased expression of MYH6 mRNA]]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of MYH6 protein] |
CTD |
PMID:31009642 PMID:37269933 |
|
NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273
|
|
G |
MYH7 |
myosin heavy chain 7 |
multiple interactions increases expression |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of MYH7 mRNA; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of MYH7 protein]; Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MYH7 mRNA]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of MYH7 mRNA]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of MYH7 mRNA] Isoproterenol results in increased expression of MYH7 mRNA; Isoproterenol results in increased expression of MYH7 protein bellidifolin inhibits the reaction [Isoproterenol results in increased expression of MYH7 protein]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of MYH7 mRNA]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of MYH7 protein]; Isoproterenol inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of MYH7 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased expression of MYH7 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased expression of MYH7 protein]; RELA mRNA promotes the reaction [Isoproterenol results in increased expression of MYH7 mRNA]; Sirolimus inhibits the reaction [Isoproterenol results in increased expression of MYH7 mRNA]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of MYH7 mRNA]] |
CTD |
PMID:10710348 PMID:18089841 PMID:18851973 PMID:25045214 PMID:28816235 PMID:31009642 PMID:37528096 More...
|
|
NCBI chr14:23,412,740...23,435,660
Ensembl chr14:23,412,740...23,435,660
|
|
G |
MYH7B |
myosin heavy chain 7B |
decreases expression |
ISO |
Isoproterenol results in decreased expression of MYH7B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:34,955,868...35,002,437
Ensembl chr20:34,955,810...35,002,437
|
|
G |
MYL1 |
myosin light chain 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of MYL1 protein |
CTD |
PMID:19854236 |
|
NCBI chr 2:210,290,150...210,315,174
Ensembl chr 2:210,290,150...210,315,174
|
|
G |
MYL3 |
myosin light chain 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of MYL3 protein |
CTD |
PMID:24286936 |
|
NCBI chr 3:46,857,872...46,882,182
Ensembl chr 3:46,835,111...46,882,178
|
|
G |
MYLIP |
myosin regulatory light chain interacting protein |
increases expression |
ISO |
Isoproterenol results in increased expression of MYLIP mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:16,129,086...16,163,887
Ensembl chr 6:16,129,086...16,148,248
|
|
G |
MYO5A |
myosin VA |
increases expression |
ISO |
Isoproterenol results in increased expression of MYO5A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:52,307,283...52,529,050
Ensembl chr15:52,307,281...52,529,132
|
|
G |
MYOT |
myotilin |
increases expression |
ISO |
Isoproterenol results in increased expression of MYOT mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:137,867,860...137,887,851
Ensembl chr 5:137,867,858...137,887,851
|
|
G |
MYRIP |
myosin VIIA and Rab interacting protein |
increases expression |
ISO |
Isoproterenol results in increased expression of MYRIP mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:39,808,914...40,260,321
Ensembl chr 3:39,808,914...40,260,321
|
|
G |
N4BP2L1 |
NEDD4 binding protein 2 like 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of N4BP2L1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:32,400,723...32,429,615
Ensembl chr13:32,400,723...32,428,311
|
|
G |
NAB1 |
NGFI-A binding protein 1 |
multiple interactions |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of NAB1 mRNA |
CTD |
PMID:10710348 |
|
NCBI chr 2:190,648,895...190,692,766
Ensembl chr 2:190,646,746...190,692,766
|
|
G |
NAB2 |
NGFI-A binding protein 2 |
multiple interactions |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of NAB2 mRNA; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of NAB2 mRNA] |
CTD |
PMID:10710348 |
|
NCBI chr12:57,089,114...57,095,476
Ensembl chr12:57,089,043...57,095,476
|
|
G |
NABP1 |
nucleic acid binding protein 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NABP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:191,678,136...191,686,943
Ensembl chr 2:191,678,068...191,741,097
|
|
G |
NAGLU |
N-acetyl-alpha-glucosaminidase |
increases activity multiple interactions |
ISO |
Isoproterenol results in increased activity of NAGLU protein Phytic Acid inhibits the reaction [Isoproterenol results in increased activity of NAGLU protein] |
CTD |
PMID:25560919 |
|
NCBI chr17:42,536,241...42,544,449
Ensembl chr17:42,536,241...42,544,449
|
|
G |
NARS1 |
asparaginyl-tRNA synthetase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of NARS1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr18:57,600,656...57,621,836
Ensembl chr18:57,600,656...57,622,213
|
|
G |
NBN |
nibrin |
decreases expression increases expression |
ISO |
Isoproterenol results in decreased expression of NBN mRNA Isoproterenol results in increased expression of NBN mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 8:89,933,331...89,984,667
Ensembl chr 8:89,924,515...90,003,228
|
|
G |
NCF1 |
neutrophil cytosolic factor 1 |
multiple interactions increases expression |
ISO |
CPU0213 inhibits the reaction [Isoproterenol results in increased expression of NCF1 mRNA] |
CTD |
PMID:18594475 |
|
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
|
|
G |
NCF2 |
neutrophil cytosolic factor 2 |
multiple interactions increases expression |
ISO |
1-(methanesulfonamido-1-naphthyloxy)-2-(N-(4-methane sulfonamidophenethyl)-N-acetamido)ethane inhibits the reaction [Isoproterenol results in increased expression of NCF2 mRNA]; 1-(methanesulfonamido-1-naphthyloxy)-2-(N-(4-methane sulfonamidophenethyl)-N-acetamido)ethane inhibits the reaction [Isoproterenol results in increased expression of NCF2 protein]; dofetilide inhibits the reaction [Isoproterenol results in increased expression of NCF2 mRNA]; dofetilide inhibits the reaction [Isoproterenol results in increased expression of NCF2 protein] Isoproterenol results in increased expression of NCF2 mRNA; Isoproterenol results in increased expression of NCF2 protein |
CTD |
PMID:20723002 |
|
NCBI chr 1:183,555,562...183,601,849
Ensembl chr 1:183,554,461...183,590,905
|
|
G |
NCSTN |
nicastrin |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of NCSTN mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of NCSTN mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 1:160,343,383...160,358,949
Ensembl chr 1:160,343,294...160,358,952
|
|
G |
NDRG1 |
N-myc downstream regulated 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of NDRG1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
|
|
G |
NDUFA11 |
NADH:ubiquinone oxidoreductase subunit A11 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFA11 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr19:5,891,229...5,903,790
Ensembl chr19:5,891,276...5,904,006
|
|
G |
NDUFA2 |
NADH:ubiquinone oxidoreductase subunit A2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NDUFA2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 5:140,645,285...140,647,630
Ensembl chr 5:140,638,740...140,647,771
|
|
G |
NDUFB2 |
NADH:ubiquinone oxidoreductase subunit B2 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 7:140,696,708...140,706,643
Ensembl chr 7:140,690,777...140,722,790
|
|
G |
NDUFB5 |
NADH:ubiquinone oxidoreductase subunit B5 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB5 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 3:179,604,794...179,627,647
Ensembl chr 3:179,604,690...179,627,647
|
|
G |
NDUFB8 |
NADH:ubiquinone oxidoreductase subunit B8 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB8 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr10:100,523,729...100,529,923
Ensembl chr10:100,523,740...100,530,000
|
|
G |
NDUFS1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 2:206,114,817...206,159,444
Ensembl chr 2:206,114,817...206,159,509
|
|
G |
NDUFS3 |
NADH:ubiquinone oxidoreductase core subunit S3 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS3 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr11:47,579,074...47,584,562
Ensembl chr11:47,565,336...47,584,562
|
|
G |
NDUFS4 |
NADH:ubiquinone oxidoreductase subunit S4 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS4 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 5:53,560,639...53,683,338
Ensembl chr 5:53,560,633...53,683,338
|
|
G |
NDUFS8 |
NADH:ubiquinone oxidoreductase core subunit S8 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS8 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr11:68,030,681...68,036,644
Ensembl chr11:68,030,617...68,036,644
|
|
G |
NDUFV1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFV1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr11:67,606,936...67,612,554
Ensembl chr11:67,605,653...67,612,554
|
|
G |
NDUFV2 |
NADH:ubiquinone oxidoreductase core subunit V2 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFV2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr18:9,102,699...9,134,341
Ensembl chr18:9,102,630...9,134,345
|
|
G |
NEB |
nebulin |
increases expression |
ISO |
Isoproterenol results in increased expression of NEB mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:151,485,339...151,734,476
Ensembl chr 2:151,485,336...151,734,487
|
|
G |
NES |
nestin |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NES mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:156,668,763...156,677,407
Ensembl chr 1:156,668,763...156,677,407
|
|
G |
NFATC1 |
nuclear factor of activated T cells 1 |
affects localization multiple interactions |
ISO |
Isoproterenol affects the localization of NFATC1 protein Cyclosporine inhibits the reaction [Isoproterenol affects the localization of NFATC1 protein]; Isoproterenol promotes the reaction [NFATC1 protein binds to GATA4 protein] |
CTD |
PMID:11435416 |
|
NCBI chr18:79,395,930...79,529,323
Ensembl chr18:79,395,856...79,529,325
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
decreases expression increases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of NFE2L2 mRNA; Isoproterenol results in decreased expression of NFE2L2 protein Isoproterenol results in increased expression of NFE2L2 mRNA; Isoproterenol results in increased expression of NFE2L2 protein [erdosteine co-treated with Isoproterenol] results in increased expression of NFE2L2 protein; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFE2L2 mRNA; anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 mRNA]; anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 protein]; Lutein inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 mRNA]; punicalagin inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 protein]; Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 mRNA] |
CTD |
PMID:28266775 PMID:30303030 PMID:32007421 PMID:33210414 PMID:34435724 PMID:35130744 PMID:35430261 PMID:36593721 PMID:37806379 More...
|
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFIC |
nuclear factor I C |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NFIC mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:3,359,630...3,469,217
Ensembl chr19:3,314,403...3,469,217
|
|
G |
NFIL3 |
nuclear factor, interleukin 3 regulated |
increases expression |
ISO |
Isoproterenol results in increased expression of NFIL3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions increases expression increases activity |
ISO |
Isoproterenol results in increased activity of [NFKB1 protein binds to RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased activity of [NFKB1 protein binds to RELA protein]] Isoproterenol results in increased expression of NFKB1 mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFKB1 mRNA Isoproterenol results in increased activity of NFKB1 protein |
CTD |
PMID:15178407 PMID:18487443 PMID:30303030 PMID:35014750 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
increases expression increases degradation multiple interactions decreases expression |
ISO |
Isoproterenol results in increased expression of NFKBIA mRNA Isoproterenol results in increased degradation of NFKBIA protein [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFKBIA mRNA; Isoproterenol promotes the reaction [G3BP2 protein binds to NFKBIA protein]; Sirolimus inhibits the reaction [Isoproterenol results in increased degradation of NFKBIA protein] Isoproterenol results in decreased expression of NFKBIA mRNA Isoproterenol results in decreased expression of NFKBIA protein Isoproterenol results in increased phosphorylation of and results in increased degradation of NFKBIA protein |
CTD |
PMID:15178407 PMID:18487443 PMID:20003209 PMID:21335049 PMID:25045214 PMID:28816235 PMID:30303030 More...
|
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NFKBIZ |
NFKB inhibitor zeta |
increases expression |
ISO |
Isoproterenol results in increased expression of NFKBIZ mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:101,827,990...101,861,022
Ensembl chr 3:101,827,991...101,861,022
|
|
G |
NGF |
nerve growth factor |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of NGF mRNA [Isoproterenol results in increased abundance of Cyclic AMP] which results in increased expression of NGF mRNA; Propranolol inhibits the reaction [Isoproterenol results in increased expression of NGF mRNA] |
CTD |
PMID:2174743 PMID:2853697 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
G |
NHERF4 |
NHERF family PDZ scaffold protein 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NHERF4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:119,185,475...119,190,213
Ensembl chr11:119,185,457...119,190,223
|
|
G |
NINJ1 |
ninjurin 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of NINJ1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:93,121,496...93,134,251
Ensembl chr 9:93,121,496...93,134,251
|
|
G |
NKIRAS2 |
NFKB inhibitor interacting Ras like 2 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NKIRAS2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr17:42,017,576...42,025,641
Ensembl chr17:42,011,382...42,025,644
|
|
G |
NKX2-5 |
NK2 homeobox 5 |
multiple interactions |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of NKX2-5 mRNA |
CTD |
PMID:10710348 |
|
NCBI chr 5:173,232,109...173,235,206
Ensembl chr 5:173,232,109...173,235,311
|
|
G |
NME6 |
NME/NM23 nucleoside diphosphate kinase 6 |
increases expression |
ISO |
Isoproterenol results in increased expression of NME6 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 3:48,288,402...48,301,367
Ensembl chr 3:48,290,722...48,301,685
|
|
G |
NMRK2 |
nicotinamide riboside kinase 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NMRK2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:3,933,069...3,942,416
Ensembl chr19:3,933,069...3,942,416
|
|
G |
NOCT |
nocturnin |
increases expression |
ISO |
Isoproterenol results in increased expression of NOCT mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:139,015,781...139,045,939
Ensembl chr 4:139,015,781...139,045,939
|
|
G |
NOL3 |
nucleolar protein 3 |
decreases phosphorylation |
ISO |
Isoproterenol results in decreased phosphorylation of NOL3 protein |
CTD |
PMID:19001025 |
|
NCBI chr16:67,170,538...67,175,737
Ensembl chr16:67,170,154...67,175,737
|
|
G |
NOS1 |
nitric oxide synthase 1 |
increases expression multiple interactions decreases expression |
ISO |
Isoproterenol results in increased expression of NOS1 protein thymoquinone inhibits the reaction [Isoproterenol results in decreased expression of NOS1 protein] |
CTD |
PMID:16702995 PMID:35940283 |
|
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
|
|
G |
NOS2 |
nitric oxide synthase 2 |
decreases expression multiple interactions increases expression |
EXP ISO |
Isoproterenol results in decreased expression of NOS2 mRNA [Isoproterenol results in increased expression of NOS2] which results in increased chemical synthesis of Nitric Oxide; Apigenin inhibits the reaction [Isoproterenol results in increased expression of NOS2 protein]; Ascorbic Acid inhibits the reaction [Isoproterenol results in increased expression of NOS2 protein]; caryophyllene inhibits the reaction [Isoproterenol results in increased expression of NOS2 protein]; N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA]; natakalim inhibits the reaction [[Isoproterenol results in increased expression of NOS2] which results in increased chemical synthesis of Nitric Oxide]; natakalim inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA]; natakalim inhibits the reaction [Isoproterenol results in increased expression of NOS2]; pimagedine inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA]; punicalagin inhibits the reaction [Isoproterenol results in increased expression of NOS2 protein]; Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA]; Tretinoin inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA] Isoproterenol results in increased expression of NOS2; Isoproterenol results in increased expression of NOS2 mRNA; Isoproterenol results in increased expression of NOS2 protein |
CTD |
PMID:18594475 PMID:18816294 PMID:19168511 PMID:19466570 PMID:24286936 PMID:27174236 PMID:27890915 PMID:30152906 PMID:32007421 PMID:34816538 PMID:35130744 PMID:35940283 PMID:37806379 More...
|
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions decreases phosphorylation increases expression decreases expression affects response to substance |
ISO |
3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Isoproterenol affects the expression of NOS3 mRNA]; 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Isoproterenol affects the expression of NOS3 protein]; 5-Methoxypsoralen inhibits the reaction [Isoproterenol results in decreased phosphorylation of NOS3 protein]; [Isoproterenol co-treated with Caffeine] results in decreased expression of NOS3 mRNA; caryophyllene inhibits the reaction [Isoproterenol results in decreased expression of NOS3 protein]; N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Isoproterenol results in decreased expression of NOS3 mRNA]; natakalim inhibits the reaction [Isoproterenol results in decreased expression of NOS3 mRNA]; thymoquinone inhibits the reaction [Isoproterenol results in increased expression of NOS3 protein] Isoproterenol results in increased expression of NOS3 mRNA; Isoproterenol results in increased expression of NOS3 protein Isoproterenol results in decreased expression of NOS3 mRNA; Isoproterenol results in decreased expression of NOS3 protein NOS3 protein affects the susceptibility to Isoproterenol NOS3 inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA] |
CTD |
PMID:12224825 PMID:16702995 PMID:17403420 PMID:17996136 PMID:18816294 PMID:19168511 PMID:27890915 PMID:29447158 PMID:32007421 PMID:34816538 PMID:35130744 PMID:35815753 PMID:35940283 More...
|
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NOTCH1 |
notch receptor 1 |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of NOTCH1 mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of NOTCH1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
|
|
G |
NOTCH4 |
notch receptor 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of NOTCH4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:32,194,843...32,224,067
Ensembl chr 6:32,194,843...32,224,067
|
|
G |
NOX4 |
NADPH oxidase 4 |
multiple interactions increases expression |
ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NOX4 mRNA]; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NOX4 protein]; Doxycycline inhibits the reaction [Isoproterenol results in increased expression of NOX4 mRNA] Isoproterenol results in increased expression of NOX4 mRNA; Isoproterenol results in increased expression of NOX4 protein |
CTD |
PMID:18089841 PMID:20003209 PMID:37528096 |
|
NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
|
|
G |
NPM1 |
nucleophosmin 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NPM1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
|
|
G |
NPM3 |
nucleophosmin/nucleoplasmin 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NPM3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:101,781,325...101,783,446
Ensembl chr10:101,781,325...101,783,446
|
|
G |
NPPA |
natriuretic peptide A |
multiple interactions increases expression decreases secretion decreases expression |
ISO EXP |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of NPPA mRNA; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NPPA protein]; celastrol methyl ester inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of NPPA mRNA]; NOS3 inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of NPPA protein]; PPARA protein promotes the reaction [celastrol methyl ester inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]]; swietenine inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of NPPA protein] isoprenaline increases expression of mRNA in neonatal rat cardiomyocytes Isoproterenol results in decreased secretion of NPPA protein Isoproterenol results in increased expression of NPPA mRNA; Isoproterenol results in increased expression of NPPA protein Isoproterenol results in decreased expression of NPPA protein ADRB1 protein promotes the reaction [Isoproterenol results in decreased expression of NPPA protein]; Atorvastatin inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NPPA protein]; CREM protein inhibits the reaction [Isoproterenol results in increased expression of NPPA protein]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of NPPA mRNA]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of NPPA protein]; Isoproterenol inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; manidipine inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; MAP2K1 protein affects the reaction [Isoproterenol results in increased expression of NPPA mRNA]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased expression of NPPA protein]; RELA mRNA promotes the reaction [Isoproterenol results in increased expression of NPPA mRNA]; Sirolimus inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; Spironolactone inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; swietenine inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; thymoquinone inhibits the reaction [Isoproterenol results in decreased secretion of NPPA protein]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA] |
CTD RGD |
PMID:8077211 PMID:9043801 PMID:9559417 PMID:10710348 PMID:10888249 PMID:10997724 PMID:11299230 PMID:11804996 PMID:12224825 PMID:12791704 PMID:18378355 PMID:18816294 PMID:18851973 PMID:19136528 PMID:19667237 PMID:23288202 PMID:25045214 PMID:28816235 PMID:31009642 PMID:32686902 PMID:34023961 PMID:35940283 PMID:37269933 PMID:37528096 PMID:37611474 PMID:26873969 More...
|
RGD:11526363 |
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
|
|
G |
NPPB |
natriuretic peptide B |
multiple interactions increases expression decreases secretion |
ISO EXP |
2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]; Enalapril inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of NPPB mRNA]; G3BP2 protein promotes the reaction [Isoproterenol results in increased expression of NPPB protein]; Glyburide inhibits the reaction [natakalim inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]]; Glyburide inhibits the reaction [natakalim inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]]; N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]; N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]; natakalim inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]; natakalim inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]; RELA mRNA promotes the reaction [Isoproterenol results in increased expression of NPPB mRNA]; Sirolimus inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]; swietenine inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]; thymoquinone inhibits the reaction [Isoproterenol results in decreased secretion of NPPB protein modified form]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]] isoprenaline increases expression of mRNA in neonatal rat cardiomyocytes bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]; celastrol methyl ester inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]; plantamajoside inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]; PPARA protein promotes the reaction [celastrol methyl ester inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]]; swietenine inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]; Valsartan inhibits the reaction [Isoproterenol results in increased expression of NPPB protein] Isoproterenol results in increased expression of NPPB mRNA; Isoproterenol results in increased expression of NPPB protein |
CTD RGD |
PMID:9043801 PMID:11804996 PMID:18806606 PMID:25045214 PMID:27890915 PMID:28816235 PMID:31009642 PMID:32686902 PMID:34023961 PMID:35940283 PMID:37269933 PMID:37528096 PMID:37611474 PMID:26873969 More...
|
RGD:11526363 |
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions decreases expression |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NQO1 mRNA Isoproterenol results in decreased expression of NQO1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NQO2 |
N-ribosyldihydronicotinamide:quinone dehydrogenase 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NQO2 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 6:2,999,894...3,019,755
Ensembl chr 6:2,987,987...3,019,755
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
decreases expression increases expression |
ISO |
Isoproterenol results in decreased expression of NR1H4 mRNA Isoproterenol results in increased expression of NR1H4 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
NR4A1 |
nuclear receptor subfamily 4 group A member 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NR4A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507
|
|
G |
NR4A3 |
nuclear receptor subfamily 4 group A member 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of NR4A3 mRNA |
CTD |
PMID:34601065 |
|
NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891
|
|
G |
NSMAF |
neutral sphingomyelinase activation associated factor |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of NSMAF mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 8:58,583,504...58,659,853
Ensembl chr 8:58,583,508...58,659,853
|
|
G |
NTF3 |
neurotrophin 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of NTF3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:5,430,332...5,495,299
Ensembl chr12:5,432,108...5,521,536
|
|
G |
NUCB2 |
nucleobindin 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of NUCB2 mRNA |
CTD |
PMID:21823215 |
|
NCBI chr11:17,276,739...17,349,980
Ensembl chr11:17,208,153...17,349,980
|
|
G |
NXT2 |
nuclear transport factor 2 like export factor 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of NXT2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:109,535,824...109,544,698
Ensembl chr X:109,535,781...109,544,698
|
|
G |
OAZ2 |
ornithine decarboxylase antizyme 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of OAZ2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:64,687,574...64,703,281
Ensembl chr15:64,687,573...64,703,281
|
|
G |
ODC1 |
ornithine decarboxylase 1 |
multiple interactions increases activity |
ISO |
Propranolol inhibits the reaction [Isoproterenol results in increased activity of ODC1 protein] |
CTD |
PMID:6284819 PMID:10354516 |
|
NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327
|
|
G |
OGA |
O-GlcNAcase |
increases expression |
ISO |
Isoproterenol results in increased expression of OGA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:101,784,450...101,818,444
Ensembl chr10:101,784,443...101,818,465
|
|
G |
OGDH |
oxoglutarate dehydrogenase |
decreases expression decreases activity multiple interactions |
ISO |
Isoproterenol results in decreased expression of OGDH mRNA Isoproterenol results in decreased activity of OGDH protein naringin inhibits the reaction [Isoproterenol results in decreased activity of OGDH protein]; S-allylcysteine inhibits the reaction [Isoproterenol results in decreased expression of OGDH mRNA]; sinapinic acid inhibits the reaction [Isoproterenol results in decreased activity of OGDH protein]; Thymol inhibits the reaction [Isoproterenol results in decreased activity of OGDH protein] |
CTD |
PMID:9753871 PMID:17182065 PMID:17994577 PMID:26721194 PMID:32627257 |
|
NCBI chr 7:44,606,627...44,709,066
Ensembl chr 7:44,606,572...44,709,066
|
|
G |
OMD |
osteomodulin |
increases expression |
ISO |
Isoproterenol results in increased expression of OMD mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:92,412,380...92,424,471
Ensembl chr 9:92,412,380...92,424,471
|
|
G |
OPA1 |
OPA1 mitochondrial dynamin like GTPase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of OPA1 protein |
CTD |
PMID:27491814 |
|
NCBI chr 3:193,593,208...193,697,811
Ensembl chr 3:193,593,144...193,697,811
|
|
G |
OSMR |
oncostatin M receptor |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of OSMR mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 5:38,846,012...38,945,579
Ensembl chr 5:38,845,858...38,945,596
|
|
G |
OTUB1 |
OTU deubiquitinase, ubiquitin aldehyde binding 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of OTUB1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:63,986,438...63,998,412
Ensembl chr11:63,985,853...64,001,811
|
|
G |
P3H2 |
prolyl 3-hydroxylase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of P3H2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:189,956,728...190,122,278
Ensembl chr 3:189,956,728...190,122,437
|
|
G |
P4HB |
prolyl 4-hydroxylase subunit beta |
increases expression |
ISO |
Isoproterenol results in increased expression of P4HB mRNA |
CTD |
PMID:21823215 |
|
NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
|
|
G |
PACRG |
parkin coregulated |
increases expression |
ISO |
Isoproterenol results in increased expression of PACRG mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:162,727,132...163,315,500
Ensembl chr 6:162,727,132...163,315,500
|
|
G |
PALLD |
palladin, cytoskeletal associated protein |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PALLD mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:168,497,052...168,928,441
Ensembl chr 4:168,497,052...168,928,457
|
|
G |
PAPSS2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of PAPSS2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:87,659,878...87,747,705
Ensembl chr10:87,659,613...87,747,705
|
|
G |
PAQR9 |
progestin and adipoQ receptor family member 9 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PAQR9 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:142,949,164...142,964,008
Ensembl chr 3:142,949,164...142,963,674
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
decreases expression multiple interactions increases expression increases cleavage |
EXP ISO |
Isoproterenol results in decreased expression of PARP1 protein erdosteine affects the reaction [Isoproterenol results in increased expression of PARP1 protein] BMP10 protein inhibits the reaction [Isoproterenol results in increased cleavage of PARP1 protein] |
CTD |
PMID:29438734 PMID:31712309 PMID:33210414 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCK1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions increases expression |
ISO |
[Isoproterenol co-treated with rosiglitazone] results in increased expression of PCK1 mRNA; Dexamethasone inhibits the reaction [Isoproterenol results in increased expression of PCK1 mRNA] |
CTD |
PMID:9518257 |
|
NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121
|
|
G |
PCMTD2 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of PCMTD2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:64,255,748...64,276,226
Ensembl chr20:64,255,695...64,304,820
|
|
G |
PDE3B |
phosphodiesterase 3B |
multiple interactions |
ISO |
[PDE3B protein co-treated with AKT1 protein] inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] |
CTD |
PMID:19167487 |
|
NCBI chr11:14,643,804...14,872,044
Ensembl chr11:14,643,804...14,872,044
|
|
G |
PDE4A |
phosphodiesterase 4A |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PDE4A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:10,416,773...10,469,631
Ensembl chr19:10,416,773...10,469,630
|
|
G |
PDE7A |
phosphodiesterase 7A |
increases expression |
ISO |
Isoproterenol results in increased expression of PDE7A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:65,714,334...65,842,064
Ensembl chr 8:65,714,334...65,842,322
|
|
G |
PDGFD |
platelet derived growth factor D |
increases expression |
ISO |
Isoproterenol results in increased expression of PDGFD mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:103,907,189...104,164,147
Ensembl chr11:103,907,189...104,164,379
|
|
G |
PDIA4 |
protein disulfide isomerase family A member 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of PDIA4 mRNA |
CTD |
PMID:21335049 PMID:21823215 |
|
NCBI chr 7:149,003,051...149,028,505
Ensembl chr 7:149,003,062...149,028,662
|
|
G |
PDIA6 |
protein disulfide isomerase family A member 6 |
increases expression |
ISO |
Isoproterenol results in increased expression of PDIA6 mRNA |
CTD |
PMID:21823215 |
|
NCBI chr 2:10,783,391...10,837,712
Ensembl chr 2:10,783,391...10,837,977
|
|
G |
PDK1 |
pyruvate dehydrogenase kinase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PDK1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:172,555,373...172,724,312
Ensembl chr 2:172,555,373...172,608,669
|
|
G |
PDXDC1 |
pyridoxal dependent decarboxylase domain containing 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PDXDC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:14,974,735...15,153,218
Ensembl chr16:14,974,591...15,139,339
|
|
G |
PEBP1 |
phosphatidylethanolamine binding protein 1 |
multiple interactions decreases expression |
EXP ISO |
PEBP1 protein promotes the reaction [Isoproterenol results in increased abundance of Cyclic AMP] [Isoproterenol co-treated with POSTN protein] results in decreased expression of PEBP1 mRNA Isoproterenol results in decreased expression of PEBP1 mRNA |
CTD |
PMID:26670611 PMID:30303030 |
|
NCBI chr12:118,136,124...118,145,584
Ensembl chr12:118,136,124...118,145,584
|
|
G |
PECR |
peroxisomal trans-2-enoyl-CoA reductase |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PECR mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 2:216,029,088...216,081,809
Ensembl chr 2:215,996,329...216,082,955
|
|
G |
PEG3 |
paternally expressed 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of PEG3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:56,810,082...56,840,726
Ensembl chr19:56,810,077...56,840,728
|
|
G |
PENK |
proenkephalin |
multiple interactions increases expression |
ISO |
Metoprolol inhibits the reaction [Isoproterenol results in increased expression of PENK mRNA]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of PENK mRNA]; Serotonin inhibits the reaction [Isoproterenol results in increased expression of PENK mRNA] |
CTD |
PMID:1363325 |
|
NCBI chr 8:56,440,957...56,446,641
Ensembl chr 8:56,436,674...56,446,671
|
|
G |
PER3 |
period circadian regulator 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PER3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:7,784,291...7,845,177
Ensembl chr 1:7,784,291...7,845,177
|
|
G |
PEX12 |
peroxisomal biogenesis factor 12 |
increases expression |
ISO |
Isoproterenol results in increased expression of PEX12 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:35,574,795...35,578,571
Ensembl chr17:35,574,795...35,578,863
|
|
G |
PEX2 |
peroxisomal biogenesis factor 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of PEX2 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 8:76,980,258...77,001,044
Ensembl chr 8:76,980,258...77,001,044
|
|
G |
PGM2L1 |
phosphoglucomutase 2 like 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PGM2L1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:74,330,316...74,398,433
Ensembl chr11:74,330,316...74,398,433
|
|
G |
PHF3 |
PHD finger protein 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of PHF3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:63,635,802...63,726,011
Ensembl chr 6:63,635,802...63,779,336
|
|
G |
PHKA1 |
phosphorylase kinase regulatory subunit alpha 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PHKA1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:72,578,814...72,714,306
Ensembl chr X:72,578,814...72,714,319
|
|
G |
PHLDA1 |
pleckstrin homology like domain family A member 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PHLDA1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
|
|
G |
PHLDA3 |
pleckstrin homology like domain family A member 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PHLDA3 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 1:201,464,278...201,469,188
Ensembl chr 1:201,464,278...201,469,237
|
|
G |
PHYHD1 |
phytanoyl-CoA dioxygenase domain containing 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PHYHD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:128,920,982...128,942,041
Ensembl chr 9:128,920,966...128,942,041
|
|
G |
PICALM |
phosphatidylinositol binding clathrin assembly protein |
increases expression |
ISO |
Isoproterenol results in increased expression of PICALM mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:85,957,175...86,069,860
Ensembl chr11:85,957,175...86,069,882
|
|
G |
PIGA |
phosphatidylinositol glycan anchor biosynthesis class A |
increases expression |
ISO |
Isoproterenol results in increased expression of PIGA mRNA |
CTD |
PMID:21823215 |
|
NCBI chr X:15,319,451...15,335,554
Ensembl chr X:15,319,452...15,335,554
|
|
G |
PIGB |
phosphatidylinositol glycan anchor biosynthesis class B |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PIGB mRNA |
CTD |
PMID:21823215 |
|
NCBI chr15:55,319,222...55,355,648
Ensembl chr15:55,318,960...55,355,648
|
|
G |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
multiple interactions increases activity |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Isoproterenol results in increased activity of PIK3CG protein]; wortmannin inhibits the reaction [Isoproterenol results in increased activity of PIK3CG protein] |
CTD |
PMID:15178407 |
|
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
|
|
G |
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PIK3R1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
|
|
G |
PIM3 |
Pim-3 proto-oncogene, serine/threonine kinase |
increases expression |
ISO |
Isoproterenol results in increased expression of PIM3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:49,960,772...49,964,072
Ensembl chr22:49,960,768...49,964,072
|
|
G |
PIR |
pirin |
increases expression |
ISO |
Isoproterenol results in increased expression of PIR mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
|
|
G |
PITPNC1 |
phosphatidylinositol transfer protein cytoplasmic 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PITPNC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:67,377,281...67,697,256
Ensembl chr17:67,377,281...67,697,256
|
|
G |
PLA2G4A |
phospholipase A2 group IVA |
increases expression |
ISO |
Isoproterenol results in increased expression of PLA2G4A mRNA |
CTD |
PMID:20211217 |
|
NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981
|
|
G |
PLA2G7 |
phospholipase A2 group VII |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of PLA2G7 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
|
|
G |
PLAGL1 |
PLAG1 like zinc finger 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PLAGL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:143,940,300...144,064,599
Ensembl chr 6:143,940,300...144,064,599
|
|
G |
PLAT |
plasminogen activator, tissue type |
multiple interactions increases secretion increases expression |
ISO |
Cycloheximide promotes the reaction [Isoproterenol results in increased expression of PLAT mRNA] Isoproterenol results in increased secretion of PLAT protein |
CTD |
PMID:2477232 |
|
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
|
|
G |
PLAU |
plasminogen activator, urokinase |
increases expression |
ISO |
Isoproterenol results in increased expression of PLAU mRNA |
CTD |
PMID:20211217 |
|
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
|
|
G |
PLCB4 |
phospholipase C beta 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of PLCB4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:9,068,678...9,480,808
Ensembl chr20:9,067,825...9,504,593
|
|
G |
PLD1 |
phospholipase D1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PLD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:171,600,404...171,810,483
Ensembl chr 3:171,600,404...171,810,950
|
|
G |
PLN |
phospholamban |
multiple interactions decreases phosphorylation increases phosphorylation |
ISO |
astragaloside A inhibits the reaction [Isoproterenol results in decreased phosphorylation of PLN protein]; candesartan inhibits the reaction [Isoproterenol results in decreased phosphorylation of PLN protein]; Isoproterenol results in decreased expression of and results in decreased phosphorylation of PLN protein; Propranolol inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased phosphorylation of PLN protein] Isoproterenol results in increased phosphorylation of PLN protein |
CTD |
PMID:10997724 PMID:16723803 PMID:17509559 PMID:21268078 |
|
NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
|
|
G |
PLXND1 |
plexin D1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PLXND1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:129,555,214...129,606,676
Ensembl chr 3:129,555,214...129,606,676
|
|
G |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression |
EXP |
Isoproterenol results in increased expression of PMAIP1 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,996...59,904,305
|
|
G |
PNLIP |
pancreatic lipase |
multiple interactions increases activity |
ISO |
oleuropein inhibits the reaction [Isoproterenol results in increased activity of PNLIP protein] |
CTD |
PMID:26056852 |
|
NCBI chr10:116,545,931...116,567,855
Ensembl chr10:116,545,931...116,567,855
|
|
G |
PNP |
purine nucleoside phosphorylase |
increases expression |
ISO |
Isoproterenol results in increased expression of PNP mRNA |
CTD |
PMID:20003209 PMID:21335049 |
|
NCBI chr14:20,469,406...20,477,089
Ensembl chr14:20,461,992...20,477,094
|
|
G |
PNPLA7 |
patatin like phospholipase domain containing 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of PNPLA7 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:137,459,952...137,550,402
Ensembl chr 9:137,459,952...137,550,402
|
|
G |
POMC |
proopiomelanocortin |
increases secretion |
ISO |
Isoproterenol results in increased secretion of POMC protein alternative form |
CTD |
PMID:10898105 |
|
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
|
|
G |
POPDC3 |
popeye domain containing 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of POPDC3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:105,157,900...105,180,014
Ensembl chr 6:105,157,900...105,180,014
|
|
G |
POSTN |
periostin |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of POSTN mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADL mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADM mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADS mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADVL mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACSL1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of AKT1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5F1A mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5F1D mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5MC1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5PO mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP6AP2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of AZI2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of BAG4 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of BIRC2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CASP7 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CDC37 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CHUK mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of COPS3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CPT1A mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CPT2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CUL1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of DMAC2L mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ELP1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of GCLM mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of GLG1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of GPX1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of HADHA mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of JUN mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KCNQ1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KEAP1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KPNA3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KPNA6 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of LRPPRC mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of MAP2K4 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of MAP3K2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NCSTN mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFA10L1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFA11 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB8 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS4 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS8 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFV1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFV2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFE2L2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFKB1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFKBIA mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NKIRAS2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NOTCH1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NQO1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NSMAF mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PEBP1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PECR mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PRKACA mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMA7 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB8 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMC5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMC6 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD11 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD13 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of SLC25A20 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of SOD2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of STAT1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of STAT3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of TBK1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of TXNRD2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of UBA1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of USP2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of XDH mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of YWHAG mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ZFAND5 mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of ATP5ME mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of ATP5PD mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of BCL2 mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of DAP mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of TNF mRNA |
CTD |
PMID:20003209 PMID:30303030 |
|
NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of PPARA mRNA Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARA mRNA]; Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARA protein]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARA mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARA protein]] Isoproterenol results in decreased expression of PPARA mRNA; Isoproterenol results in decreased expression of PPARA protein osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARA mRNA]; PPARA protein promotes the reaction [celastrol methyl ester inhibits the reaction [Isoproterenol results in decreased expression of MYH6 mRNA]]; PPARA protein promotes the reaction [celastrol methyl ester inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]]; PPARA protein promotes the reaction [celastrol methyl ester inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]] |
CTD |
PMID:21854795 PMID:24286936 PMID:25045214 PMID:37269933 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of PPARG mRNA 2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]; [Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein; Enalapril inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein]; Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]]; Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]; Hesperidin inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein] Isoproterenol results in decreased expression of PPARG mRNA; Isoproterenol results in decreased expression of PPARG protein osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA] |
CTD |
PMID:21854795 PMID:24286936 PMID:24954035 PMID:30623541 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
increases expression multiple interactions decreases expression |
ISO |
Isoproterenol results in increased expression of PPARGC1A mRNA Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARGC1A mRNA]; Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARGC1A protein]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARGC1A mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARGC1A protein]] Isoproterenol results in decreased expression of PPARGC1A mRNA; Isoproterenol results in decreased expression of PPARGC1A protein |
CTD |
PMID:19808358 PMID:25045214 PMID:34601065 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
PPARGC1B |
PPARG coactivator 1 beta |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PPARGC1B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:149,730,310...149,857,959
Ensembl chr 5:149,730,298...149,855,022
|
|
G |
PPFIBP1 |
PPFIA binding protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PPFIBP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:27,524,206...27,695,564
Ensembl chr12:27,523,431...27,695,564
|
|
G |
PPFIBP2 |
PPFIA binding protein 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of PPFIBP2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:7,513,999...7,667,304
Ensembl chr11:7,513,298...7,657,127
|
|
G |
PPIF |
peptidylprolyl isomerase F |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PPIF mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:79,347,469...79,355,334
Ensembl chr10:79,347,469...79,355,334
|
|
G |
PPIL6 |
peptidylprolyl isomerase like 6 |
increases expression |
ISO |
Isoproterenol results in increased expression of PPIL6 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:109,390,215...109,441,171
Ensembl chr 6:109,390,215...109,441,171
|
|
G |
PPIP5K2 |
diphosphoinositol pentakisphosphate kinase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of PPIP5K2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:103,120,301...103,212,799
Ensembl chr 5:103,120,149...103,212,799
|
|
G |
PPM1E |
protein phosphatase, Mg2+/Mn2+ dependent 1E |
increases expression |
ISO |
Isoproterenol results in increased expression of PPM1E mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:58,755,854...58,985,179
Ensembl chr17:58,755,854...58,985,179
|
|
G |
PPM1J |
protein phosphatase, Mg2+/Mn2+ dependent 1J |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PPM1J mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:112,709,998...112,715,332
Ensembl chr 1:112,709,994...112,715,332
|
|
G |
PPP1R14C |
protein phosphatase 1 regulatory inhibitor subunit 14C |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PPP1R14C mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:150,143,044...150,250,392
Ensembl chr 6:150,143,044...150,250,392
|
|
G |
PPP1R15A |
protein phosphatase 1 regulatory subunit 15A |
increases expression |
ISO |
Isoproterenol results in increased expression of PPP1R15A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059
|
|
G |
PPP2CA |
protein phosphatase 2 catalytic subunit alpha |
affects response to substance |
ISO |
PPP2CA protein affects the susceptibility to Isoproterenol |
CTD |
PMID:15247211 |
|
NCBI chr 5:134,194,332...134,226,073
Ensembl chr 5:134,194,035...134,226,073
|
|
G |
PRDX1 |
peroxiredoxin 1 |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of PRDX1 mRNA; Isoproterenol results in decreased expression of PRDX1 protein geraniol inhibits the reaction [Isoproterenol results in decreased expression of PRDX1 mRNA]; geraniol inhibits the reaction [Isoproterenol results in decreased expression of PRDX1 protein] |
CTD |
PMID:35608392 |
|
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
|
|
G |
PRG4 |
proteoglycan 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of PRG4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:186,296,273...186,314,567
Ensembl chr 1:186,296,279...186,314,567
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions increases phosphorylation |
ISO |
Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein; orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; triacsin C inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein] Isoproterenol results in increased phosphorylation of PRKAA1 protein [PDE3B protein co-treated with AKT1 protein] inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein]; INS protein inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein]; OPC 3911 inhibits the reaction [INS protein inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein]]; orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] |
CTD |
PMID:18390901 PMID:19167487 |
|
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
|
|
G |
PRKAA2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions decreases expression |
ISO |
xanthone inhibits the reaction [Isoproterenol results in decreased expression of PRKAA2 mRNA] |
CTD |
PMID:36414029 |
|
NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335
|
|
G |
PRKACA |
protein kinase cAMP-activated catalytic subunit alpha |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PRKACA mRNA |
CTD |
PMID:30303030 |
|
NCBI chr19:14,091,688...14,117,762
Ensembl chr19:14,091,688...14,118,084
|
|
G |
PRKAR2B |
protein kinase cAMP-dependent type II regulatory subunit beta |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of PRKAR2B protein natakalim inhibits the reaction [Isoproterenol results in decreased expression of PRKAR2B protein] |
CTD |
PMID:27890915 |
|
NCBI chr 7:107,044,705...107,161,811
Ensembl chr 7:107,044,705...107,161,811
|
|
G |
PRKCA |
protein kinase C alpha |
increases expression |
ISO |
Isoproterenol results in increased expression of PRKCA mRNA; Isoproterenol results in increased expression of PRKCA protein |
CTD |
PMID:12775975 |
|
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
|
|
G |
PRKCB |
protein kinase C beta |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PRKCB mRNA |
CTD |
PMID:21335049 |
|
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
|
|
G |
PRKCD |
protein kinase C delta |
multiple interactions increases phosphorylation increases expression |
ISO |
2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKCD protein] Isoproterenol results in increased expression of PRKCD mRNA; Isoproterenol results in increased expression of PRKCD protein |
CTD |
PMID:12775975 PMID:16716347 |
|
NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
|
|
G |
PRKCE |
protein kinase C epsilon |
multiple interactions increases expression increases phosphorylation |
ISO |
1-(methanesulfonamido-1-naphthyloxy)-2-(N-(4-methane sulfonamidophenethyl)-N-acetamido)ethane inhibits the reaction [Isoproterenol results in increased expression of PRKCE mRNA]; 1-(methanesulfonamido-1-naphthyloxy)-2-(N-(4-methane sulfonamidophenethyl)-N-acetamido)ethane inhibits the reaction [Isoproterenol results in increased expression of PRKCE protein]; 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKCE protein]; CPU0213 inhibits the reaction [Isoproterenol results in increased expression of PRKCE mRNA]; CPU0213 inhibits the reaction [Isoproterenol results in increased expression of PRKCE protein modified form]; CPU0213 inhibits the reaction [Isoproterenol results in increased expression of PRKCE protein]; dofetilide inhibits the reaction [Isoproterenol results in increased expression of PRKCE mRNA]; dofetilide inhibits the reaction [Isoproterenol results in increased expression of PRKCE protein] Isoproterenol results in increased expression of PRKCE mRNA; Isoproterenol results in increased expression of PRKCE protein; Isoproterenol results in increased expression of PRKCE protein modified form |
CTD |
PMID:12775975 PMID:16716347 PMID:20307649 PMID:20723002 |
|
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
|
|
G |
PRL |
prolactin |
increases expression |
ISO |
Isoproterenol results in increased expression of PRL |
CTD |
PMID:1208595 |
|
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
|
|
G |
PRMT1 |
protein arginine methyltransferase 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PRMT1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:49,676,153...49,688,447
Ensembl chr19:49,675,786...49,689,029
|
|
G |
PRND |
prion like protein doppel |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PRND mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:4,721,909...4,728,460
Ensembl chr20:4,721,909...4,728,460
|
|
G |
PRODH |
proline dehydrogenase 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PRODH mRNA |
CTD |
PMID:21335049 |
|
NCBI chr22:18,912,781...18,936,553
Ensembl chr22:18,912,777...18,936,553
|
|
G |
PROX1 |
prospero homeobox 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PROX1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:213,983,151...214,041,510
Ensembl chr 1:213,983,181...214,041,510
|
|
G |
PSEN1 |
presenilin 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PSEN1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr14:73,136,417...73,223,691
Ensembl chr14:73,136,418...73,223,691
|
|
G |
PSIP1 |
PC4 and SRSF1 interacting protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PSIP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:15,464,066...15,510,970
Ensembl chr 9:15,464,066...15,510,995
|
|
G |
PSMA7 |
proteasome 20S subunit alpha 7 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMA7 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr20:62,136,733...62,143,394
Ensembl chr20:62,136,733...62,143,440
|
|
G |
PSMB1 |
proteasome 20S subunit beta 1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 6:170,535,120...170,553,307
Ensembl chr 6:170,535,120...170,553,307
|
|
G |
PSMB5 |
proteasome 20S subunit beta 5 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB5 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr14:23,025,851...23,035,220
Ensembl chr14:23,016,543...23,035,230
|
|
G |
PSMB8 |
proteasome 20S subunit beta 8 |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of PSMB8 mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB8 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 6:32,840,717...32,844,679
Ensembl chr 6:32,840,717...32,844,679
|
|
G |
PSMC5 |
proteasome 26S subunit, ATPase 5 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMC5 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr17:63,827,431...63,832,019
Ensembl chr17:63,827,152...63,832,026
|
|
G |
PSMC6 |
proteasome 26S subunit, ATPase 6 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMC6 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr14:52,707,200...52,728,590
Ensembl chr14:52,707,178...52,728,590
|
|
G |
PSMD1 |
proteasome 26S subunit, non-ATPase 1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 2:231,056,867...231,172,827
Ensembl chr 2:231,056,845...231,173,116
|
|
G |
PSMD11 |
proteasome 26S subunit, non-ATPase 11 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD11 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr17:32,444,510...32,483,319
Ensembl chr17:32,444,379...32,483,319
|
|
G |
PSMD13 |
proteasome 26S subunit, non-ATPase 13 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD13 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr11:236,976...252,984
Ensembl chr11:236,966...252,984
|
|
G |
PSMD2 |
proteasome 26S subunit ubiquitin receptor, non-ATPase 2 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 3:184,299,241...184,309,050
Ensembl chr 3:184,299,198...184,309,050
|
|
G |
PSMD5 |
proteasome 26S subunit, non-ATPase 5 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD5 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 9:120,816,053...120,842,922
Ensembl chr 9:120,815,496...120,842,951
|
|
G |
PSMD9 |
proteasome 26S subunit, non-ATPase 9 |
increases expression |
ISO |
Isoproterenol results in increased expression of PSMD9 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr12:121,888,790...121,918,297
Ensembl chr12:121,888,732...121,918,297
|
|
G |
PTEN |
phosphatase and tensin homolog |
increases expression |
ISO |
Isoproterenol results in increased expression of PTEN mRNA Isoproterenol results in increased expression of PTEN mRNA; Isoproterenol results in increased expression of PTEN protein |
CTD |
PMID:16188065 PMID:20003209 |
|
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
G |
PTGDS |
prostaglandin D2 synthase |
increases expression |
ISO |
Isoproterenol results in increased expression of PTGDS mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:136,977,504...136,981,742
Ensembl chr 9:136,975,092...136,981,742
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PTGS1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression increases expression |
ISO EXP |
Apigenin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein]; BAY 58-2667 inhibits the reaction [Isoproterenol results in increased expression of PTGS2 mRNA]; Doxorubicin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein]; mangostin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] Isoproterenol results in decreased expression of PTGS2 mRNA Isoproterenol results in increased expression of PTGS2 mRNA; Isoproterenol results in increased expression of PTGS2 protein |
CTD |
PMID:18424012 PMID:19466570 PMID:19667237 PMID:22908232 PMID:30152906 PMID:32816093 More...
|
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTH1R |
parathyroid hormone 1 receptor |
increases expression |
ISO |
Isoproterenol results in increased expression of PTH1R mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:46,877,721...46,903,799
Ensembl chr 3:46,877,721...46,903,799
|
|
G |
PTP4A1 |
protein tyrosine phosphatase 4A1 |
increases expression |
ISO |
Isoproterenol results in increased expression of PTP4A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:63,516,440...63,583,588
Ensembl chr 6:63,521,746...63,583,588
|
|
G |
PTPN11 |
protein tyrosine phosphatase non-receptor type 11 |
increases expression |
ISO |
Isoproterenol results in increased expression of PTPN11 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918
|
|
G |
PTPN12 |
protein tyrosine phosphatase non-receptor type 12 |
increases expression |
ISO |
Isoproterenol results in increased expression of PTPN12 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:77,537,295...77,640,069
Ensembl chr 7:77,537,295...77,640,069
|
|
G |
PTPN5 |
protein tyrosine phosphatase non-receptor type 5 |
multiple interactions increases expression |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Isoproterenol results in increased expression of PTPN5 protein]; Anisomycin inhibits the reaction [Isoproterenol results in increased expression of PTPN5 protein]; Atenolol inhibits the reaction [Isoproterenol results in increased expression of PTPN5 protein]; Cycloheximide inhibits the reaction [Isoproterenol results in increased expression of PTPN5 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of PTPN5 protein]; Sirolimus inhibits the reaction [Isoproterenol results in increased expression of PTPN5 protein]; SL 327 inhibits the reaction [Isoproterenol results in increased expression of PTPN5 protein] |
CTD |
PMID:17623046 |
|
NCBI chr11:18,727,928...18,792,721
Ensembl chr11:18,727,928...18,792,721
|
|
G |
PTPRD |
protein tyrosine phosphatase receptor type D |
decreases expression |
ISO |
Isoproterenol results in decreased expression of PTPRD mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 9:8,314,246...10,613,002
Ensembl chr 9:8,314,246...10,613,002
|
|
G |
PTPRF |
protein tyrosine phosphatase receptor type F |
increases expression |
ISO |
Isoproterenol results in increased expression of PTPRF mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:43,522,051...43,623,666
Ensembl chr 1:43,525,187...43,623,666
|
|
G |
PTX3 |
pentraxin 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of PTX3 mRNA |
CTD |
PMID:20003209 PMID:21823215 |
|
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
|
|
G |
PVR |
PVR cell adhesion molecule |
increases expression |
ISO |
Isoproterenol results in increased expression of PVR mRNA |
CTD |
PMID:20211217 |
|
NCBI chr19:44,643,910...44,666,162
Ensembl chr19:44,643,798...44,666,162
|
|
G |
PYGL |
glycogen phosphorylase L |
increases activity |
ISO |
Isoproterenol results in increased activity of PYGL protein |
CTD |
PMID:6430282 |
|
NCBI chr14:50,905,217...50,944,483
Ensembl chr14:50,857,891...50,944,483
|
|
G |
QDPR |
quinoid dihydropteridine reductase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of QDPR mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 4:17,486,395...17,512,090
Ensembl chr 4:17,460,261...17,512,206
|
|
G |
R3HDM1 |
R3H domain containing 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of R3HDM1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:135,531,484...135,725,269
Ensembl chr 2:135,531,455...135,725,270
|
|
G |
RAB1A |
RAB1A, member RAS oncogene family |
increases expression |
ISO |
Isoproterenol results in increased expression of RAB1A mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 2:65,086,854...65,130,106
Ensembl chr 2:65,070,696...65,130,331
|
|
G |
RAB27A |
RAB27A, member RAS oncogene family |
increases expression |
ISO |
Isoproterenol results in increased expression of RAB27A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:55,202,966...55,289,813
Ensembl chr15:55,202,966...55,319,113
|
|
G |
RAB33B |
RAB33B, member RAS oncogene family |
increases expression |
ISO |
Isoproterenol results in increased expression of RAB33B mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 4:139,438,376...139,476,609
Ensembl chr 4:139,453,232...139,476,609
|
|
G |
RAB4A |
RAB4A, member RAS oncogene family |
increases expression |
ISO |
Isoproterenol results in increased expression of RAB4A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:229,271,111...229,305,894
Ensembl chr 1:229,271,062...229,305,894
|
|
G |
RAD52 |
RAD52 homolog, DNA repair protein |
increases expression |
ISO |
Isoproterenol results in increased expression of RAD52 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:911,736...991,122
Ensembl chr12:911,736...990,053
|
|
G |
RAMP1 |
receptor activity modifying protein 1 |
decreases expression increases expression |
ISO |
Isoproterenol results in decreased expression of RAMP1 mRNA Isoproterenol results in increased expression of RAMP1 mRNA; Isoproterenol results in increased expression of RAMP1 protein |
CTD |
PMID:16987513 PMID:17250927 PMID:17306419 PMID:20003209 |
|
NCBI chr 2:237,858,880...237,912,106
Ensembl chr 2:237,858,893...237,912,106
|
|
G |
RAMP2 |
receptor activity modifying protein 2 |
multiple interactions increases expression |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of RAMP2 mRNA Isoproterenol results in increased expression of RAMP2 mRNA; Isoproterenol results in increased expression of RAMP2 protein |
CTD |
PMID:12732346 PMID:16987513 PMID:17250927 PMID:17306419 |
|
NCBI chr17:42,761,227...42,763,041
Ensembl chr17:42,758,447...42,763,041
|
|
G |
RAMP3 |
receptor activity modifying protein 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of RAMP3 mRNA; Isoproterenol results in increased expression of RAMP3 protein |
CTD |
PMID:16987513 PMID:17306419 |
|
NCBI chr 7:45,157,791...45,184,250
Ensembl chr 7:45,157,791...45,186,302
|
|
G |
RANBP9 |
RAN binding protein 9 |
increases expression |
ISO |
Isoproterenol results in increased expression of RANBP9 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:13,621,498...13,711,835
Ensembl chr 6:13,621,498...13,711,835
|
|
G |
RANGAP1 |
Ran GTPase activating protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of RANGAP1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr22:41,244,779...41,302,369
Ensembl chr22:41,244,779...41,286,187
|
|
G |
RAPGEF3 |
Rap guanine nucleotide exchange factor 3 |
increases expression increases response to substance multiple interactions |
ISO |
Isoproterenol results in increased expression of RAPGEF3 mRNA RAPGEF3 results in increased susceptibility to Isoproterenol RAPGEF3 mutant form inhibits the reaction [Isoproterenol inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]] |
CTD |
PMID:17557924 PMID:21745194 |
|
NCBI chr12:47,734,363...47,758,880
Ensembl chr12:47,734,363...47,771,040
|
|
G |
RAPGEF4 |
Rap guanine nucleotide exchange factor 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of RAPGEF4 mRNA |
CTD |
PMID:17557924 |
|
NCBI chr 2:172,735,318...173,052,893
Ensembl chr 2:172,735,274...173,052,893
|
|
G |
RAPH1 |
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of RAPH1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:203,433,682...203,535,301
Ensembl chr 2:203,394,345...203,535,335
|
|
G |
RASA1 |
RAS p21 protein activator 1 |
affects localization multiple interactions |
ISO |
Isoproterenol affects the localization of RASA1 protein Isoproterenol results in increased expression of and results in increased phosphorylation of RASA1 protein |
CTD |
PMID:1382416 |
|
NCBI chr 5:87,267,883...87,391,916
Ensembl chr 5:87,267,883...87,391,931
|
|
G |
RASD1 |
ras related dexamethasone induced 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of RASD1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:17,494,437...17,496,395
Ensembl chr17:17,494,437...17,496,395
|
|
G |
RASGEF1B |
RasGEF domain family member 1B |
increases expression |
ISO |
Isoproterenol results in increased expression of RASGEF1B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:81,426,393...81,471,907
Ensembl chr 4:81,426,393...82,044,244
|
|
G |
RASL10A |
RAS like family 10 member A |
increases expression |
ISO |
Isoproterenol results in increased expression of RASL10A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:29,312,933...29,319,859
Ensembl chr22:29,312,933...29,319,679
|
|
G |
RASSF1 |
Ras association domain family member 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RASSF1 mRNA; Isoproterenol results in decreased expression of RASSF1 protein |
CTD |
PMID:24945829 |
|
NCBI chr 3:50,329,788...50,340,836
Ensembl chr 3:50,329,782...50,340,980
|
|
G |
RASSF4 |
Ras association domain family member 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of RASSF4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:44,959,802...44,995,891
Ensembl chr10:44,959,407...44,995,891
|
|
G |
RBBP4 |
RB binding protein 4, chromatin remodeling factor |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RBBP4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:32,651,208...32,686,211
Ensembl chr 1:32,651,142...32,686,211
|
|
G |
RBL2 |
RB transcriptional corepressor like 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of RBL2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:53,434,471...53,491,648
Ensembl chr16:53,433,977...53,491,648
|
|
G |
RBM33 |
RNA binding motif protein 33 |
increases expression |
ISO |
Isoproterenol results in increased expression of RBM33 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:155,644,661...155,781,480
Ensembl chr 7:155,644,451...155,781,485
|
|
G |
RBMX |
RNA binding motif protein X-linked |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RBMX mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:136,869,192...136,880,725
Ensembl chr X:136,848,004...136,880,764
|
|
G |
RBP7 |
retinol binding protein 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of RBP7 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:9,997,228...10,016,021
Ensembl chr 1:9,997,206...10,016,021
|
|
G |
REEP1 |
receptor accessory protein 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of REEP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:86,213,993...86,338,083
Ensembl chr 2:86,213,993...86,338,083
|
|
G |
REG3A |
regenerating family member 3 alpha |
decreases expression increases expression |
ISO |
Isoproterenol results in decreased expression of REG3B mRNA Isoproterenol results in increased expression of REG3B mRNA |
CTD |
PMID:20211217 PMID:24286936 |
|
NCBI chr 2:79,157,006...79,159,753
Ensembl chr 2:79,157,003...79,159,753
|
|
G |
REG3G |
regenerating family member 3 gamma |
decreases expression |
EXP |
Isoproterenol results in decreased expression of REG3G mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 2:79,025,702...79,028,501
Ensembl chr 2:79,025,686...79,028,505
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases expression affects localization increases localization increases activity |
ISO |
Isoproterenol results in increased activity of [NFKB1 protein binds to RELA protein]; osthol inhibits the reaction [Isoproterenol results in increased expression of RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased activity of [NFKB1 protein binds to RELA protein]] Isoproterenol results in increased expression of RELA mRNA; Isoproterenol results in increased expression of RELA protein Isoproterenol affects the localization of RELA protein Isoproterenol results in increased localization of RELA protein Isoproterenol results in increased activity of RELA protein anethole inhibits the reaction [Isoproterenol results in increased expression of RELA protein]; Enalapril inhibits the reaction [Isoproterenol results in increased expression of RELA protein]; Hesperidin inhibits the reaction [Isoproterenol results in increased expression of RELA protein]; Isoproterenol affects the reaction [Lipopolysaccharides affects the localization of RELA protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of RELA protein]; punicalagin inhibits the reaction [Isoproterenol results in increased expression of RELA protein]; RELA mRNA promotes the reaction [Isoproterenol results in increased expression of MYH7 mRNA]; RELA mRNA promotes the reaction [Isoproterenol results in increased expression of NPPA mRNA]; RELA mRNA promotes the reaction [Isoproterenol results in increased expression of NPPB mRNA]; Sirolimus inhibits the reaction [Isoproterenol affects the localization of RELA protein] |
CTD |
PMID:15178407 PMID:15710352 PMID:18487443 PMID:21854795 PMID:25045214 PMID:28816235 PMID:30303030 PMID:30623541 PMID:35430261 PMID:36593721 PMID:37806379 More...
|
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
REN |
renin |
increases activity multiple interactions increases expression increases secretion |
EXP ISO |
Isoproterenol results in increased activity of REN protein [Sodium, Dietary deficiency results in increased susceptibility to Isoproterenol] which results in increased secretion of REN protein; Isoproterenol promotes the reaction [CD38 gene mutant form results in increased activity of REN protein] [aliskiren co-treated with Carvedilol] inhibits the reaction [Isoproterenol results in increased activity of REN protein]; aliskiren inhibits the reaction [Isoproterenol results in increased activity of REN protein]; Carvedilol inhibits the reaction [Isoproterenol results in increased activity of REN protein]; Losartan promotes the reaction [Isoproterenol results in increased expression of REN protein]; Quinapril promotes the reaction [Isoproterenol results in increased expression of REN protein]; Ramipril inhibits the reaction [Isoproterenol results in increased expression of REN protein] Isoproterenol results in increased secretion of REN protein Propranolol inhibits the reaction [Isoproterenol results in increased expression of REN protein] Isoproterenol results in increased expression of REN mRNA |
CTD |
PMID:1653766 PMID:3515047 PMID:3910304 PMID:6314140 PMID:9539862 PMID:10432392 PMID:11709406 PMID:21424707 PMID:23343681 PMID:26982530 More...
|
|
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
|
|
G |
RFC5 |
replication factor C subunit 5 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RFC5 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr12:118,016,703...118,041,448
Ensembl chr12:118,013,588...118,033,130
|
|
G |
RHOJ |
ras homolog family member J |
increases expression |
ISO |
Isoproterenol results in increased expression of RHOJ mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:63,204,443...63,293,508
Ensembl chr14:63,204,114...63,293,508
|
|
G |
RHOU |
ras homolog family member U |
increases expression |
ISO |
Isoproterenol results in increased expression of RHOU mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:228,644,647...228,746,669
Ensembl chr 1:228,735,479...228,746,664
|
|
G |
RIPK1 |
receptor interacting serine/threonine kinase 1 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of RIPK1 protein thymoquinone inhibits the reaction [Isoproterenol results in increased expression of RIPK1 protein] |
CTD |
PMID:35940283 |
|
NCBI chr 6:3,063,967...3,115,187
Ensembl chr 6:3,063,824...3,115,187
|
|
G |
RIPK3 |
receptor interacting serine/threonine kinase 3 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of RIPK3 protein thymoquinone inhibits the reaction [Isoproterenol results in increased expression of RIPK3 protein] |
CTD |
PMID:35940283 |
|
NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
|
|
G |
RLN3 |
relaxin 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of RLN3 mRNA; Isoproterenol results in increased expression of RLN3 protein |
CTD |
PMID:16112403 |
|
NCBI chr19:14,028,148...14,031,551
Ensembl chr19:14,028,148...14,031,551
|
|
G |
RNASE4 |
ribonuclease A family member 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of RNASE4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:20,684,560...20,701,216
Ensembl chr14:20,684,560...20,701,216
|
|
G |
RND1 |
Rho family GTPase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of RND1 mRNA |
CTD |
PMID:20211217 PMID:23558518 |
|
NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870
|
|
G |
RNF103 |
ring finger protein 103 |
increases expression |
ISO |
Isoproterenol results in increased expression of RNF103 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:86,603,393...86,623,877
Ensembl chr 2:86,603,398...86,623,866
|
|
G |
RNF128 |
ring finger protein 128 |
increases expression |
ISO |
Isoproterenol results in increased expression of RNF128 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:106,693,838...106,797,016
Ensembl chr X:106,693,794...106,797,016
|
|
G |
RNF144B |
ring finger protein 144B |
increases expression |
ISO |
Isoproterenol results in increased expression of RNF144B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:18,387,350...18,468,870
Ensembl chr 6:18,387,350...18,468,870
|
|
G |
RNF207 |
ring finger protein 207 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RNF207 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:6,206,119...6,221,299
Ensembl chr 1:6,205,475...6,221,299
|
|
G |
RO60 |
Ro60, Y RNA binding protein |
increases expression |
ISO |
Isoproterenol results in increased expression of RO60 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:193,059,612...193,091,777
Ensembl chr 1:193,059,454...193,091,777
|
|
G |
RPL27A |
ribosomal protein L27a |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RPL27A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:8,682,792...8,689,872
Ensembl chr11:8,682,788...8,714,759
|
|
G |
RPL37A |
ribosomal protein L37a |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RPL37A mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 2:216,498,844...216,504,086
Ensembl chr 2:216,498,825...216,579,180
|
|
G |
RPN1 |
ribophorin I |
increases expression |
ISO |
Isoproterenol results in increased expression of RPN1 mRNA |
CTD |
PMID:21823215 |
|
NCBI chr 3:128,619,969...128,650,818
Ensembl chr 3:128,619,969...128,681,075
|
|
G |
RPS26 |
ribosomal protein S26 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RPS26 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr12:56,041,918...56,044,697
Ensembl chr12:56,041,351...56,044,697
|
|
G |
RPS27A |
ribosomal protein S27a |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RPS27A mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 2:55,231,903...55,235,853
Ensembl chr 2:55,231,903...55,235,853
|
|
G |
RPS3A |
ribosomal protein S3A |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RPS3A mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 4:151,099,628...151,104,642
Ensembl chr 4:151,099,624...151,104,642
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
increases phosphorylation affects expression |
ISO |
Isoproterenol results in increased phosphorylation of RPS6KB1 protein Isoproterenol affects the expression of RPS6KB1 mRNA |
CTD |
PMID:18812163 PMID:28099878 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
RRAD |
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
decreases expression |
ISO |
Isoproterenol results in decreased expression of RRAD mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:66,921,685...66,925,535
Ensembl chr16:66,921,685...66,925,535
|
|
G |
RSC1A1 |
regulator of solute carriers 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of RSC1A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:15,659,713...15,662,033
Ensembl chr 1:15,659,713...15,662,033
|
|
G |
RSF1 |
remodeling and spacing factor 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of RSF1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:77,660,009...77,872,232
Ensembl chr11:77,660,009...77,820,869
|
|
G |
RYR2 |
ryanodine receptor 2 |
multiple interactions increases phosphorylation |
ISO EXP |
candesartan inhibits the reaction [Isoproterenol results in increased phosphorylation of RYR2 protein] carvedilol inhibits the reaction [Isoproterenol results in increased phosphorylation of RYR2 protein] |
CTD |
PMID:16723803 PMID:21743453 |
|
NCBI chr 1:237,042,184...237,833,988
Ensembl chr 1:237,042,184...237,833,988
|
|
G |
S100A11 |
S100 calcium binding protein A11 |
increases expression |
ISO |
Isoproterenol results in increased expression of S100A11 protein |
CTD |
PMID:10886724 |
|
NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907
|
|
G |
S100A4 |
S100 calcium binding protein A4 |
increases expression |
ISO |
Isoproterenol results in increased expression of S100A4 protein |
CTD |
PMID:10886724 |
|
NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
|
|
G |
S100A8 |
S100 calcium binding protein A8 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of S100A8 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
|
|
G |
S100A9 |
S100 calcium binding protein A9 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of S100A9 mRNA] Isoproterenol results in increased expression of S100A9 protein Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of S100A9 protein]; pifithrin inhibits the reaction [Isoproterenol results in increased expression of S100A9 protein]; S100A9 protein affects the reaction [Isoproterenol results in increased expression of and results in increased phosphorylation of TP53 protein]; S100A9 protein affects the reaction [Isoproterenol results in increased expression of C3 protein]; S100A9 protein affects the reaction [Isoproterenol results in increased expression of C5 protein]; S100A9 protein affects the reaction [Isoproterenol results in increased expression of CASP3 protein] |
CTD |
PMID:18089841 PMID:20003209 PMID:32924446 |
|
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
|
|
G |
S1PR1 |
sphingosine-1-phosphate receptor 1 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of S1PR1 mRNA]; Doxycycline inhibits the reaction [Isoproterenol results in increased expression of S1PR1 protein] Isoproterenol results in increased expression of S1PR1 mRNA; Isoproterenol results in increased expression of S1PR1 protein |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 1:101,236,899...101,242,313
Ensembl chr 1:101,236,865...101,243,713
|
|
G |
SAA1 |
serum amyloid A1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SAA1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr11:18,266,264...18,269,967
Ensembl chr11:18,266,260...18,269,977
|
|
G |
SAA3P |
serum amyloid A3, pseudogene |
increases expression |
ISO |
Isoproterenol results in increased expression of SAA3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:18,112,472...18,116,132
Ensembl chr11:18,112,472...18,116,132 Ensembl chr11:18,112,472...18,116,132
|
|
G |
SAA4 |
serum amyloid A4, constitutive |
increases expression |
ISO |
Isoproterenol results in increased expression of SAA4 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr11:18,231,355...18,236,802
Ensembl chr11:18,231,355...18,236,802
|
|
G |
SBNO2 |
strawberry notch homolog 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of SBNO2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:1,107,638...1,174,268
Ensembl chr19:1,107,637...1,174,268
|
|
G |
SCARA5 |
scavenger receptor class A member 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of SCARA5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:27,869,883...27,992,673
Ensembl chr 8:27,869,883...27,992,673
|
|
G |
SCARB2 |
scavenger receptor class B member 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of SCARB2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:76,158,737...76,234,532
Ensembl chr 4:76,158,737...76,234,536
|
|
G |
SCGB3A1 |
secretoglobin family 3A member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SCGB3A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:180,590,105...180,591,499
Ensembl chr 5:180,590,105...180,591,499
|
|
G |
SCN3A |
sodium voltage-gated channel alpha subunit 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of SCN3A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:165,087,526...165,204,050
Ensembl chr 2:165,087,526...165,204,050
|
|
G |
SCN4B |
sodium voltage-gated channel beta subunit 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SCN4B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:118,133,377...118,152,823
Ensembl chr11:118,133,377...118,152,888
|
|
G |
SCN5A |
sodium voltage-gated channel alpha subunit 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of SCN5A mRNA |
CTD |
PMID:17526999 |
|
NCBI chr 3:38,548,062...38,649,687
Ensembl chr 3:38,548,057...38,649,687
|
|
G |
SCN7A |
sodium voltage-gated channel alpha subunit 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of SCN7A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:166,403,573...166,494,249
Ensembl chr 2:166,403,573...166,611,482
|
|
G |
SCPEP1 |
serine carboxypeptidase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SCPEP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:56,978,131...57,006,768
Ensembl chr17:56,978,129...57,006,768
|
|
G |
SCUBE2 |
signal peptide, CUB domain and EGF like domain containing 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SCUBE2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:9,019,476...9,091,599
Ensembl chr11:9,019,476...9,138,114
|
|
G |
SDF2L1 |
stromal cell derived factor 2 like 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SDF2L1 mRNA |
CTD |
PMID:21823215 |
|
NCBI chr22:21,642,302...21,644,299
Ensembl chr22:21,642,302...21,644,299
|
|
G |
SELE |
selectin E |
multiple interactions |
EXP |
Isoproterenol inhibits the reaction [TNF protein results in increased secretion of SELE mRNA] |
CTD |
PMID:8780174 |
|
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
|
|
G |
SELENOP |
selenoprotein P |
increases expression |
ISO |
Isoproterenol results in increased expression of SELENOP mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
|
|
G |
SELL |
selectin L |
multiple interactions |
EXP |
Isoproterenol promotes the reaction [Theophylline inhibits the reaction [Platelet Activating Factor results in increased secretion of SELL protein]] |
CTD |
PMID:9762784 |
|
NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702
|
|
G |
SEMA3G |
semaphorin 3G |
increases expression |
ISO |
Isoproterenol results in increased expression of SEMA3G mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:52,433,035...52,445,103
Ensembl chr 3:52,433,035...52,445,103
|
|
G |
SEMA5A |
semaphorin 5A |
increases expression |
ISO |
Isoproterenol results in increased expression of SEMA5A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:9,035,033...9,546,075
Ensembl chr 5:9,035,033...9,546,075
|
|
G |
SERINC3 |
serine incorporator 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of SERINC3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:44,496,221...44,522,070
Ensembl chr20:44,496,221...44,522,085
|
|
G |
SERPINA7 |
serpin family A member 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of SERPINA7 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr X:106,032,435...106,038,727
Ensembl chr X:106,032,435...106,038,727
|
|
G |
SERPINE1 |
serpin family E member 1 |
increases expression decreases expression |
ISO |
Isoproterenol results in increased expression of SERPINE1 mRNA Isoproterenol results in decreased expression of SERPINE1 protein |
CTD |
PMID:20211217 PMID:23558518 PMID:24286936 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SERPING1 |
serpin family G member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SERPING1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
|
|
G |
SESN1 |
sestrin 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SESN1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:108,984,309...109,094,846
Ensembl chr 6:108,984,309...109,094,846
|
|
G |
SET |
SET nuclear proto-oncogene |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SET mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:128,683,424...128,696,396
Ensembl chr 9:128,683,424...128,696,400
|
|
G |
SETDB2 |
SET domain bifurcated histone lysine methyltransferase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of SETDB2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:49,444,274...49,495,003
Ensembl chr13:49,444,274...49,495,003
|
|
G |
SFN |
stratifin |
decreases expression |
EXP |
Isoproterenol results in decreased expression of SFN mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456
|
|
G |
SGCG |
sarcoglycan gamma |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SGCG |
CTD |
PMID:18808529 |
|
NCBI chr13:23,160,508...23,325,162
Ensembl chr13:23,180,979...23,325,162
|
|
G |
SGMS1 |
sphingomyelin synthase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SGMS1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:50,305,600...50,625,184
Ensembl chr10:50,305,586...50,625,163
|
|
G |
SH3D19 |
SH3 domain containing 19 |
increases expression |
ISO |
Isoproterenol results in increased expression of SH3D19 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:151,120,281...151,325,605
Ensembl chr 4:151,102,751...151,325,605
|
|
G |
SH3KBP1 |
SH3 domain containing kinase binding protein 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SH3KBP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:19,533,977...19,887,600
Ensembl chr X:19,533,977...19,887,600
|
|
G |
SHROOM2 |
shroom family member 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of SHROOM2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:9,786,429...9,949,443
Ensembl chr X:9,786,429...9,949,443
|
|
G |
SIK1 |
salt inducible kinase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SIK1 mRNA |
CTD |
PMID:34601065 |
|
NCBI chr21:43,414,483...43,427,131
Ensembl chr21:43,414,483...43,427,131
|
|
G |
SIRT6 |
sirtuin 6 |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of SIRT6 mRNA xanthone inhibits the reaction [Isoproterenol results in decreased expression of SIRT6 mRNA] |
CTD |
PMID:36414029 |
|
NCBI chr19:4,174,109...4,182,563
Ensembl chr19:4,174,109...4,182,566
|
|
G |
SIVA1 |
SIVA1 apoptosis inducing factor |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SIVA1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:104,753,147...104,759,654
Ensembl chr14:104,753,147...104,768,494
|
|
G |
SIX4 |
SIX homeobox 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of SIX4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:60,709,539...60,724,351
Ensembl chr14:60,709,539...60,724,351
|
|
G |
SLC10A6 |
solute carrier family 10 member 6 |
increases expression |
ISO |
Isoproterenol results in increased expression of SLC10A6 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:86,823,468...86,849,384
Ensembl chr 4:86,823,468...86,849,384
|
|
G |
SLC25A10 |
solute carrier family 25 member 10 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SLC25A10 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:81,712,284...81,721,012
Ensembl chr17:81,712,236...81,721,016
|
|
G |
SLC25A20 |
solute carrier family 25 member 20 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of SLC25A20 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 3:48,856,926...48,898,882
Ensembl chr 3:48,856,926...48,898,904
|
|
G |
SLC25A30 |
solute carrier family 25 member 30 |
increases expression |
ISO |
Isoproterenol results in increased expression of SLC25A30 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:45,393,316...45,434,016
Ensembl chr13:45,393,316...45,418,455
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SLC2A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|
G |
SLC2A4 |
solute carrier family 2 member 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SLC2A4 protein |
CTD |
PMID:19826179 |
|
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
|
|
G |
SLC36A2 |
solute carrier family 36 member 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SLC36A2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:151,314,972...151,347,559
Ensembl chr 5:151,314,972...151,347,590
|
|
G |
SLC40A1 |
solute carrier family 40 member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SLC40A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:189,560,590...189,580,786
Ensembl chr 2:189,560,590...189,583,758
|
|
G |
SLC43A3 |
solute carrier family 43 member 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of SLC43A3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:57,406,954...57,427,580
Ensembl chr11:57,406,954...57,427,580
|
|
G |
SLC45A3 |
solute carrier family 45 member 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of SLC45A3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:205,657,851...205,680,509
Ensembl chr 1:205,657,851...205,680,509
|
|
G |
SLC6A1 |
solute carrier family 6 member 1 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of SLC6A1 protein (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Isoproterenol results in increased expression of SLC6A1 protein] |
CTD |
PMID:30170018 |
|
NCBI chr 3:10,992,748...11,039,247
Ensembl chr 3:10,992,186...11,039,247
|
|
G |
SLC7A11 |
solute carrier family 7 member 11 |
increases expression |
EXP |
Isoproterenol results in increased expression of SLC7A11 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
|
|
G |
SLC8A1 |
solute carrier family 8 member A1 |
multiple interactions increases expression |
ISO |
EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 mRNA]; EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 protein]; Propranolol inhibits the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 protein] Isoproterenol results in increased expression of SLC8A1 mRNA |
CTD |
PMID:11179087 PMID:15621046 |
|
NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053
|
|
G |
SLCO3A1 |
solute carrier organic anion transporter family member 3A1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SLCO3A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:91,853,708...92,172,435
Ensembl chr15:91,853,708...92,172,435
|
|
G |
SLPI |
secretory leukocyte peptidase inhibitor |
increases expression |
EXP |
Isoproterenol results in increased expression of SLPI mRNA |
CTD |
PMID:32816093 |
|
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
|
|
G |
SMAD1 |
SMAD family member 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SMAD1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176
|
|
G |
SMAD2 |
SMAD family member 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of SMAD2 mRNA |
CTD |
PMID:35014750 |
|
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
|
|
G |
SMAD3 |
SMAD family member 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of SMAD3 mRNA |
CTD |
PMID:35014750 |
|
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
|
|
G |
SMAP1 |
small ArfGAP 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SMAP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:70,667,883...70,862,015
Ensembl chr 6:70,667,776...70,862,011
|
|
G |
SMARCA1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SMARCA1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:129,446,506...129,523,490
Ensembl chr X:129,446,501...129,523,500
|
|
G |
SMC5 |
structural maintenance of chromosomes 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of SMC5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:70,258,978...70,354,873
Ensembl chr 9:70,258,978...70,354,873
|
|
G |
SMOC2 |
SPARC related modular calcium binding 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SMOC2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:168,441,184...168,667,992
Ensembl chr 6:168,441,151...168,673,445
|
|
G |
SMTN |
smoothelin |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SMTN mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:31,064,118...31,104,624
Ensembl chr22:31,064,105...31,104,757
|
|
G |
SMURF2 |
SMAD specific E3 ubiquitin protein ligase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of SMURF2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:64,542,282...64,662,307
Ensembl chr17:64,542,282...64,662,307
|
|
G |
SMYD1 |
SET and MYND domain containing 1 |
multiple interactions decreases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in decreased expression of SMYD1 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 2:88,067,825...88,113,384
Ensembl chr 2:88,067,825...88,113,384
|
|
G |
SNAPIN |
SNAP associated protein |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SNAPIN mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:153,658,654...153,661,852
Ensembl chr 1:153,658,703...153,661,852
|
|
G |
SNRPB |
small nuclear ribonucleoprotein polypeptides B and B1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SNRPB mRNA |
CTD |
PMID:21335049 |
|
NCBI chr20:2,461,642...2,470,789
Ensembl chr20:2,461,634...2,470,853
|
|
G |
SNRPF |
small nuclear ribonucleoprotein polypeptide F |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SNRPF mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:95,858,952...95,866,140
Ensembl chr12:95,858,952...95,903,828
|
|
G |
SOCS3 |
suppressor of cytokine signaling 3 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of SOCS3 mRNA] |
CTD |
PMID:18089841 PMID:20003209 PMID:21335049 PMID:21823215 |
|
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
|
|
G |
SOD1 |
superoxide dismutase 1 |
increases expression decreases activity multiple interactions affects binding |
ISO EXP |
Isoproterenol results in increased expression of SOD1 protein Isoproterenol results in decreased activity of SOD1 protein benidipine inhibits the reaction [Isoproterenol results in decreased activity of SOD1 protein]; Carvedilol inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased activity of SOD1 protein]; imetit inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased activity of SOD1 protein]; Isoproterenol results in decreased expression of and results in decreased activity of SOD1 protein Isoproterenol binds to SOD1 protein; Isoproterenol binds to SOD1 protein mutant form |
CTD |
PMID:16702995 PMID:23612299 PMID:25269373 PMID:25496245 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
[ADCY5 protein results in increased susceptibility to Isoproterenol] which results in decreased expression of SOD2 protein; SOD2 protein inhibits the reaction [ADCY5 protein results in increased susceptibility to Isoproterenol] [Isoproterenol co-treated with POSTN protein] results in decreased expression of SOD2 mRNA |
CTD |
PMID:23536361 PMID:30303030 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SORBS1 |
sorbin and SH3 domain containing 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SORBS1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:95,311,773...95,561,371
Ensembl chr10:95,311,771...95,561,414
|
|
G |
SORBS3 |
sorbin and SH3 domain containing 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of SORBS3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:22,544,973...22,575,788
Ensembl chr 8:22,544,986...22,575,788
|
|
G |
SORCS2 |
sortilin related VPS10 domain containing receptor 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SORCS2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:7,192,538...7,742,827
Ensembl chr 4:7,192,538...7,742,827
|
|
G |
SORD |
sorbitol dehydrogenase |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SORD mRNA |
CTD |
PMID:21335049 |
|
NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185
|
|
G |
SOX17 |
SRY-box transcription factor 17 |
increases expression |
ISO |
Isoproterenol results in increased expression of SOX17 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:54,457,935...54,460,892
Ensembl chr 8:54,457,935...54,460,892
|
|
G |
SOX6 |
SRY-box transcription factor 6 |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of SOX6 mRNA; Isoproterenol results in decreased expression of SOX6 protein JUNB protein promotes the reaction [Isoproterenol results in decreased expression of SOX6 mRNA]; JUNB protein promotes the reaction [Isoproterenol results in decreased expression of SOX6 protein] |
CTD |
PMID:21177286 |
|
NCBI chr11:15,966,449...16,738,477
Ensembl chr11:15,966,449...16,739,591
|
|
G |
SOX9 |
SRY-box transcription factor 9 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of SOX9 protein bellidifolin inhibits the reaction [Isoproterenol results in increased expression of SOX9 protein] |
CTD |
PMID:35586685 |
|
NCBI chr17:72,121,020...72,126,416
Ensembl chr17:72,121,020...72,126,416
|
|
G |
SP1 |
Sp1 transcription factor |
multiple interactions |
ISO |
[Phenylephrine co-treated with Isoproterenol] results in increased expression of SP1 mRNA; EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of SP1 mRNA] |
CTD |
PMID:10710348 |
|
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
|
|
G |
SPAG9 |
sperm associated antigen 9 |
increases expression |
ISO |
Isoproterenol results in increased expression of SPAG9 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:50,962,174...51,120,868
Ensembl chr17:50,962,174...51,120,868
|
|
G |
SPHK1 |
sphingosine kinase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SPHK1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:76,383,204...76,387,855
Ensembl chr17:76,376,584...76,387,860
|
|
G |
SPHK2 |
sphingosine kinase 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SPHK2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:48,619,506...48,630,405
Ensembl chr19:48,619,291...48,630,717
|
|
G |
SPNS2 |
SPNS lysolipid transporter 2, sphingosine-1-phosphate |
increases expression |
ISO |
Isoproterenol results in increased expression of SPNS2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:4,498,881...4,539,035
Ensembl chr17:4,498,881...4,539,035
|
|
G |
SPOCK2 |
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of SPOCK2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:72,059,034...72,089,032
Ensembl chr10:72,059,034...72,089,032
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
increases expression decreases expression |
ISO |
Isoproterenol results in increased expression of SPP1 mRNA Isoproterenol results in decreased expression of SPP1 mRNA |
CTD |
PMID:20003209 PMID:20211217 PMID:21335049 PMID:23558518 PMID:24286936 |
|
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
SPSB1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SPSB1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:9,292,894...9,369,532
Ensembl chr 1:9,292,894...9,369,532
|
|
G |
SPTA1 |
spectrin alpha, erythrocytic 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SPTA1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:158,610,704...158,686,715
Ensembl chr 1:158,610,704...158,686,715
|
|
G |
SPTLC2 |
serine palmitoyltransferase long chain base subunit 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of SPTLC2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:77,505,997...77,616,637
Ensembl chr14:77,505,997...77,616,637
|
|
G |
SQLE |
squalene epoxidase |
increases expression |
ISO |
Isoproterenol results in increased expression of SQLE mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
|
|
G |
SQSTM1 |
sequestosome 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of SQSTM1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SRM |
spermidine synthase |
increases expression |
ISO |
Isoproterenol results in increased expression of SRM mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 1:11,054,589...11,060,018
Ensembl chr 1:11,054,584...11,060,020
|
|
G |
SRSF2 |
serine and arginine rich splicing factor 2 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SRSF2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:76,734,115...76,737,411
Ensembl chr17:76,734,115...76,737,333
|
|
G |
ST7L |
suppression of tumorigenicity 7 like |
increases expression |
ISO |
Isoproterenol results in increased expression of ST7L mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:112,517,803...112,619,684
Ensembl chr 1:112,523,514...112,620,825
|
|
G |
ST8SIA6 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
increases expression |
ISO |
Isoproterenol results in increased expression of ST8SIA6 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:17,315,421...17,454,595
Ensembl chr10:17,315,421...17,454,595
|
|
G |
STARD5 |
StAR related lipid transfer domain containing 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of STARD5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:81,309,053...81,324,141
Ensembl chr15:81,309,053...81,324,183
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of STAT1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
affects localization multiple interactions increases phosphorylation increases expression |
ISO EXP |
Isoproterenol affects the localization of STAT3 protein STAT3 protein affects the reaction [BMP10 protein results in decreased susceptibility to Isoproterenol] STAT3 protein affects the reaction [BMP10 protein inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]] Isoproterenol results in increased phosphorylation of STAT3 protein Isoproterenol results in increased expression of STAT3 mRNA Isoproterenol results in increased expression of STAT3; Isoproterenol results in increased expression of STAT3 protein [Isoproterenol co-treated with POSTN protein] results in decreased expression of STAT3 mRNA; Betaine promotes the reaction [Isoproterenol results in increased phosphorylation of STAT3 protein]; Cyclosporine inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased expression of STAT3 protein]; Isoproterenol results in increased phosphorylation of and results in increased expression of STAT3 protein; Verapamil inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased expression of STAT3 protein] |
CTD |
PMID:19299911 PMID:21335049 PMID:25080425 PMID:29355689 PMID:30303030 PMID:31712309 More...
|
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
STAT5A |
signal transducer and activator of transcription 5A |
decreases expression |
ISO |
Isoproterenol results in decreased expression of STAT5A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:42,287,439...42,311,943
Ensembl chr17:42,287,547...42,311,943
|
|
G |
STC1 |
stanniocalcin 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of STC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:23,841,929...23,854,806
Ensembl chr 8:23,841,929...23,854,806
|
|
G |
STON1 |
stonin 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of STON1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:48,530,154...48,598,513
Ensembl chr 2:48,529,383...48,598,513
|
|
G |
STT3A |
STT3 oligosaccharyltransferase complex catalytic subunit A |
increases expression |
ISO |
Isoproterenol results in increased expression of STT3A mRNA |
CTD |
PMID:21823215 |
|
NCBI chr11:125,591,769...125,623,091
Ensembl chr11:125,591,712...125,625,215
|
|
G |
STX3 |
syntaxin 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of STX3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:59,754,188...59,805,878
Ensembl chr11:59,713,456...59,805,882
|
|
G |
SULT1A2 |
sulfotransferase family 1A member 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of SULT1A1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:28,591,943...28,597,050
Ensembl chr16:28,591,943...28,597,050
|
|
G |
SULT1B1 |
sulfotransferase family 1B member 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of SULT1B1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 4:69,721,167...69,760,620
Ensembl chr 4:69,721,167...69,787,961
|
|
G |
SYK |
spleen associated tyrosine kinase |
increases expression |
ISO |
Isoproterenol results in increased expression of SYK mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:90,801,600...90,898,549
Ensembl chr 9:90,801,787...90,898,549
|
|
G |
SYN2 |
synapsin II |
increases expression |
ISO |
Isoproterenol results in increased expression of SYN2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:12,004,388...12,192,032
Ensembl chr 3:12,004,388...12,192,032
|
|
G |
SYT12 |
synaptotagmin 12 |
increases expression |
ISO |
Isoproterenol results in increased expression of SYT12 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:67,006,771...67,050,863
Ensembl chr11:67,006,778...67,050,863
|
|
G |
TAC1 |
tachykinin precursor 1 |
affects response to substance |
ISO |
TAC1 protein affects the susceptibility to Isoproterenol |
CTD |
PMID:11270094 |
|
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
|
|
G |
TACC2 |
transforming acidic coiled-coil containing protein 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of TACC2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr10:121,989,163...122,254,542
Ensembl chr10:121,989,163...122,254,545
|
|
G |
TAX1BP1 |
Tax1 binding protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of TAX1BP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:27,739,373...27,829,767
Ensembl chr 7:27,739,331...27,844,564
|
|
G |
TBC1D15 |
TBC1 domain family member 15 |
increases expression |
ISO |
Isoproterenol results in increased expression of TBC1D15 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:71,839,759...71,924,313
Ensembl chr12:71,839,707...71,927,248
|
|
G |
TBK1 |
TANK binding kinase 1 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of TBK1 mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of TBK1 mRNA |
CTD |
PMID:20003209 PMID:30303030 |
|
NCBI chr12:64,452,120...64,502,114
Ensembl chr12:64,452,090...64,502,114
|
|
G |
TBL1XR1 |
TBL1X/Y related 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of TBL1XR1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:177,019,344...177,201,800
Ensembl chr 3:177,019,340...177,228,000
|
|
G |
TCF23 |
transcription factor 23 |
increases expression |
ISO |
Isoproterenol results in increased expression of TCF23 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:27,149,004...27,156,974
Ensembl chr 2:27,149,004...27,156,974
|
|
G |
TCF3 |
transcription factor 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TCF3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:1,609,292...1,652,615
Ensembl chr19:1,609,291...1,652,615
|
|
G |
TCN2 |
transcobalamin 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of TCN2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:30,607,174...30,627,271
Ensembl chr22:30,607,003...30,627,271
|
|
G |
TDG |
thymine DNA glycosylase |
increases expression |
ISO |
Isoproterenol results in increased expression of TDG mRNA |
CTD |
PMID:21335049 |
|
NCBI chr12:103,965,872...103,988,874
Ensembl chr12:103,965,822...103,988,874
|
|
G |
TECRL |
trans-2,3-enoyl-CoA reductase like |
increases expression |
ISO |
Isoproterenol results in increased expression of TECRL mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:64,276,298...64,409,460
Ensembl chr 4:64,275,257...64,409,468
|
|
G |
TFDP2 |
transcription factor Dp-2 |
increases expression |
ISO |
Isoproterenol results in increased expression of TFDP2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:141,944,428...142,149,544
Ensembl chr 3:141,944,428...142,149,544
|
|
G |
TFRC |
transferrin receptor |
decreases expression |
EXP ISO |
Isoproterenol results in decreased expression of TFRC protein Isoproterenol results in decreased expression of TFRC mRNA |
CTD |
PMID:2989362 PMID:20003209 |
|
NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
decreases expression increases expression multiple interactions |
EXP ISO |
Isoproterenol results in decreased expression of TGFB1 mRNA isoprenaline increases expression of Tgfb1 protein in blood serum Isoproterenol results in increased expression of TGFB1 mRNA; Isoproterenol results in increased expression of TGFB1 protein celastrol methyl ester inhibits the reaction [Isoproterenol results in increased expression of TGFB1 mRNA]; osthol inhibits the reaction [Isoproterenol results in increased expression of TGFB1 mRNA]; osthol inhibits the reaction [Isoproterenol results in increased expression of TGFB1 protein] BAY 58-2667 inhibits the reaction [Isoproterenol results in increased expression of TGFB1 mRNA]; Glyburide promotes the reaction [Isoproterenol results in increased expression of TGFB1 protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of TGFB1 protein]; pyrvinium inhibits the reaction [Glyburide promotes the reaction [Isoproterenol results in increased expression of TGFB1 protein]]; pyrvinium inhibits the reaction [Isoproterenol results in increased expression of TGFB1 protein]; Quercetin inhibits the reaction [Isoproterenol results in increased expression of TGFB1 mRNA]; Quercetin inhibits the reaction [Isoproterenol results in increased expression of TGFB1 protein]; Rutin inhibits the reaction [Isoproterenol results in increased expression of TGFB1 mRNA]; Rutin inhibits the reaction [Isoproterenol results in increased expression of TGFB1 protein] |
CTD RGD |
PMID:11821714 PMID:19667237 PMID:21854795 PMID:24117263 PMID:35014750 PMID:35305975 PMID:36593721 PMID:37269933 PMID:27318893 More...
|
RGD:156430318 |
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TGFB2 |
transforming growth factor beta 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of TGFB2 mRNA |
CTD |
PMID:20211217 PMID:23558518 |
|
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
|
|
G |
TGFBR2 |
transforming growth factor beta receptor 2 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of TGFBR2 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,601...30,694,142
|
|
G |
TGM2 |
transglutaminase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of TGM2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:38,127,385...38,168,475
Ensembl chr20:38,127,385...38,166,578
|
|
G |
THBS2 |
thrombospondin 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of THBS2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:169,215,785...169,253,846
Ensembl chr 6:169,215,780...169,254,050
|
|
G |
THOC3 |
THO complex subunit 3 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of THOC3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:175,959,531...175,968,315
Ensembl chr 5:175,917,873...176,034,680
|
|
G |
THRA |
thyroid hormone receptor alpha |
multiple interactions increases expression |
ISO |
[Isoproterenol co-treated with Amiodarone] results in increased expression of THRA mRNA alternative form Isoproterenol results in increased expression of THRA mRNA alternative form |
CTD |
PMID:7598731 |
|
NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
|
|
G |
THRB |
thyroid hormone receptor beta |
multiple interactions increases expression |
ISO |
[Isoproterenol co-treated with Amiodarone] results in increased expression of THRB mRNA alternative form; Amiodarone inhibits the reaction [Isoproterenol results in increased expression of THRB mRNA alternative form] |
CTD |
PMID:7598731 |
|
NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
|
|
G |
THY1 |
Thy-1 cell surface antigen |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of THY1 Propranolol inhibits the reaction [Isoproterenol results in decreased expression of THY1] |
CTD |
PMID:7558147 |
|
NCBI chr11:119,415,476...119,424,985
Ensembl chr11:119,415,476...119,424,985
|
|
G |
TIAM1 |
TIAM Rac1 associated GEF 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of TIAM1 mRNA |
CTD |
PMID:20211217 |
|
NCBI chr21:31,118,418...31,559,087
Ensembl chr21:31,118,416...31,559,977
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
increases expression decreases expression |
ISO EXP |
Isoproterenol results in increased expression of TIMP1 mRNA Isoproterenol results in increased expression of TIMP1 mRNA; Isoproterenol results in increased expression of TIMP1 protein Isoproterenol results in decreased expression of TIMP1 mRNA |
CTD |
PMID:20003209 PMID:20211217 PMID:23558518 PMID:24286936 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
increases expression decreases expression multiple interactions |
EXP ISO |
Isoproterenol results in increased expression of TIMP3 protein Isoproterenol results in decreased expression of TIMP3 protein natakalim inhibits the reaction [Isoproterenol results in decreased expression of TIMP3 protein] |
CTD |
PMID:24286936 PMID:27890915 |
|
NCBI chr22:32,801,705...32,863,041
Ensembl chr22:32,801,705...32,863,041
|
|
G |
TIMP4 |
TIMP metallopeptidase inhibitor 4 |
increases expression decreases expression |
ISO EXP |
Isoproterenol results in increased expression of TIMP4 mRNA Isoproterenol results in decreased expression of TIMP4 protein |
CTD |
PMID:20003209 PMID:24286936 |
|
NCBI chr 3:12,153,068...12,158,912
Ensembl chr 3:12,153,068...12,158,912
|
|
G |
TINAGL1 |
tubulointerstitial nephritis antigen like 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of TINAGL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:31,576,515...31,587,686
Ensembl chr 1:31,576,485...31,587,686
|
|
G |
TK1 |
thymidine kinase 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TK1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr17:78,174,079...78,187,204
Ensembl chr17:78,174,091...78,187,233
|
|
G |
TLE1 |
TLE family member 1, transcriptional corepressor |
increases expression |
ISO |
Isoproterenol results in increased expression of TLE1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:81,583,683...81,689,547
Ensembl chr 9:81,583,683...81,689,547
|
|
G |
TLR4 |
toll like receptor 4 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of TLR4 mRNA anethole inhibits the reaction [Isoproterenol results in increased expression of TLR4 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of TLR4 protein]; Metformin inhibits the reaction [Isoproterenol results in increased expression of TLR4 mRNA] Isoproterenol results in increased expression of TLR4 mRNA; Isoproterenol results in increased expression of TLR4 protein |
CTD |
PMID:20003209 PMID:24842192 PMID:35430261 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TMBIM1 |
transmembrane BAX inhibitor motif containing 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of TMBIM1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:218,274,197...218,292,503
Ensembl chr 2:218,274,197...218,292,586
|
|
G |
TMCC3 |
transmembrane and coiled-coil domain family 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of TMCC3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:94,567,122...94,650,557
Ensembl chr12:94,567,122...94,650,557
|
|
G |
TMEM140 |
transmembrane protein 140 |
increases expression |
ISO |
Isoproterenol results in increased expression of TMEM140 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:135,148,072...135,166,215
Ensembl chr 7:135,148,072...135,166,215
|
|
G |
TMEM141 |
transmembrane protein 141 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TMEM141 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:136,791,344...136,793,317
Ensembl chr 9:136,791,344...136,793,317
|
|
G |
TMEM144 |
transmembrane protein 144 |
increases expression |
ISO |
Isoproterenol results in increased expression of TMEM144 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:158,210,486...158,255,416
Ensembl chr 4:158,201,604...158,255,416
|
|
G |
TMEM164 |
transmembrane protein 164 |
increases expression |
ISO |
Isoproterenol results in increased expression of TMEM164 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:110,002,369...110,184,251
Ensembl chr X:110,002,631...110,182,734
|
|
G |
TMEM176A |
transmembrane protein 176A |
increases expression |
ISO |
Isoproterenol results in increased expression of TMEM176A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:150,800,769...150,805,118
Ensembl chr 7:150,800,403...150,805,118
|
|
G |
TMEM38B |
transmembrane protein 38B |
increases expression |
ISO |
Isoproterenol results in increased expression of TMEM38B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:105,694,541...105,776,629
Ensembl chr 9:105,694,541...105,776,629
|
|
G |
TMOD4 |
tropomodulin 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TMOD4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:151,169,987...151,175,981
Ensembl chr 1:151,169,986...151,176,284
|
|
G |
TMSB4X |
thymosin beta 4 X-linked |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TMSB4X mRNA |
CTD |
PMID:21335049 |
|
NCBI chr X:12,975,110...12,977,223
Ensembl chr X:12,975,110...12,977,227
|
|
G |
TMTC1 |
transmembrane O-mannosyltransferase targeting cadherins 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of TMTC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:29,500,813...29,784,759
Ensembl chr12:29,500,840...29,784,759
|
|
G |
TMX1 |
thioredoxin related transmembrane protein 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TMX1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:51,240,247...51,257,655
Ensembl chr14:51,240,162...51,257,655
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases secretion increases expression decreases expression |
EXP ISO |
Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Isoproterenol inhibits the reaction [TNF protein results in increased secretion of SELE mRNA] Isoproterenol results in increased secretion of TNF protein Isoproterenol results in increased expression of TNF mRNA; Isoproterenol results in increased expression of TNF protein Isoproterenol results in decreased expression of TNF mRNA Isoproterenol results in increased expression of TNF; Isoproterenol results in increased expression of TNF mRNA 5-Methoxypsoralen inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; [Isoproterenol co-treated with POSTN protein] results in increased expression of TNF mRNA; anethole inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Apigenin inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA]; Enalapril inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; erdosteine inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; ferruginol inhibits the reaction [Isoproterenol results in increased secretion of TNF protein]; geraniol inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Glyburide promotes the reaction [Isoproterenol results in increased expression of TNF protein]; Hesperidin inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; ICI 118551 inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; ICI 118551 inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; Isoproterenol inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Isoproterenol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of TNF protein]; Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Isoproterenol results in increased expression of and results in increased secretion of TNF protein; mangiferin inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; mangostin inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Metformin inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of TNF protein]; Metformin inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; punicalagin inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; pyrvinium inhibits the reaction [Glyburide promotes the reaction [Isoproterenol results in increased expression of TNF protein]]; pyrvinium inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Quercetin inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Sirolimus inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA]; Sirolimus inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADL mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADM mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT1B mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT2 mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARA mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARA protein]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARGC1A mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of PPARGC1A protein]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL1B mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL2 mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of IL2 protein]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of MYH7 mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of NPPB mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased expression of TNF protein]]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in increased phosphorylation of MTOR protein]]; Tretinoin inhibits the reaction [Isoproterenol results in increased expression of TNF protein] bellidifolin inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA]; Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; SB 206553 inhibits the reaction [Isoproterenol results in increased expression of TNF]; ZD 7155 inhibits the reaction [Isoproterenol results in increased expression of TNF protein] |
CTD |
PMID:8096834 PMID:8780174 PMID:9038718 PMID:9688336 PMID:10525314 PMID:11752888 PMID:15081246 PMID:15302781 PMID:15710352 PMID:18424012 PMID:19023134 PMID:19172585 PMID:19904010 PMID:21762681 PMID:24286936 PMID:24842192 PMID:25045214 PMID:26277537 PMID:27527349 PMID:30152906 PMID:30303030 PMID:30623541 PMID:32007421 PMID:32946155 PMID:33210414 PMID:35014750 PMID:35130744 PMID:35305975 PMID:35430261 PMID:35608392 PMID:35815753 PMID:36593721 PMID:37528096 PMID:37806379 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFAIP6 |
TNF alpha induced protein 6 |
decreases expression |
EXP |
Isoproterenol results in decreased expression of TNFAIP6 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
|
|
G |
TNFRSF12A |
TNF receptor superfamily member 12A |
increases expression |
ISO |
Isoproterenol results in increased expression of TNFRSF12A mRNA |
CTD |
PMID:21335049 |
|
NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
decreases expression increases expression |
EXP ISO |
Isoproterenol results in decreased expression of TNFRSF1A mRNA Isoproterenol results in increased expression of TNFRSF1A mRNA |
CTD |
PMID:24286936 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
increases expression |
ISO |
Isoproterenol results in increased expression of TNFSF10 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
|
|
G |
TNIK |
TRAF2 and NCK interacting kinase |
increases expression |
ISO |
Isoproterenol results in increased expression of TNIK mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:171,058,414...171,460,408
Ensembl chr 3:171,058,414...171,460,408
|
|
G |
TNKS |
tankyrase |
increases expression |
ISO |
Isoproterenol results in increased expression of TNKS mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 8:9,555,912...9,782,346
Ensembl chr 8:9,555,912...9,782,346
|
|
G |
TNNI3 |
troponin I3, cardiac type |
increases expression increases secretion multiple interactions |
ISO |
Isoproterenol results in increased expression of TNNI3 protein Isoproterenol results in increased secretion of TNNI3 protein 5-Methoxypsoralen inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein]; ferruginol inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein]; Glyburide promotes the reaction [Isoproterenol results in increased expression of TNNI3 protein]; pyrvinium inhibits the reaction [Glyburide promotes the reaction [Isoproterenol results in increased expression of TNNI3 protein]]; pyrvinium inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein]; Quercetin inhibits the reaction [Isoproterenol results in increased secretion of TNNI3 protein]; Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein]; thymoquinone inhibits the reaction [Isoproterenol results in increased secretion of TNNI3 protein]; Tretinoin inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein]; xanthone inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein] |
CTD |
PMID:17654401 PMID:19549929 PMID:19854236 PMID:22878004 PMID:24286936 PMID:27491814 PMID:27527349 PMID:32007421 PMID:32946155 PMID:35130744 PMID:35305975 PMID:35430261 PMID:35815753 PMID:35940283 PMID:36414029 PMID:37806379 More...
|
|
NCBI chr19:55,151,767...55,157,732
Ensembl chr19:55,151,767...55,157,773
|
|
G |
TNNT1 |
troponin T1, slow skeletal type |
multiple interactions |
ISO |
Isoproterenol results in increased expression of and results in increased secretion of TNNT1 protein; oleuropein inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of TNNT1 protein] |
CTD |
PMID:26056852 |
|
NCBI chr19:55,132,698...55,149,206
Ensembl chr19:55,132,698...55,149,206
|
|
G |
TNNT2 |
troponin T2, cardiac type |
affects expression decreases expression multiple interactions increases secretion increases expression |
ISO |
Isoproterenol affects the expression of TNNT2 protein Isoproterenol results in decreased expression of TNNT2 protein 5-Methoxypsoralen inhibits the reaction [Isoproterenol results in increased expression of TNNT2 protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of TNNT2 protein]; ferruginol inhibits the reaction [Isoproterenol results in increased expression of TNNT2 protein]; Gallic Acid inhibits the reaction [Isoproterenol results in increased secretion of TNNT2 protein]; Lutein inhibits the reaction [Isoproterenol results in decreased expression of TNNT2 protein]; naringin inhibits the reaction [Isoproterenol results in increased expression of TNNT2 protein]; Quercetin inhibits the reaction [Isoproterenol results in increased secretion of TNNT2 protein]; Vincristine inhibits the reaction [Isoproterenol results in increased secretion of TNNT2 protein] |
CTD |
PMID:17188415 PMID:17654401 PMID:17848144 PMID:19146839 PMID:19812120 PMID:19854236 PMID:21762681 PMID:22878004 PMID:24286936 PMID:25537132 PMID:32946155 PMID:34435724 PMID:35815753 More...
|
|
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
|
|
G |
TNPO1 |
transportin 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of TNPO1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:72,816,661...72,914,388
Ensembl chr 5:72,816,312...72,916,733
|
|
G |
TP53 |
tumor protein p53 |
increases expression multiple interactions decreases expression |
ISO EXP |
Isoproterenol results in increased expression of TP53 protein Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of and results in increased phosphorylation of TP53 protein]; Isoproterenol results in increased expression of and results in increased phosphorylation of TP53 protein; pifithrin inhibits the reaction [Isoproterenol results in increased expression of and results in increased phosphorylation of TP53 protein]; S100A9 protein affects the reaction [Isoproterenol results in increased expression of and results in increased phosphorylation of TP53 protein] Isoproterenol results in decreased expression of TP53 mRNA Isoproterenol results in increased expression of TP53 mRNA |
CTD |
PMID:19466570 PMID:24286936 PMID:32924446 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TP53INP1 |
tumor protein p53 inducible nuclear protein 1 |
multiple interactions increases expression |
ISO |
Doxycycline inhibits the reaction [Isoproterenol results in increased expression of TRP53INP1 mRNA] |
CTD |
PMID:18089841 PMID:20003209 |
|
NCBI chr 8:94,925,972...94,949,378
Ensembl chr 8:94,925,972...94,949,378
|
|
G |
TPM1 |
tropomyosin 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TPM1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,620...63,071,915
|
|
G |
TPO |
thyroid peroxidase |
decreases activity |
ISO |
Isoproterenol results in decreased activity of TPO protein |
CTD |
PMID:26884060 |
|
NCBI chr 2:1,374,047...1,543,673
Ensembl chr 2:1,374,066...1,543,711
|
|
G |
TRAK1 |
trafficking kinesin protein 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TRAK1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:42,013,093...42,225,890
Ensembl chr 3:42,013,802...42,225,890
|
|
G |
TRIM7 |
tripartite motif containing 7 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TRIM7 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:181,193,924...181,205,196
Ensembl chr 5:181,193,924...181,205,293
|
|
G |
TRMT5 |
tRNA methyltransferase 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of TRMT5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:60,971,441...60,981,690
Ensembl chr14:60,971,441...60,981,170
|
|
G |
TSC22D3 |
TSC22 domain family member 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of TSC22D3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr X:107,713,221...107,775,988
Ensembl chr X:107,713,221...107,777,342
|
|
G |
TSC22D4 |
TSC22 domain family member 4 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TSC22D4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:100,466,519...100,479,214
Ensembl chr 7:100,463,359...100,479,232
|
|
G |
TSFM |
Ts translation elongation factor, mitochondrial |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TSFM mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:57,782,787...57,802,856
Ensembl chr12:57,782,761...57,808,071
|
|
G |
TSPYL4 |
TSPY like 4 |
increases expression |
ISO |
Isoproterenol results in increased expression of TSPYL4 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:116,249,964...116,254,075
Ensembl chr 6:116,249,964...116,254,075
|
|
G |
TTLL7 |
tubulin tyrosine ligase like 7 |
increases expression |
ISO |
Isoproterenol results in increased expression of TTLL7 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:83,865,024...83,999,132
Ensembl chr 1:83,865,024...83,999,150
|
|
G |
TTR |
transthyretin |
increases expression |
ISO |
Isoproterenol results in increased expression of TTR mRNA |
CTD |
PMID:20003209 |
|
NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833
|
|
G |
TUBA1B |
tubulin alpha 1b |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TUBA1B mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:49,127,782...49,131,395
Ensembl chr12:49,127,782...49,131,397
|
|
G |
TUBA4A |
tubulin alpha 4a |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TUBA4A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:219,249,710...219,254,740
Ensembl chr 2:219,249,710...219,277,902
|
|
G |
TUBA8 |
tubulin alpha 8 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TUBA8 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr22:18,110,809...18,131,732
Ensembl chr22:18,110,100...18,146,683
|
|
G |
TUBB |
tubulin beta class I |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TUBB5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:30,720,352...30,725,422
Ensembl chr 6:30,717,435...30,725,538
|
|
G |
TUBB2A |
tubulin beta 2A class IIa |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TUBB2A mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544
|
|
G |
TUBB6 |
tubulin beta 6 class V |
increases expression |
ISO |
Isoproterenol results in increased expression of TUBB6 mRNA |
CTD |
PMID:20211217 |
|
NCBI chr18:12,307,669...12,329,826
Ensembl chr18:12,307,669...12,344,320
|
|
G |
TXN |
thioredoxin |
decreases expression multiple interactions |
ISO |
Isoproterenol results in decreased expression of TXN1 mRNA Lutein inhibits the reaction [Isoproterenol results in decreased expression of TXN protein] |
CTD |
PMID:21335049 PMID:34435724 |
|
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
|
|
G |
TXNDC5 |
thioredoxin domain containing 5 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of TXNDC5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:7,881,517...7,910,788
Ensembl chr 6:7,881,517...7,910,788
|
|
G |
TXNIP |
thioredoxin interacting protein |
multiple interactions increases expression |
ISO |
Lutein inhibits the reaction [Isoproterenol results in increased expression of TXNIP protein] |
CTD |
PMID:34435724 |
|
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
|
|
G |
TXNRD2 |
thioredoxin reductase 2 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of TXNRD2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
|
|
G |
TYW1 |
tRNA-yW synthesizing protein 1 homolog |
increases expression |
ISO |
Isoproterenol results in increased expression of TYW1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 7:66,996,833...67,239,514
Ensembl chr 7:66,995,173...67,239,514
|
|
G |
U2AF1 |
U2 small nuclear RNA auxiliary factor 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of U2AF1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr21:43,092,956...43,107,578
Ensembl chr21:43,092,956...43,107,570
|
|
G |
UAP1 |
UDP-N-acetylglucosamine pyrophosphorylase 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of UAP1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:162,561,531...162,601,240
Ensembl chr 1:162,561,722...162,601,240
|
|
G |
UBA1 |
ubiquitin like modifier activating enzyme 1 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of UBA1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr X:47,190,847...47,215,128
Ensembl chr X:47,190,861...47,215,128
|
|
G |
UBB |
ubiquitin B |
increases expression |
ISO |
Isoproterenol results in increased expression of UBB mRNA |
CTD |
PMID:21335049 |
|
NCBI chr17:16,380,779...16,382,745
Ensembl chr17:16,380,798...16,382,745
|
|
G |
UBC |
ubiquitin C |
decreases expression |
ISO |
Isoproterenol results in decreased expression of UBC mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:124,911,646...124,914,650
Ensembl chr12:124,911,604...124,917,368
|
|
G |
UBE2D1 |
ubiquitin conjugating enzyme E2 D1 |
increases expression |
ISO |
Isoproterenol results in increased expression of UBE2D1 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr10:58,335,006...58,370,748
Ensembl chr10:58,334,979...58,370,751
|
|
G |
UBR2 |
ubiquitin protein ligase E3 component n-recognin 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of UBR2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:42,564,029...42,693,505
Ensembl chr 6:42,564,029...42,693,505
|
|
G |
UCHL1 |
ubiquitin C-terminal hydrolase L1 |
increases expression |
ISO |
Isoproterenol results in increased expression of UCHL1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
|
|
G |
UCK2 |
uridine-cytidine kinase 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of UCK2 mRNA |
CTD |
PMID:20211217 |
|
NCBI chr 1:165,827,614...165,911,618
Ensembl chr 1:165,827,614...165,911,618
|
|
G |
UCP1 |
uncoupling protein 1 |
increases expression |
ISO |
Isoproterenol results in increased expression of UCP1 protein |
CTD |
PMID:17250927 |
|
NCBI chr 4:140,559,431...140,568,961
Ensembl chr 4:140,559,431...140,568,961
|
|
G |
UCP2 |
uncoupling protein 2 |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of UCP2 mRNA Edaravone inhibits the reaction [Isoproterenol results in increased expression of UCP2 mRNA]; Edaravone inhibits the reaction [Isoproterenol results in increased expression of UCP2 protein] Isoproterenol results in increased expression of UCP2 mRNA; Isoproterenol results in increased expression of UCP2 protein |
CTD |
PMID:16580698 PMID:20003209 |
|
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843
|
|
G |
UCP3 |
uncoupling protein 3 |
increases expression decreases expression |
EXP ISO |
Isoproterenol results in increased expression of UCP3 mRNA Isoproterenol results in decreased expression of UCP3 mRNA |
CTD |
PMID:24286936 |
|
NCBI chr11:74,000,277...74,009,085
Ensembl chr11:74,000,277...74,009,085
|
|
G |
UGDH |
UDP-glucose 6-dehydrogenase |
increases expression |
ISO |
Isoproterenol results in increased expression of UGDH mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 4:39,498,755...39,527,439
Ensembl chr 4:39,498,755...39,528,311
|
|
G |
UGT1A3 |
UDP glucuronosyltransferase family 1 member A3 |
increases expression |
ISO |
Isoproterenol results in increased expression of UGT1A2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
|
|
G |
UNG |
uracil DNA glycosylase |
increases expression |
ISO |
Isoproterenol results in increased expression of UNG mRNA |
CTD |
PMID:21335049 |
|
NCBI chr12:109,097,597...109,110,992
Ensembl chr12:109,097,597...109,126,725
|
|
G |
UQCC1 |
ubiquinol-cytochrome c reductase complex assembly factor 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of UQCC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr20:35,302,578...35,411,973
Ensembl chr20:35,302,566...35,412,031
|
|
G |
USP2 |
ubiquitin specific peptidase 2 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of USP2 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr11:119,355,215...119,381,690
Ensembl chr11:119,355,215...119,381,711
|
|
G |
UVRAG |
UV radiation resistance associated |
increases expression |
ISO |
Isoproterenol results in increased expression of UVRAG mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:75,815,210...76,144,232
Ensembl chr11:75,815,210...76,144,232
|
|
G |
VASP |
vasodilator stimulated phosphoprotein |
multiple interactions decreases expression |
ISO |
natakalim inhibits the reaction [Isoproterenol results in decreased expression of VASP protein] |
CTD |
PMID:27890915 |
|
NCBI chr19:45,507,479...45,526,983
Ensembl chr19:45,506,579...45,526,989
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of VCAM1 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VCAN |
versican |
increases expression |
ISO |
Isoproterenol results in increased expression of VCAN mRNA |
CTD |
PMID:20211217 |
|
NCBI chr 5:83,471,744...83,582,302
Ensembl chr 5:83,471,618...83,582,303
|
|
G |
VEGFA |
vascular endothelial growth factor A |
increases expression decreases expression |
ISO EXP |
Isoproterenol results in increased expression of VEGFA mRNA Isoproterenol results in decreased expression of VEGF protein; Isoproterenol results in decreased expression of VEGFA mRNA |
CTD |
PMID:10788502 PMID:21335049 PMID:24286936 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VGLL3 |
vestigial like family member 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of VGLL3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:86,937,973...86,991,149
Ensembl chr 3:86,876,388...86,991,149
|
|
G |
VIM |
vimentin |
decreases expression |
ISO |
Isoproterenol results in decreased expression of VIM mRNA |
CTD |
PMID:21335049 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
G |
VWF |
von Willebrand factor |
increases expression |
ISO |
Isoproterenol results in increased expression of VWF mRNA |
CTD |
PMID:20003209 |
|
NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770
|
|
G |
WDR3 |
WD repeat domain 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of WDR3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 1:117,929,739...117,966,543
Ensembl chr 1:117,929,720...117,966,543
|
|
G |
WFDC1 |
WAP four-disulfide core domain 1 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of WFDC1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:84,294,878...84,329,844
Ensembl chr16:84,294,846...84,329,844
|
|
G |
XDH |
xanthine dehydrogenase |
increases expression multiple interactions |
ISO |
Isoproterenol results in increased expression of XDH mRNA [Isoproterenol co-treated with POSTN protein] results in decreased expression of XDH mRNA |
CTD |
PMID:20003209 PMID:30303030 |
|
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
|
|
G |
XPA |
XPA, DNA damage recognition and repair factor |
increases expression |
ISO |
Isoproterenol results in increased expression of XPA mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 9:97,654,398...97,697,340
Ensembl chr 9:97,674,909...97,697,340
|
|
G |
YPEL2 |
yippee like 2 |
increases expression |
ISO |
Isoproterenol results in increased expression of YPEL2 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr17:59,331,655...59,401,729
Ensembl chr17:59,331,655...59,401,729
|
|
G |
YPEL3 |
yippee like 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of YPEL3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr16:30,092,314...30,096,213
Ensembl chr16:30,092,314...30,096,915
|
|
G |
YWHAG |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of YWHAG mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 7:76,326,799...76,358,991
Ensembl chr 7:76,326,799...76,358,991
|
|
G |
YY1 |
YY1 transcription factor |
increases expression |
ISO |
Isoproterenol results in increased expression of YY1 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr14:100,239,144...100,282,788
Ensembl chr14:100,238,298...100,282,788
|
|
G |
ZBTB11 |
zinc finger and BTB domain containing 11 |
increases expression |
ISO |
Isoproterenol results in increased expression of ZBTB11 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 3:101,648,889...101,677,132
Ensembl chr 3:101,648,889...101,677,135
|
|
G |
ZBTB16 |
zinc finger and BTB domain containing 16 |
increases expression |
ISO |
Isoproterenol results in increased expression of ZBTB16 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:114,059,711...114,256,770
Ensembl chr11:114,059,041...114,256,765
|
|
G |
ZBTB44 |
zinc finger and BTB domain containing 44 |
increases expression |
ISO |
Isoproterenol results in increased expression of ZBTB44 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr11:130,226,677...130,314,917
Ensembl chr11:130,226,677...130,314,917
|
|
G |
ZFAND5 |
zinc finger AN1-type containing 5 |
multiple interactions |
ISO |
[Isoproterenol co-treated with POSTN protein] results in decreased expression of ZFAND5 mRNA |
CTD |
PMID:30303030 |
|
NCBI chr 9:72,351,413...72,365,208
Ensembl chr 9:72,351,413...72,365,235
|
|
G |
ZMYM5 |
zinc finger MYM-type containing 5 |
increases expression |
ISO |
Isoproterenol results in increased expression of ZMYM5 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr13:19,823,482...19,863,649
Ensembl chr13:19,823,482...19,863,649
|
|
G |
ZNF207 |
zinc finger protein 207 |
increases expression |
ISO |
Isoproterenol results in increased expression of ZFP207 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr17:32,350,157...32,381,885
Ensembl chr17:32,350,132...32,381,885
|
|
G |
ZNF236 |
zinc finger protein 236 |
increases expression |
ISO |
Isoproterenol results in increased expression of ZFP236 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr18:76,822,557...76,972,901
Ensembl chr18:76,822,557...76,972,901
|
|
G |
ZNF346 |
zinc finger protein 346 |
increases expression |
ISO |
Isoproterenol results in increased expression of ZFP346 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 5:177,022,696...177,081,189
Ensembl chr 5:177,022,696...177,081,189
|
|
G |
ZNF428 |
zinc finger protein 428 |
decreases expression |
ISO |
Isoproterenol results in decreased expression of ZFP428 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr19:43,607,224...43,619,629
Ensembl chr19:43,607,224...43,619,629
|
|
G |
ZNF451 |
zinc finger protein 451 |
increases expression |
ISO |
Isoproterenol results in increased expression of ZFP451 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 6:57,090,188...57,170,305
Ensembl chr 6:57,086,844...57,170,305
|
|
G |
ZRANB3 |
zinc finger RANBP2-type containing 3 |
increases expression |
ISO |
Isoproterenol results in increased expression of ZRANB3 mRNA |
CTD |
PMID:20003209 |
|
NCBI chr 2:135,196,969...135,531,218
Ensembl chr 2:135,136,916...135,531,218
|
|
G |
ZW10 |
zw10 kinetochore protein |
increases expression |
ISO |
Isoproterenol results in increased expression of ZW10 mRNA |
CTD |
PMID:21335049 |
|
NCBI chr11:113,733,187...113,773,692
Ensembl chr11:113,733,187...113,773,735
|
|